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ABSTRACT 
 
Brushite cements have potential as drug carriers and bone filling materials. They can 
also act as a reservoir for calcium and phosphate ions in remineralisation of hard 
tissues.  
Aim and objectives: To optimize brushite cement properties and assess the effect of 
incorporation of a novel antimicrobial ε-polylysine (PLS) into brushite.  
Materials and Methods: Powders were mixed with aqueous solutions at a powder to 
liquid ratio of 3.3:1 or 4:1 to produce cement pastes and start the setting reaction. The 
powder consisted of 1g of monocalcium phosphate monohydrate (MCPM) and 1.23 g 
of β -tricalcium phosphate (β-TCP). Two different types of MCPM and different β-TCP 
particle size range from 4 micron to 34 micron were used. The liquid phase was 
prepared by dissolving PLS powder in aqueous citric acid 800 mM in incrementally 
percentages. In control formulations, only citric acid 800 without the PLS was 
employed. Biaxial flexural strength and modulus were determined using a ball on ring 
jig. Setting kinetics and chemistry were examined using Fourier transforms infrared 
spectroscopy (FTIR). Microstructure of brushite cements were examined with scanning 
electron microscopy (SEM).   
Results: The largest particle size of β-TCP (34 micron) produced the highest flexural 
strength of 30 MPa. The handling of brushite cements was better with MCPM 2 
(Sigma). This was observed to have much larger flat crystals rather than the more 
powdered MCPM 1 from Himed. Powder to liquid ratio 4:1 overall increased the 
strength 5 MPa – 7 MPa compared to powder to liquid ratio 3.3:1. High levels of PLS 
could be added with only a minor reduction in the strength. Setting time however was 
delayed and an alternative anhydrous dicalcium phosphate complex formed rather than 
all brushite which is hydrated dicalcium phosphate. 
Conclusion: The findings of this research demonstrated that very high levels of PLS 
could be introduced into brushite cements without serious detrimental effects on 
mechanical properties. PLS however, did delay the setting time and altered the final 
chemistry and microstructure of the dicalcium phosphate product. 
.  
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1 INTRODUCTION 
1.1 Statement of the problem  
In children, premature tooth loss as a result of traumatic dental injuries or caries 
can be a challenge to clinicians. Early extraction of teeth will result in alveolar bone 
loss which subsequently complicates the treatment outcome. Alveolar bone resorption 
as a sequel to premature tooth loss can be very rapid and result in loss of bone height 
and volume. Post extraction alveolar bone remodelling often results in aesthetic 
compromise in the area of tooth extraction site. It is also leads to inadequate bone for 
ideal implant positioning or placement.  
 
Currently, dental implants are considered the best solution for management of 
tooth loss but in children they have to be delayed until the child has reached full 
maturity. This will potentially lead to a long time period between the loss of the tooth 
and the placement of implant. If no measure is taken to preserve or generate the 
alveolar bone after tooth loss, future implants will be a problem since bone volume will 
be insufficient (Day et al., 2008).  
 
Brushite cements have great potential as a bone substitute. Brushite cements 
have an ability to act as a reservoir of calcium and phosphate ions for remineralisation 
of hard tissue. Due to the excellent bioresorbability of brushite cement, newly forming 
immature / woven bone might substitute the cements after implantation (Dorozhkin, 
2008). In clinical applications, the brushite cements can be used in the form of blocks 
or as a self–setting paste.  
 
In children, immediate bone filling of extraction sockets with brushite cements is 
a potential therapy to minimise bone loss if the properties of these cements can be 
improved for alveolar bone regenerative therapy. The following study therefore focuses 
on optimizing brushite cements to achieve this aim. Injectable brushite cements would 
ideally be placed in the socket immediately after tooth extraction with the aim to 
maintain the alveolar bone height, width and contour in children.  
 
However there are several issues which must be addressed in order to optimize 
the possible benefits of brushite cements in preserving alveolar bone. These issues 
include: 
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i) Injectability 
 
ii) Low mechanical strength: 
Compressive cement strengths must be at least as high as trabecular 
bone, which is close to 10 MPa. Since brushite cements originated from 
ceramic, they are also brittle, have both a low impact resistance and 
particularly low flexural strength.  
 
iii) Cement microstructure and porosity 
Brushite cements can be highly porous materials. Adequate porosity is 
often sought to enhance the material’s resorbability and makes these 
materials a good carrier for controlled drug delivery systems. 
Unfortunately, the mechanical properties of brushite cements are found 
to decrease exponentially with the porosity increase (Dorozhkin, 2008). 
Porosity can therefore limit the use of this material to only low load-
bearing applications.  
 
iv) Incorporation of antibacterial agent: 
Various factors influence any drug delivery device. These include the 
microstructure (porosity, permeability and surface area), the drug 
solubility, the potential degradation of the materials and the interaction 
between drug and the material matrix. Drug release from brushite 
cements often tends to have fast initial release due to porosity.  
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2 BACKGROUND 
2.1 Tooth loss in children 
Tooth loss can occur for a variety of reasons including trauma and caries. 
Extraction of a tooth is followed by three-dimensional bone resorption that delays 
dental restoration procedures. The resorption is lifelong, irreversible, chronic and 
cumulative (Bodic et al., 2005). Alveolar ridge resorption following tooth extraction is a 
frequently observed phenomenon that may decrease the possibility of placing dental 
implants or impair the aesthetic result after prosthodontics treatment.  
 
2.1.1 Caries 
Although dental caries is a preventable disease it is a persistent public health 
problem. Once a child contracts the disease it has a significant impact on their quality 
of life. Dental caries can progress to the extent that teeth are beyond the ability to be 
restored to function. Decay can also lead to significant infection in the bone around the 
ends of the roots requiring tooth extraction to prevent further infectious complications. 
The DMFT (decay, missing and filling teeth) for 14 year olds is 1.48 with missing 
component 0.10 (Pitts et al., 2004). 
 
2.1.2 Trauma 
Traumatic injury to the oro-dental region may involve both soft and hard tissues 
(Roberts and Longhurst, 1996). Trauma can cause loss of teeth in a variety of ways. 
Andreasen’s classification contains 19 groups and includes injuries to the teeth, 
supporting structures, gingiva and oral mucosa (Andresen et al., 2007). A national 
study in the United Kingdom in 1993 found a prevalence of 17.0% at age 14 years 
(O'Brien, 1994). Accidents within and around the home have been reported as the 
major source of injury to the primary dentition.  
 
For the permanent dentition, accidents at home and school are the major factor 
of trauma (Galea, 1984, Forsberg and Tedestam, 1990). Accidents as a result of 
sports, violence and road traffic accidents were also a common cause of dental trauma. 
Uncomplicated crown fracture without pulp exposure was the common injury to the 
permanent dentition (Kania et al., 1996, Caliskan and Turkun, 1995).  
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Subluxations and complete luxation were the most frequently occurring injuries 
in the primary dentition (Galea, 1984, Martin et al., 1990). The maxillary central incisors 
were the most frequent injured teeth in all studies for both the primary and secondary 
dentitions.  
 
Removal of a permanent maxillary incisor is not a common occurrence. Indeed 
every effort is usually made to avoid such extractions. However, there are some clinical 
situations where incisor loss is inevitable. These mainly include trauma-related sequel 
such as persistent uncontrollable periapical infection and vertical root fractures. 
Epidemiological data have shown that 19% of 12 year olds suffer some trauma to their 
maxillary incisor and three in every 1000 incisors will be lost as result of trauma 
(O’Brien, 1994).  
   
2.2 Alveolar bone and alveolar ridge resorption 
Alveolar bone is the part of the maxilla and mandible which supports the teeth 
and serves as a fibrous attachment for the periodontal ligament fibres, and thus 
alveolar bone is part of the periodontium (Bath and Fehrenbach, 2006). Essentially the 
alveolar process consists of two parallel plates of cortical bone, buccal and palatal 
(maxilla) or lingual (mandible) plates. The alveolar process which separates each tooth 
socket is known as interalveolar or interdental septa. In multirooted teeth the sockets 
are divided by interradicular septa. The cancellous bone occupies most of the 
interdental septa but only a relatively small portion of buccal and palatal bone plates 
(Lindhe et al., 2008).  
 
2.1.2 Function of Alveolar Bone 
1. Supporting tissue 
2. To distribute and resorb forces generated by mastication and other tooth    
      contacts (Lindhe et al., 2008) 
3. Giving attachment to muscles 
4. Providing a framework for bone marrow 
5. Acting as a reservoir for ions especially calcium 
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2.3 Consequences of alveolar bone loss 
Alveolar bone resorption is an inevitable and undesirable consequence of tooth 
loss. Local factors known to exacerbate the resorptive process include persistence 
infection, bony fracture of the thin buccal plate during tooth removal and subsequent 
loading of the alveolar ridge from the removable prosthesis (Jeffcoat, 1993).  
 
Following permanent maxillary incisor loss in a young population, clinical 
experience suggests that a variable degree of alveolar resorption does ensue. The 
sequence of events that lead to alveolar healing after tooth extraction has been 
documented as follows (Amler, 1969, Schroeder, 1986):  
 
1. Immediately after removal of the tooth, a blood clot with a tight fibrin network 
fills the alveolus. Polymorph nuclear cells and fibroblast invade the clot. 
2. Granulation tissue starts to develop after 2-3 days. 
3. On the fourth day, epithelial tissue grows out from the edge of the alveolus. 
Osteoclasts resorb the alveolar ridge. 
4. On the seventh day, connective tissue containing a few areas of osteoid 
tissue develops. 
5. Re-epithelialisation is complete by day 20. When mineralization starts, it 
produces woven bone that subsequently undergoes remodelling. 
6. Forty days after tooth extraction, the ridge height is decrease by about one 
third. 
 
The resorption of the alveolar process after tooth extraction in the maxilla or 
mandible is significantly larger at the buccal aspect than at the lingual aspect 
(Pietrokovski and Massler, 1967).  Extraction of anterior maxillary teeth is associated 
with a progressive loss of bone mainly from the labial side (Cawood and Howell, 1988).    
A 25% decrease in volume of the anterior maxilla during the first year post extraction 
has been reported (Carlsson and Persson, 1967, Pietrokovski and Massler, 1967). 
Other investigators have reported a 10% loss of ridge volume determined at 2 months 
and 18% at 12 months (Adam LP and RJC, 1985). 
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A study has been done in a young patient to investigate changes in the alveolar 
ridge width following removal of ankylosed second primary molars. The changes were 
measured on dental study casts. Alveolar ridge width was found to decrease 25% 
within 3 years after the extraction (Ostler and Kokich, 1994). 
 
Post extraction bone resorption has also been quantified by examining 
radiographs. One study estimated an annual 0.5 mm reduction in alveolar height in 
adults following tooth removal (Atwood, 1973). Over 25 years, the alveolar ridge may 
lose up to 10 mm in height at the mandible. Height loss is usually about four times 
smaller at the maxilla than at the mandible. This may be ascribable to the fact that 
loads are distributed over a smaller surface at the mandible than at the maxilla. 
 
2.4 Current methods of alveolar bone preservation 
Reduction in alveolar bone mass will have a considerable impact on future 
treatment options. Implant, resin bonded bridges and dentures all require adequate 
bone mass for the successful and aesthetic replacement of missing anterior teeth. 
Therefore, it would be an advantage to avoid this loss of tissue (Levin et al., 2008). 
Approaches to maintain alveolar bone are listed below.  
 
2.4.1 Immediate placement of dental implant 
Implant placement in children is not indicated as they are still growing and the 
implant will become infra-occluded.  
 
2.4.2 Decoronation  
Ankylosis and replacement resorption are frequent sequelae of severe tooth 
injuries (Filippi et al., 2001) in the growing child. This usually will lead to predictable 
loss of the teeth and localized interference of jaw development (Andreasen et al., 
2007). In children, when ankylosed or heavily resorbed teeth are present, these teeth 
could be indicated for decoronation (Malmgren, 2000). The procedure involves 
removing of the tooth crown and root filling, leaving the root in situ to be resorbed by 
the process of replacement resorption. The retained root is then covered with a 
mucoperiosteal flap.  
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Any roots intentionally retained must be monitored clinically and 
radiographically and endodontically treated or removed if infection arises (Day et al., 
2008). Decoronation of a tooth undergoing replacement resorption may help to 
maintain bone width (buccopalatally) for future implant placement (Filippi et al., 2001).  
 
2.4.3 Immediate bone filling of extraction socket 
 Immediate bone filling with bone substitutes offer an alternative to managing 
alveolar bone loss following an extraction.  Immediate bone filling offers a non–surgical 
approach in preserving the alveolar bone after tooth loss in children. In attempts to 
maintain alveolar bone width and height for future implant placement in children, ideally 
the bone substitute should have the following properties:- 
1. Biocompatible 
2. Bioresorbable 
3. Promotes bone regeneration 
4. Injectable into socket (to avoid surgical approach).  
 
To be injected in vivo, the material must have two features which are 
injectability and cohesion (Bohner et al., 2000b). Injectability refers to the ability of the 
material to be extruded through a small and long needle without demixing (liquid being 
expelled without the particle). Material with appropriate cohesion (forces which causing 
various particle to unite) will set in a fluid without disintegrating.  
 
The following section will focus on different materials that are currently used for 
bone repair and the properties of the ideal material. 
 
2.5 Bone graft material 
 There are various types of bone filling materials that have been extensively 
studied. There are two main approaches which have been studied: 
1. biologic approaches – bone graft material  
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i) Autograft 
ii) Allograft  
iii) xenografts   
 
2. Synthetic bone graft approaches - alloplasts (synthetic hydroxyapatite, 
bioactive glass, tricalcium phosphate ceramics and osteoactive polymers) 
which act as foreign scaffold material (Meyer et al., 2009).  
 
They operate by promoting osteointegration, osteogenesis, osteoinduction or 
osteoconduction. Osteointegration is the ability to chemically bond to the surface of 
bone without an intervening layer of fibrous tissue (Costantino and Friedman, 1994).  
Osteogenesis is the formation of new bone by osteoblastic cells present within the graft 
material (Cypher and Grossman, 1996). It occurs when viable osteoblasts and 
precursor osteoblasts are transplanted with the grafting material into the defects, where 
they may establish centres of bone formation. Autogenous iliac bone and marrow grafts 
are examples of transplants with osteogenic properties (Lindhe et al., 2008). 
 
Osteoinduction is the ability to induce differentiation of pluripotential stem cells 
from surrounding tissue to an osteoblastic phenotype (Cypher and Grossman, 1996). It 
involves new bone formation by the differentiation of local uncommitted connective 
tissue cells into bone–forming cells under the influence of one or more inducing agents 
(Lindhe et al., 2008). 
 
Osteoconduction is the ability to support the growth of bone over its surface 
(Constantino and Friedman, 1994). It occurs when non–vital implant material serves as 
a scaffold for the ingrowth of precursor osteoblasts into the defect. This process is 
usually followed by a gradual resorption of the implant material. Autogenous cortical 
bone or banked bone allografts may be examples of grafting of grafting materials with 
osteoconductive properties However degradation and substitution by viable bone is 
often poor. If the implanted material is not resorbable, the incorporation is restricted to 
bone apposition to the material surface, but no substitution occurs during the 
remodelling phase (Lindhe et al., 2008). Collagen is also known to have the 
osteoconductive properties due to its structure which promotes mineral deposition. 
Collagen also binds matrix proteins that initiate and control mineralization (Meyer et al., 
2009). 
29 
 
2.6 Biological bone graft material 
The biological approaches operate on the principle that the bone graft material 
should mimic as closely as possible the positive attributes of bone (Meyer et al., 2009). 
Bone substitutes should also have the osteotransductive property, i.e., the bone grafts 
are replaced by a new bone tissue after implantation (Dorozhkin, 2008). 
 
 2.6.1 Autograft 
 Autografts are grafts transferred from one position to another within the same 
individual. They is harvested either from intraoral or extraoral donor sites. This type of 
graft comprises: 
 Cortical bone 
 Cancellous bone and marrow 
 
Autografts of bone are advocated by some clinicians to augment the alveolar 
bone. Autologous iliac crest bone is currently the gold standard in bone graft material 
(Meyer et al., 2009). The rationale of advocating autogenous grafts in regenerative 
therapy is that they may retain viable cells to promote bone healing through 
osteogenesis or osteoconduction. They are gradually resorbed and replaced by new 
viable bone. Issues of histocompatibility and disease transmission are eliminated with 
autogenous grafts (Lindhe et al., 2008). 
 
The disadvantages of this approach include increased operative time and 
associated morbidity related to chronic pain, blood loss, wound complication and local 
sensory loss (Moore et al., 2001). This is due to the need for a second surgical site and 
requirement of surgical intervention to harvest the bone from the donor site. 
Furthermore, often the amount of graft materials is inadequate (Lu et al., 1999).  
 
2.6.2 Allograft 
 Allograft refers to a graft which is transferred between genetically dissimilar 
members of the same species. Allograft can be frozen, freeze–dried or demineralised 
freeze – dried.  A calcified freeze–dried allogeneic bone graft (FDBA) is a 
mineralized/calcified bone graft.  
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FDBA loses its viability through the manufacturing process and it is supposed to 
promote bone regeneration through osteoconduction / osteoinduction (Lindhe et al., 
2008). On the other hand, a decalcified freeze–dried allogenic bone graft (DFDBA) has 
been suggested to enhance osteogenic potential by exposing bone morphogenic 
proteins which have the ability to induce host cells to differentiate into osteoblasts 
(Lindhe et al., 2008). Both FDBA and DFDBA have been studied in attempts for 
alveolar bone preservation and regeneration.  
 
The advantage of allograft include availability and avoidance of morbidity 
associated with harvesting autogenous graft. Allografts are of particular importance 
when there are large bone defects which require structural support or when inadequate 
autogenous graft is available.  However, the use of allogeneic grafts carries a certain 
risk regarding antigenicity even though the grafts are usually pre-treated by freezing 
radiation or chemicals in order to suppress foreign body reactions (Lindhe et al., 2008). 
Other complications include fracture, non-union and infection.  
 
2.6.3 Xenogenic graft 
Xenogeneic grafts are taken from a donor of another species. Xenogeneic 
grafts have been used in managing ridge defects (Norton et al., 2003) and in alveolar 
ridge preservation (Carmagnola et al., 2003). Example of the xenogeneic graft is a 
deproteinized bovine bone mineral (DBBM, market name is Bio-Oss). The DBBM is a 
biocompatible bone derivative (Artzi et al., 2000) and has been shown to be 
osteoconductive (Camelo et al., 1998). However, it was concluded that Bio-Oss® 
merely acts as a scaffold for tissue formation during healing rather than enhancing 
bone formation (Araujo and Lindhe, 2009) and complete alveolar bone preservation 
with DBBM is not possible (Fickl et al., 2008). Furthermore, with xenograft materials, 
there is a potential for cross contamination. 
 
2.7 Alloplasts 
Alloplastic materials are synthetic or inorganic implant materials which are used 
as substitute for bone grafts. Ideally synthetic bone grafts should be biocompatible, 
have minimal fibrotic reaction and undergo remodelling and encourage new bone 
formation.  
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Synthetic bone grafts should have a similar strength to the cortical / cancellous 
bone that is being replaced. This also needs be of similar modulus of elasticity to 
prevent stress as well as maintaining adequate toughness to prevent fatigue fracture 
under cycle loading. Synthetic materials that demonstrate some of these properties are 
often calcium, silicon, aluminium or polymer-based. Examples of commonly used 
alloplastic materials include:  
1. Silicon based: bioactive glass or glass ionomer cements 
2. Aluminium oxide 
3. Polymethylmethacrylate (PMMA) 
4. Synthetic hydroxyapatite, beta tricalcium phosphate, and calcium phosphate 
cements 
 
2.7.1 Bioactive glass and Glass ionomer cements 
 Silicon based compounds have the ability to bond directly to bone. These are 
the bioactive glasses and the glass ionomers. Bioactive glasses are hard, solid and 
non-porous materials. These materials possess both osteointegrative and 
osteoconductive properties. A mechanically strong bond between bioactive glass and 
bone forms as a result of a silica-rich gel layer that forms on the surface of the 
bioactive glasses when exposed to physiological aqueous solutions (Gross et al., 
1988).   
 
Bioactive glasses have been successfully used as a bone graft expander and 
alone in maxillofacial surgery (Kinnunen et al., 2000). However, bioactive glasses have 
low fracture toughness in relation to cortical bone. Bioactive glass blocks resist drilling 
and shaping. They are relatively brittle and prone to fracture with cyclic loading. This 
makes it difficult to fix in the skeleton (Peltola et al., 2000). Despite the increase in 
strength and toughness, materials also showed a higher modulus of elasticity 
compared to cortical bone. Glass ionomer cements (GIC) were first introduced in 1971 
for dental use. Their primary use is for tooth restoration but they have also been used 
in bone. Ionomer cements consist of calcium / aluminium / fluorosilicate glass powder 
which is mixed with polycarboxylic acid.  
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The paste sets hard approximately after 5 minutes but prior to this, it must be 
protected from wound fluid which will dissolve it. After 24 hours it has a compressive 
strength (180-220MPa) and modulus of elasticity comparable to cortical bone 
(Bresciani et al., 2004). It is also biocompatible and can be osteointegrated as well as 
bioactive glasses. Increasing its porous structure aids osteoconduction and subsequent 
bone ingrowth. The drawback of glass ionomers cements, however, is non-resorbable 
properties and therefore it is not replaced by bone.   
 
2.7.2 Aluminium oxide 
 Alumina is a component of several bioactive materials but can also act as a 
bone graft substitute on its own. Alumina ceramics are very hard, rigid and have 
greater resistance to flexural fracture as compared to ceramic HA. They have been 
used as a bone graft expander, orbital implants and prosthetic joint lining (Constantino 
and Friedman, 1994). However, their application has been limited by their inability to 
become osteointegrated. 
 
2.7.3 Polymethylmethacrylate 
 Polymethylmethacrylate (PMMA) bone cements are the material of choice in 
vertebroplasty for the treatment of metastatic, cystic lesion and osteoporotic spine 
fracture (Turner et al., 2008). The drawback of this material is their significant 
exothermic setting reaction during polymerization that carries the risk of localized 
thermal tissue necrosis (Belkoff and Molloy, 2003).  
 
The high compressive strength and stiffness of PMMA causes a biomechanical 
mismatch between treated and untreated vertebral levels that leads to vertebral 
collapse (Berlemann et al., 2002). Furthermore, PMMA is non-resorbable and allergy to 
PMMA bone cements or its components has also been reported. PMMA may also have 
antibiotics and high molecular weight proteins added to them for slow release 
properties (Thomas et al., 2008). However, glass ionomers have the ability to release 
protein more efficiently than PMMA and are less likely to damage heat-labile proteins 
(Moore et al., 2001). 
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2.7.4 Beta tricalcium Phosphate 
Beta tricalcium phosphate (β-TCP) was one of the earliest calcium phosphate 
compounds to be used as a bone graft substitute. Porous β-TCP has compressive and 
tensile strength similar to cancellous bone. β-TCP undergoes reabsorption via 
dissolution and fragmentation. Unfortunately, β-TCP has been found to be brittle and 
weak under tension and shear but it is resistant to compressive loads (Houmard et al., 
2013). 
 
2.7.5 Synthetic hydroxyapatite 
 Hydroxyapatite (HA) forms the principal mineral component of bone. It comes in 
ceramic or non-ceramic forms as porous or solid and blocks or granules. Ceramic 
refers to HA crystals that have been heated at between 700 and 1300°C to form a 
highly crystalline structure. Ceramic HA are resistant to reabsorption in vivo compared 
to non-ceramic HA that is more readily reabsorbed. Synthetic HA have good 
compressive strength but a week in tension and shear. They are brittle and are fracture 
prone on shock loading areas. Synthetic HA in solid block forms are difficult to shape, 
do not permit fibro-osseous ingrowth and have a higher modulus of elasticity than bone 
(Habibovic et al., 2008).  
 
2.7.6 Calcium phosphate Cements 
Calcium phosphate cements (CPC) have been extensively studied and have 
great potential as bone substitutes. These cements are self – setting, bioactive and 
biodegradable grafting materials in the form of a powder and a liquid.  
 
These cements also possess an excellent osteoconductivity, moulding 
capabilities and are easy to manipulate. In contrast to PMMA based cement, the setting 
reaction of these cements occur with minimal exothermal at physiological pH value 
without the release of monomer. Nearly perfect adaptation of the tissue surface in bone 
defects and gradual bioresorption followed by new bone formation are additional 
advantage of these cements.  These properties of the calcium orthophosphate cements 
contribute to their usage as a potential regenerative material (Tamimi et al., 2012). 
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The cements are obtained by mixing one or several reactive calcium phosphate 
powders with an aqueous solution to form a paste that hardens within a period of time, 
thus differentiating calcium orthophosphate cements from traditional bone substitute 
preparations (Bohner et al., 2005). Due to the potential of these materials for repair, 
augmentation and regeneration of bones, sometimes they are also known as calcium 
phosphate bone cements (Dorozhkin, 2008). The implanted CPC might be resorbed by 
two possible mechanisms:-  
 Active resorption – mediated by the cellular activity of macrophages, 
osteoclasts by phagocytosis (Grossardt et al., 2010). 
 
 Passive resorption due to either chemical dissolution (Dorozhkin, 2008) 
or chemical hydrolysis. Chemical hydrolysis only applies to brushite 
cements (Grover et al., 2003).  
 
Apart from the potential regenerative property, CPC also can be used for 
controlled drug delivery. In principle, drugs might be incorporated into both liquid and a 
powder phase of the cements. After setting, the drugs are slowly released through the 
cements pores. This cement has been used as a carrier to deliver: 
 Antibiotics 
 Anti – inflammatory drugs 
 Growth factors 
 Bone morphogenetic proteins 
 
Over the years, many different forms and composition of CPC have been 
formulated and commercialized. Based on the final end product of the formulation 
reactions, CPC are classified into two categories:  
 
 Hydroxyapatite 
 
 Brushite Cement 
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2.8. Hydroxyapatite 
One of the most extensively studied bioactive ceramics is hydroxyapatite. Bone, 
enamel, dentine and cementum all contain biological apatite, which comprise the 
mineral phases of calcified tissues.  
 
The biological apatite is similar to synthetic hydroxyapatite (HA) but they are 
differing in terms of composition, stoichiometry, physical and mechanical properties. 
The synthetic hydroxyapatite shows biocompatibility with not only hard tissues, but also 
soft tissues such as skin and muscle. Another advantage of HA is it is bioactive and 
promotes osseointegration when directly implanted into bone. The setting reaction of 
HA does not increase the local pH and it has favourable mechanical properties 
(Ambard and Mueninghoff, 2006, Ginebra et al., 2010). 
 
Unfortunately the inability of hydroxyapatite to degrade for full replacement of 
surrounding tissues poses a major problem in the regenerative therapy of alveolar 
bone. The commonly used conventional bioactive material HA is extremely weak in its 
porous form which limits its application to none or low-load bearing areas and cannot 
be used as structural bone. Furthermore, the properties cannot be easily, structurally 
and synthetically adjusted for bone implantation.  
 
Hydroxyapatite forming cements have a long setting time, thus during 
preparation of this material, the mixing liquid is reduced to a minimum (Bohner et al., 
2000b). By altering the ratio of mixing liquid the product becomes more viscous, easily 
mouldable, but tends to be difficult to inject. As previously mentioned, injectability of 
material is one important criteria for novel bone substitute in children. HA also have 
limited solubility which leads to a growing interest in highly soluble brushite cements. 
 
2.9 Brushite Cements 
In 1987, Mirtchi and Lemaître reported the formation of brushite cements from 
the reaction of β-tricalcium phosphate (β-TCP) and monocalcium phosphate 
monohydrate (MCPM)(Mirtchi et al., 1989). Brushite cements also known as dicalcium 
phosphate dihydrate (DCPD). It generally forms at a pH of less than 4.2. The main 
components include: 
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1. Alkaline calcium source 
Different sources of calcium have been use for example, calcium oxide 
(Nurit et al., 2002), calcium hydroxide (Desai and Chandler, 2009), 
tetracalcium phosphate (TTCP) (Lilley et al., 2005), tricalcium phosphate 
(TCP) and hydroxyapatite (HA) (Matsunaga et al., 2010). TTCP is an ideal 
choice because it has calcium to phosphate ratio of 2 but its preparation is 
highly energy demanding (Lilley et al., 2005)).  
 
TCP with calcium to phosphate ratio 1:5 has two crystallographic forms 
known as β-TCP and α-TCP and both have been used to prepare DCP 
cements. β-TCP has lower energy requirement for its production making it 
the more suitable choice (Bohner et al., 2000a, Pina et al., 2010). 
 
2. Acidic phosphate source 
The simplest choice is phosphoric acid (PA) because it is inexpensive 
and has been used in many cement formulations (Bohner et al., 2000b, 
Lilley et al., 2005, Bohner et al., 2000a). However, monocalcium phosphate 
monohydrate (MCPM) is often used as it provides superior cement handling 
properties (Marino et al., 2007, Nurit et al., 2002). 
 
3. Water 
 
4. Additives 
To improve DCP properties, additives have been included. The most 
significant of these are: 
1. Pyrophosphates, for example calcium pyrophosphates (Mirtchi et 
al., 1989) and pyrophosphoric acid (Grover et al., 2006). These 
have been added to regulate the setting reaction. 
 
2. Sulphates have also been found to modify the setting reaction of 
brushite cements by substituting for phosphate ions and interacting 
with calcium phosphates (Bohner et al., 2000a). 
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3. Carboxylate and carboxylic acids are used as a setting retardant in 
brushite cements for example as sodium citrate and citric acids 
(Barralet et al., 2004).  
 
4. Polymers are added to improve injectibility, cohesion and 
mechanical properties. To improve injectability and cohesion, 
hydrophilic polymers such as xanthan gum (Flautre et al., 2003) and 
polyacrylic acid (Bohner et al., 1997b) are used. 
 
5. Ionic substitutions can have an important effect on the reaction and 
final properties of the materials. Metallic ions such as strontium 
(Alkhraisat et al., 2008b) and magnesium (Boaninia et al., 2009) can 
be added to the cements simply by mixing the cements powder 
phase with a salt containing the ion that is needed. Alternatively, 
metal ion salts instead of pure calcium and phosphate precursors 
can be used (Huan and Chang, 2009, Pina et al., 2010). 
 
Brushite cements setting reaction consists of: 
1. Dissolution of the cement powder in a solvent 
2. Super-saturated gel formation. 
3. Nucleation within the gel 
4. Formation of a solid interlocked crystal by crystal growth. 
 
2.9.1 Setting time 
Brushite cements setting reaction begins by the dissolution of MCPM which 
causes a rapid decrease in pH (Bohner and Gbureck, 2008, Bohner et al., 1997a). 
Cements with excess MCPM will have a pH that remains low even after the setting 
reaction is complete. Conversely, cements that have excess β-TCP have their pH settle 
at ~5.  
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Upon exposure to water, MCPM tends to hydrolyse into diphosphate and 
calcium ions, via an endothermic reaction (Bohner and Gbureck, 2008). As a result of 
acid exposure, simultaneous exothermic dissolution of β-TCP occurs. The cements 
experience a second pH jump as a result of the exothermic precipitation of brushite 
crystals after the initial dissolution of the reagents (Hofmann et al., 2006b).   
 
Adding any additive to brushite cement can affect the dissolution of the reagent, 
precipitation of the brushite crystal or both thereby altering the setting reaction time. 
For example citrate ions can interact with β-TCP particles and affect the dissolution 
(Alkhraisat et al., 2008a). Alternatively, sulphate, pyrophosphate and citric acid can 
inhibit brushite precipitation (Bohner and Gbureck, 2008) resulting in prolongation of 
the cements initial low pH (Bohner et al., 2000a).  
 
The effects of sulphate ions will vary dependent on the concentration used. 
Adding a low concentration will delay the cement reaction whereas a high 
concentration will lead to the formation of calcium sulphate dihydrate crystals that can 
act as nuclei for the crystallization of brushite thus accelerating the setting reaction 
(Mirtchi et al., 1989, Bohner et al., 1997a, Van Landuyt et al., 1999).  
 
Organic acids have the ability to bind with calcium ions and interact with 
brushite cements crystals, leading to inhibition of setting times. α- Hydroxyl carboxylic 
acids (e.g. tartaric, glycolic and especially citric acids) have an inhibitory effect on 
brushite cements setting reaction (Marino et al., 2007, Barralet et al., 2004, Lilley et al., 
2005) whereas carboxylic acids with no hydroxyl groups have been shown to have no 
inhibitory effect on brushite crystal growth and may shorten the cement setting time 
(Marino et al., 2007, Giocondi et al., 2010). 
  
Protein also can interact with brushite crystals and alter the setting reaction. 
The effect of protein varies depending on the ability of the protein to absorb onto the 
calcium phosphate surface. (Metz et al., 2006). Another important factor regulating the 
setting time is the amount of water present in the cement paste. Limiting the water 
available for the setting reaction will favour a faster precipitation of brushite crystals 
hence accelerating the setting time. This is usually seen when cement with low powder 
to liquid ratio is used (Mirtchi et al., 1989, Alkhraisat et al., 2010, Tamimi-Marino et al., 
2007).  
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Another way to control the setting reaction of brushite cements is by premixing 
it with a non-aqueous liquid, for example glycerol, in order to form a premixed calcium 
phosphate cement that can only set when in contact with water (Aberg et al., 2010, 
Han et al., 2009). The cements can also freeze once they are mixed to stop the setting 
reaction, stored for a long time and thawed when needed. The resulting cements have 
a similar porosity and composition compared to the unfrozen cements (Grover et al., 
2008).  
 
2.9.2 Mechanical properties 
 Ideally, any cements and bioceramics for bone generation should have 
mechanical properties similar to bone. According to the current standards for testing 
bone cements of the American Society for Testing and Materials (ISO 5833, 2002) 
(ASfTa, 1999),  cements are allowed to set for at least 24 hours prior to testing 
(Tamimi-Marino et al., 2007, Tamimi et al., 2010, Barralet et al., 2004, Hofmann et al., 
2009).  
Cements can be cured either in dry condition (room temperature and humidity) 
(Tamimi-Marino et al., 2007) or in physiological condition (37oC and 100% humidity) 
(Hofmann et al., 2009) which are more preferred as it is more relevant to clinical 
application. Two mechanical assessments that are usually performed are compressive 
strength and tensile strength. Mechanical properties of this cement can be modified by 
several factors such as: 
1. Porosity 
2. Powder to liquid ratio 
3. Particle sizes 
4. Degree of cements setting 
5. Delayed cements setting 
6. Ultrastructural organization 
7. Presence of additive 
8. Addition of free ions or certain proteins 
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 The strength of brushite cements are inversely correlated to the porosity which 
means mechanical performance will be higher when porosity of the cements is lower 
(Flautre et al., 2003).  Cements with a low powder to liquid ratio will have excess water 
in the setting reaction that results in increased porosity and poorer mechanical 
properties. On the other hand, if a high powder to liquid ratio is used, it will result in 
cements that are difficult to handle and cannot be properly mixed. 
 
The mechanical properties of brushite cement can be improved by modifying 
particle sizes of the cements reactants. For example, adjusting particle size of reagents 
in MCPM/β-TCP- based cements has been shown to increase its mechanical 
properties (Hofmann et al., 2009). Some cement additives have also been proven to 
increase the cements mechanical properties. Adding pyrophosphate salt and α-
hydroxyl carboxylic acids such as citric, glycolic and tartaric acids help to increase 
cement powder to liquid ratio. This will result in easier mixing of cements and resulting 
in improved mechanical properties (Marino FT et al., 2007, Alkhraisat MH et al., 2008b, 
Bohner M et al., 2000a, Van Landuyt P et al., 1997, Barralet JE et al, 2004).  
 
Nevertheless, any additive used usually has an optimal concentration, too much 
or too little can adversely affect other properties. For example, a high concentration of 
citric acid will weaken the brushite cements (Hofmann et al., 2006b). In contrast,  with 
optimised cement particle size, powder to liquid ratio and cement retardant 
concentration (800 mM citric acid in the cement liquid phase) cements have been 
shown to have the highest reported wet compressive strength 52 MPa (Hofmann et al., 
2009). Addition of free ions to the cements system will also affect the mechanical 
properties of the cements. Adding metallic ions such as strontium chloride was shown 
to have no valuable effect on the mechanical properties (Alkhralsat MH et al., 2008b). 
 Furthermore, brushite cements with magnesium substitute in either α-TCP or 
β-TCP result in increased compressive strength up to 40 MPa (Klammert, 2010, Pina 
S, 2009). Addition of certain protein such as albumin will interfere with crystal-crystal 
interaction within the cements ultrastructure that leads to negative effect on mechanical 
properties of brushite cements (Metz et al., 2006). Nevertheless, adding collagen type I 
to TTCP/MCPM cements system has been shown to slightly increase the cements 
compressive strength (Guo and Li, 2009).  
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 Increasing the ultrastructural organization of the brushite cements is also one of 
the methods that have been found to increase mechanical properties of the cements. 
This can be achieved by adding additives such as gentamicin sulphate and calcium 
sulphate hemi-hydrates to the brushite cements that will act as crystallization nuclei 
and therefore will enhance the mechanical properties (Perez et al., 2012, Cai et al., 
2011). Other methods such as freezing the cements during the mixing process will lead 
to formation of ice crystals that will help to arrange growing brushite crystals upon 
precipitation that result in increasing cements compressive strength (Grover et al., 
2008).  
 
2.9.3. Shelf-life 
Long term stability of the cements is important and will be affected by 
temperature, humidity and mixing. Additives may help to preserve the cement 
properties for longer periods of time (Gbureck et al., 2005). When cements containing 
pyrophosphate are stored for long periods of time, it will result in spontaneous 
hydrolysis of pyrophosphate into orthophosphate. This reaction can affect the cements 
mechanical properties and shorten the setting time. On the other hand, adding citric 
acids to the cements powder and keeping in an inert cold atmosphere has been proven 
to prolong the cement storage life and stability (Van Landuyt P et al., 1999, Gbureck et 
al., 2005). 
 
2.9.4 Injectability  
 It is important to have good cement injectability particularly for minimal invasive 
surgical procedures that require injection of the cements into the bone defect (Baroud 
et al., 2005). During the injection process, the liquid to powder ratios should not change 
in order to be capable for injectability but many brushite cements were found to suffer 
from phase separation during injection. These make it hard for them to be injected. 
There are a few changes that can be made in the cements composition that will help to 
enhance the cement injectability such as: 
 
1. Decreasing the powder to liquid ratio (Habib et al., 2008).  
2. Increasing the viscosity of the mixing liquid by adding gelling agent for 
example as xanthan gum (Habib et al., 2008). 
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3. Lowering the particle-particle interaction by using additive such as 
carboxylic acids (Habib et al., 2008). 
4. Decreasing the particle size of the powder by extensive milling of the 
cement powder (Habib et al., 2008). 
5. Increasing the extrusion velocity (Habib et al., 2008). 
6. Using a small syringe with a short cannula (Habib et al., 2008). 
7. Dissolving citric acids or sodium citrate in the cements liquid phase 
(Barralet et al., 2004). 
 
Nevertheless, caution should be taken when any modification is done because 
it may affect other important properties of the brushite cements. For example, lowering 
the powder to liquid ratio will increase the injectability but it also will result in reduction 
in the cements mechanical properties. Some studies have shown that the most 
convincing method to increase injectable properties of cements is by reducing particle 
size and adding hydrogels to the cements liquid phase (Alkhraisat et al., 2009, Habib et 
al., 2008).  
 
2.9.5 Degradation 
Brushite cements are resorbed in vivo to a much greater extent compared to 
hydroxyl apatite cements. During the first weeks following implantation, brushite 
appears to be rapidly resorbed by simple dissolution and cellular activity (Theiss et al., 
2005, Frayssinet et al., 2000) . In vivo observations have shown that early resorption of 
brushite cements is regulated by macrophages rather than osteoclasts (Kuemmerle et 
al., 2005). Initial resorption of brushite is affected by the inherent cement properties 
such as cement porosity, the rate of fluid exchange and the properties of the 
surrounding medium (Grover et al., 2003). Under physiological conditions brushite 
cements exhibit an increase in porosity, a decrease in mass, deterioration and a 
reduction in the cement mechanical properties (Grover et al., 2006, Ikenaga et al., 
1998). This initial drop in mechanical properties is an important clinical issue when 
cement is used to repair load-bearing bone defects. Therefore further research is 
needed to address this problem. Nevertheless, after a few weeks implantation the 
mechanical properties of the cement may improve due to bone in-growth into the 
biomaterial (Ikenaga et al., 1998).  
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After the initial fast degradation of the cement the remaining brushite is 
converted into less soluble apatite. It has been observed that after 24 weeks of in vivo 
implantation in sheep, brushite cements completely convert to poorly crystalline 
carbonated apatite. At this point there is almost no dissolution of the cement and 
resorption is carried out solely by osteoclast activity, rather than macrophage 
phagocytosis (Grossardt et al., 2010, Constantz et al., 1998). 
 
2.9.6 Adhesion 
 Proper adhesion between bone and cements is very important to allow better 
transmission of force at the cement-bone interface. Brushite cements have poor 
adhesion quality. Nevertheless it can be improved by adding pyrophosphoric acids in 
the liquid phase that are shown to have an increased adherence to bone. However 
more research needs to be done (Grover et al., 2006). 
 
2.9.7 Cohesion  
 Cohesion of bone cements is very important for clinical applications because if 
cement particles are released into the bloodstream, it could result in pulmonary 
embolism and other potentially life threatening consequences (Bohner et al., 2006). 
Cements cohesion is evaluated by measuring the amount of solid particles released 
from the cements proceeding to its final setting (Bohner et al., 2006, Alkhraisat et al., 
2008a). Cohesion of the cements can be influenced by: 
 
1. Particle size (Bohner et al., 2006). 
2. Presence of additives such as citric acids and SrCI2 which reduce the 
particle-particle interaction in the cements and cause the particles to 
release from the cement and reduce the cohesion (Alkhraisat et al., 
2008b). 
3. Hydrogel that increase the viscosity of the cement liquid phase and 
improve cements cohesion by several folds for examples as collagen 
type I and silica gel (Alkhraisat et al., 2008b, 2009, 2010, Tamimi et al., 
2008). 
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2.9.8 Bone formation 
Brushite cements have been prepared and used for bone regeneration in 
different physical forms. These range from injectable paste, pre-set casted blocks, 3-D 
printed blocks and granules. Brushite cements are generally well tolerated by bone and 
soft tissues and do not cause inflammations in the long term (Theiss et al., 2005).  
 
Following implantation, brushite cements are first enclosed in loose connective 
tissue (Frayssinet P et al., 1998) or surrounded by fibrous connective tissue if the 
cement composition is too acidic (Tamimi et al., 2009). The surfaces of brushite 
stimulate osteoblast activity in vitro (Klammert et al., 2009). This is followed by 
centripetal trabecular in-growth towards the material, leading to remodelling of the 
bone. During the later stages the brushite resorption rate slows down due to 
conversion to hydroxyl apatite. New bone is formed in direct contact with the cement 
margins resulting in osteointegration of the cement and its later remodelling (Frayssinet 
et al., 1998, Lu et al., 1999).  
 
Brushite cement has been successfully tested in the regeneration of bone at 
various surgical sites in animal models such as in tibial condyle (Lu et al., 1999) and 
calvaria (Kuemmerle et al., 2005). However the amount of bone formation is highly 
dependent on the site of the implantation and the vascular supply, as an adequate 
blood supply can increase the speed of cement resorption and replacement by new 
woven bone (Constantz et al., 1998).  
 
2.9.9 Macroporosity 
 It is important to allow cellular infiltration and proliferation inside the biomaterial 
and this can be achieved by altering the macroporosity of bone bioceramics. Cements 
should have a balanced incorporation of macropores within the cements structure 
without increasing the overall cement porosity due to the fact that increasing the 
cements porosity will have direct effect in reducing mechanical properties of brushite 
cements. Adding porogens such as mannitol will widen the pores in brushite cements 
to 250-500 µm without reducing the initial compressive strength of the cements (Cama 
et al., 2009) while adding gelatine powder as template will open pores about 100-200 
µm (Yin et al., 2003).  
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The other way of creating macroporosity is by using computer aided design of 
3-D printed brushite cements that allow  specific pore design but this technique was 
limited by rapid prototyping technique pore resolution that currently only set at 0.5mm 
(Habibovic et al., 2008). 
 
2.9.10 Application 
 Brushite cements have been tested in vitro, in vivo and clinically for various 
applications for example as drug delivery devices, in orthopaedics, craniofacial surgery, 
cancer therapy and amperometric biosensors. 
  
1. Drug delivery: 
 
Different bioactive molecules have been added to brushite cements to 
improve the biological properties. These bioactive molecules can be added to 
the cements either as solid particles, by dissolving in the cement liquid phase or 
by soaking the set cement in a solution containing the drug (Tamimi et al., 
2008, Alkhraisat et al., 2010).  
 
Drugs incorporated into brushite cements need to be stable in acidic 
environments due to the initial low pH of the cements, withstand the 
temperature changes during the setting reaction and have appropriate 
adsorption to the cement. The antibiotics and antiseptics that have been used 
for drug release from brushite cements include vancomycin, doxycycline, 
tetracycline, gentamycin, ciprofloxacin and chlorhexidine. Vancomycin is used 
in prevention of Staphylococcus aureus or osteomyelitis and upon release from 
the brushite cements matrix able to effectively eliminate the bacteria in the local 
environment (Jiang et al., 2009).  
 
Brushite cements loaded with doxycycline have antibacterial activity 
against periodontal pathogens, rendering it an interesting material for bone 
regeneration in periodontal bone defects (Tamimi et al., 2008). Brushite 
cements also have been used to release growth factors to stimulate 
angiogenesis and bone regeneration (De la Riva et al., 2009).  
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2. Orthopaedics 
 
I. Restoration of metaphyseal defects: 
 
A few studies have been done in both animal and humans for 
restoration of metaphyseal defects using injectable brushite cements. 
These cements have shown significant potential in the treatment of 
fractures in the tibial plateau done in animal studies (Theiss et al., 2005, 
Ryf, 2009). It also shows 89% success rate for reconstruction of tibial 
plateau fracture and 76% success in distal radial metaphysic fracture in 
clinical studies (Ryf et al., 2009).  
 
The failure of brushite cements for these clinical studies were 
reported due to lack of stable fixation, poor bone quality between 
cements or joint and leakage of the cements into the adjacent tissue but 
it was then resorbed without any complication (Ryf C et al., 2009). 
 
II. Ligament anchor: 
 
Recent studies have shown that brushite cements have the potential 
to anchor ligaments to bone and create proper mechanical interface in 
vitro. The cements composition and shape of the anchor system had to 
be determined carefully in order to achieve this effect (Paxton et al., 
2010). These studies have investigated the use of a 3-D printing 
technique of brushite and monetite bracket for bone-ligament-bone 
replacement compared to hand made bracket to optimize the cements 
ligament sinews. It resulted in similar strength (Ma et al., 2012).  
 
III. Reinforcement of ostesynthesis screws: 
 
Brushite cements have been shown to increase the pull- out forces 
needed to remove an osteosynthesis screw from artificial polyurethane 
bone in vitro by 3-fold (Van Landuyt et al., 1999). It is very important to 
stabilize the ostesynthesis screws in order to achieve positive results in 
patients with complicated bone fractures. This is a more critical issue 
when dealing with patients suffering from osteoporosis. 
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3. Vertebroplasty 
 
Injectable brushite cements have been used as a filling material in 
repairing damage in osteoporotic vertebrae with results showing 20-50% 
increasing of bone mineral density of osteoporotic vertebrae and 120% increase 
in vertebral stiffness in vertebrae. Nevertheless, the 12% cases of cements 
extrusion to the spinal canal had been reported and the finding also concluded 
that brushite cements had no significant effect on healthy vertebra (Heini et al., 
2001). 
 
4. Craniofacial surgery 
Brushite cements have been tested for cranioplasty treatment and in 
oral and maxillofacial bone regeneration. Some have been used for craniotomy 
defects in several animal models. For example one study used brushite 
cements to treat 23mm wide cranial defects in sheep. The results showed some 
resorption with moderate bone formation and formations of fibrous tissue on the 
treated areas (Kuemmerle et al., 2005). Another recent study used brushite 
cements clinically to prevent temporal depression in parietal craniotomies. The 
cement use enabled precise and easy contouring of the defect and produced a 
superior aesthetic outcome for simple repair by preventing depression of the 
temporal bone after craniotomy procedures. 
 
However, a long period of time for full resorption of the material and 
replacement of the new bone was needed (Ji and Ahn, 2004). Brushite cements 
have been tested for bone regeneration in oral and maxillofacial surgery as 
injectable cements and pre-set cement granules. Both techniques have been 
used for vertical bone augmentation and bone defect healing (Tamimi et al., 
2009, Marinno et al., 2007).  
 
Injectable brushite cements have been used for minimal invasive 
craniofacial vertical bone augmentation in an animal study. In one study, the 
brushite cements were injected under the periosteum of the treated area and 
was allowed to set on the bone surface. The results showed that brushite 
cements help to promote vertical bone growth (Tamimi et al., 2009).  
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Several studies also showed that injectable brushite cements were 
capable of regenerating oral and maxillofacial bone in atrophic areas, buccal 
dehiscence and maxillary sinuses (Tamimi et al., 2010). Nevertheless, the 
development of complete bioresorbable cements is needed to allow more 
clinical applications in the future. Pre-set brushite cements granules have been 
tested in animal studies and result in promoting craniofacial vertical bone 
augmentation (Marinno et al., 2007).  
 
Some in vivo study have also been done comparing them to commercial 
bovine materials for bone regeneration. It was shown that brushite cements 
showed a higher amount of vertical bone growth suggesting good potential 
application of these cements in the future (Tamimi et al., 2006). 
5. Cancer therapy 
 
Filling bone defect created by pathological tumours. This has been done 
in animal models. First bone defects were created in the animal at the distal 
femoral condyle and the defects were than filled with brushite cements and 
collagen gels or PMMA cements by percutaneous injection into the trabecular 
defect. The result showed that bone formation gaining with brushite cements 
was superior compared to the PMMA cements (Pasquier et al., 1998).  
 
As a biomaterial to target and destroy cancer cells, this can be done by 
co-precipitated brushite cements with ferrous chloride to form a magnetic 
nanoparticle for the hyperthermic treatment of cancer. In vitro studies showed 
that these nanoparticles have the ability to kill the cancer cells without 
damaging the normal cells (Hou et al., 2009) 
 
6. Amperometric biosensors 
 
Amperometric biosensors are electronic devices based on monitoring 
enzymatic reaction on highly sensitive electrodes that are able to detect small 
amount of specific molecules in either gases or solution. Traditional biosensor 
systems are based on polymeric or clay matrices.  Brushite cements as a new 
biosensor have been shown to result in more faster signalling and higher 
sensitivity compared to traditional biosensor system detection.  
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Two recent studies on brushite-based biosensors reported detection of 
glucose using the enzyme glucose oxidase (Lopez et al., 2006) and phenol by 
combining the brushite cements with enzyme tyrosinase (Sanchez-Paniagua 
Lopez et al., 2009). Brushite cements have two properties that are important for 
such devices: 
I. Ability to conduct electricity through a mechanism known as proton 
conduction. 
 
II. Ability to adsorb proteins. 
 
2.10 Brushite cements with antibacterial properties 
Bacterial infection is one of the main complications after surgery and may lead 
to permanent damage of tissue and bone (Fialkov et al., 2001). PMMA antibiotic loaded 
bone cements have been used in orthopaedic surgery (van de Belt et al., 2001). PMMA 
bone cements are however not bioresorbable. Calcium phosphate cements (CPC) 
have excellent bioactivity, bioresorbability and biocompatibility properties compared to 
PMMA.  
 
CPC also can easily be moulded and injected to defects and it sets in situ 
(Ginebra et al., 2006b). Large numbers of studies have investigated the release of 
antibiotic using HA bone cements. However, HA cements were not able to degrade for 
full replacement by the surrounding tissue (Bohner et al., 2000a, Bohner et al., 2005). 
For this reason, degradable brushite cements have been evaluated as potential drug 
carriers. Different antibacterial agents, such as chlorhexidine, Nisin F, doxycycline and 
ε-polylysine, have been introduced in both commercial and experimental brushite 
cements. Recent studies have shown the feasibility of drug release from brushite 
cements for periodontal applications (Tamimi et al., 2008). For the treatment of 
common infections in the oral cavity and jaw bone, use of antibiotics was extensive. 
The frequent use of antibiotic-loaded bone cement may increase the chances of 
developing antibiotic resistance (Thomes et al., 2002). Chlorhexidine (CHX) and 
polylysine may offer an alternative to conventional antibiotics.  
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2.10.1 Chlorhexidine 
 Chlorhexidine (CHX) is a highly effective non-antibiotic with antibacterial 
properties. CHX has been used extensively in dentistry mostly for the treatment of 
periodontal infection (Heasman et al., 2001) and as an anti-plaque mouthwash (e.g. 
Corsodyl TM). CHX has a broad spectrum of activity against both gram-positive and 
negative bacteria, yeast, dermatophytes and some viruses (Hassan et al., 2008). 
However, the presence of CHX might interfere with the hydrolysis reaction of any 
brushite cements systems (Hofmann et al., 2006b, Bohner et al., 2006). Furthermore, 
CHX release was found to be rapid due to porosity of brushite cements thus limiting the 
desired antimicrobial effectiveness (Young et al., 2008). This has led us to consider a 
new natural biomaterial by its physico-chemical properties, controlled release capability 
as well for its antimicrobial activity. This agent is polylysine. 
 
2.10.2 ε-Polylysine 
ε-Polylysine is pale yellow powder and has a slightly bitter taste. Epsilon (ε) 
refers to the linkage of the lysine molecules. ε-Polylysine belongs to the group of 
cationic polymers. The systematic name of ε-polylysine is (S)-poly (amino (2-amino-1-
oxo-1, 6-hexanediyl). ε-Polylysine is a basic polyamide that consist of 25-30 residues of 
L-lysine, one of essential amino acids. It is linked by peptide bond formed with α-
carboxyl of L-lysine and ε-azyl from another L-lysine. It has strong hygroscopicity and 
easily soluble in water and hydrochloric acid but not in organic solvents such as alcohol 
or ether. The chemical formula of ε-polylysine is:  
 
      
 
Figure 2-1: The chemical structure of ε-polylysine 
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In water, ε-polylysine contains a positively charged hydrophilic amino group. ε-
Polylysine has a molecular formula for the typical homopolymer molecule of 
C180H362N60O31 and a molecular weight of approximately 4700 (Hiraki et al., 2003). ε-
Polylysine is commercially produced by Streptomyces albulus ssp under aerobic 
conditions. The Gram-positive bacterium S.albulus ssp.lysinopolymerus strain 346 was 
first isolated from Japanese soil (Shima et al., 1984). A mutant of strains 346 which 
produced four times higher amount of ε-polylysine was later isolated (Kahar et al., 
2001, Hamano et al., 2007).   
 
No degradation is observed even when the ε-polylysine solution is boiled at 100 
°C for 30 min or autoclaved at 120 °C for 2 min (Kawai et al., 2003). ε-Polylysine has 
good water solubility, nature, odourless and do not affect food flavour. ε-Polylysine has 
hydrophobic methylene groups on the inside and amino groups on the outside of the 
molecule in polar solution. ε-Polylysine molecules are cationic and surface active due 
to the positively charged amino groups in water. Cationic surface active compounds 
generally inhibit the proliferation of microorganism.  
 
2.10.2.1 Application of ε-polylysine 
Naturally occurring ε-polylysine is water soluble, biodegradable, edible and 
nontoxic toward human and environment. Therefore, ε-polylysine and its derivatives 
have been of interest in food, medicine and electronics industries.  
 
1. ε-Polylysine as preservative  
ε-Polylysine is an approved antimicrobial preservative for food use in 
Japan. ε-Polylysine are used as preservatives in multiple foods including fish 
sushi, boiled rice, soup stocks, sukiyaki, noodles and cooked vegetables. The 
levels of ε-polylysine used in the foods range from 10ppm to 5000ppm. Studies 
have shown that feeding of ε-polylysine to rats using relatively high maximum 
concentrations in the diet of 20,000ppm and 50,000ppm had produced no 
toxicologically significant adverse effect in the animals. ε-Polylysine was 
practically non-toxic in an acute oral toxicity study in rats with no mortality up to 
5g/kg and was not mutagenic in bacterial reversion assays (Fukutome et al., 
1995).  
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Absorption, distribution, metabolism and excretion (ADME) studies of ε-
polylysine revealed low absorption from the gastrointestinal tract and 
approximately 94% ε-polylysine passes unabsorbed through the gastrointestinal 
tract in the faeces. Whole body autoradiography did not show concentration of 
absorbed ε-polylysine in any organ or tissue (Hiraki et al., 2003, (Fukutome et 
al., 1995). The probable reasons for ε-polylysine’s lack of toxicity are its poor 
absorption from the gastrointestinal tract and the absence of any chemical 
moiety of likely hazard in the ε-polylysine polymer (Hamano, 2011).  
 
2. ε-Polylysine as antimicrobial agent 
 
ε-Polylysine has been shown to be an effective antimicrobial by growth 
inhibition studies with yeast, fungi, gram positive and gram negative bacterial 
species, indicating broad-spectrum antimicrobial activity and is stable in a broad 
range of pH (Kito et al., 2002, Yoshida and Nagasawa, 2003). ε-Polylysine is 
believed to exert antimicrobial activity by adsorbing electrostatically onto the 
cellular membrane. The process followed by stripping off the membrane and 
abnormal distribution of the cytoplasm (Shima et al., 1984). ε-Polylysine was 
found significantly potent against streptococcus mutans and total aerobic oral 
microflora with the rate of reduction of microbial counts was proportional to the 
amount of ε-polylysine used (Najjar et al., 2009). Recently, ε-polylysine has 
been immobilized on polyethylene terephthalate fabrics. The immobilized fabric 
showed antimicrobial activity against both Gram positive and Gram negative 
bacteria (Lin et al., 2011).  
 
3. ε-Polylysine as a drug carrier 
ε-Polylysine is available in a large variety of molecular weights. As a 
polypeptide, ε-polylysine can be degraded by cells effortlessly. Therefore, it has 
been used as a delivery vehicle for small drugs (Shen and Ryser, 1981). It can 
also be used as a carrier in the membrane transport of protein and drugs as it 
was found to be easily taken up by cultured cells. The conjugation of drugs to ε-
polylysine markedly increase its cellular uptake and offer a new way to 
overcome drug resistance related to deficient transport (Ryser and Shen, 1980, 
Shen and Ryser, 1981).  
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4.  ε-Polylysine as nanoparticles 
 
Nowadays, ε-polylysine is also being used for gene delivery and 
controlled drug delivery. The epsilon amino group of lysine is positively charged 
at physiological pH. Thus the polycationic polylysine ionically interacts with 
polyanion, such as DNA. In addition, the epsilon amino group is a good 
nucleophile above pH 8.0 and easily reacts with a variety of reagents to form a 
stable bond and covalently attached ligands to the molecule. Nanoparticle 
construct of polylysine has been reported by several studies such as polylysine-
graft imidazole acetic acid-DNA (Locher et al., 2003). Recently, antimicrobial 
activities of multiwalled carbon nanotubes (MWNT) were found to increase by 
coupling it with ε-polylysine using hexamethylene diisocyanate as a coupling 
agent. The new Nano composite showed enhance antimicrobial activity as 
compared to MWNT and killed about 97.6% of E. coli, 91.5% of Pseudomonas 
aeruginosa and 88.5% Staphylococcus aureus. The new MWNT- ε-polylysine 
was found to facilitate its use as antimicrobial material in food and 
pharmaceutical industries (Yu et al., 2011). 
 
5. ε-Polylysine as liposomes 
 
Liposomes are widely used as carrier for a variety of drug and also for 
gene delivery (Ma and Wei, 1996, Waelti and Gluck, 1998). Liposomes offer a 
protective biocompatible and biodegradable delivery system that can enhance 
cellular uptake (Thierry et al., 1993). Biodegradability and low permeability to 
small hydrophilic molecules make liposomes excellent reservoirs for drug 
loading or release. However, liposomes are quite unstable and can release an 
active entrapped compound into the biological fluids. ε-Polylysine coating of 
liposomes stabilizes them against disruption upon adsorption (Michel et al., 
2005, Michel et al., 2004). 
 
6. ε-Polylysine as coating material 
 
ε-Polylysine had been used as the coated tissue for animal cell culture 
(Ahn et al., 2004). ε-Polylysine is also used to improve cell attachment to plastic 
and glass surfaces. Tissue culture flasks with a net negative charge are 
produced by treatment of polystyrene.  
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The negatively charged polystyrene becomes positively charged on its 
surface by coating with ε-polylysine. It was also seen that when a serum-free or 
reduced-serum media was used, the cultivation efficiency of individual cell lines 
was improved by coating the culture surface with ε-polylysine. Many cell types 
adhere better to this surface and are less dependent on the presence of serum 
proteins.  
 
7. ε-Polylysine as lipase inhibitor 
 
ε-Polylysine and taurocholate forms a surface-active complex that binds 
to emulsion particles, thereby retarding lipase adsorption and triacylglycerol 
hydrolysis in both in vivo and in vitro. It was concluded that the ε-polylysine acts 
as an anti-obesity agent and it was found that inhibition increases with the 
degree of ε-polylysine polymerization (Tsujita et al., 2006, Tsujita et al., 2007). 
 
2.11 Citric acid as setting retardant 
As mention earlier, brushite cements have short setting times and are too weak 
to be used in load – bearing areas. Many studies have been done to improve the 
mechanical properties of the set cements. Incorporating setting retardants into the 
brushite cements will help to increase the cements setting time. It will also lead to 
precipitation of smaller crystals and thus an improvement of the mechanical properties 
of the cements (Grases et al., 2000, Bohner M et al., 1996).  
 
Examples of setting retardants used are sodium pyrophosphate, citrate ions 
and sulphates. Pyrophosphate inhibit the crystallization of brushite by binding to the 
crystalline nuclei preventing the incorporation of ions into the crystal lattice, thus 
inhibited the crystal growth. 
 
 The addition of citric acid to the liquid phase improves the setting time, 
injectability and mechanical properties (Barralet et al., 2004). It was reported that all 
these acids prolong the setting reaction with different effects on the mechanical 
properties. For example, citric acid solution produced stronger cements when 
compared to cement produced by lactic acids. However, there is an upper limit to the 
use of citric acids as a setting retardant.  
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When citric acid is used in the cement reaction at concentrations higher than 
800 mM, citrate ions slowly diffuse out of the cement, allowing greater conversion of 
dicalcium phosphate anhydrate (DCPA) into dicalcium phosphate dehydrate (DCPD) 
leading to more heterogeneous and therefore weaker structure (Hofmann et al., 
2006a).  
 
Citric acid anhydrous appears as an odourless white crystalline granule with a 
strong acidic taste. It is very soluble in water, freely soluble in alcohol and slightly 
soluble in ether. The pH of a 0.1 M solution of citric acid is 2.1.Citric acid has three 
carboxyl or - COOH groups. The systematic name for citric acid is 2-hydroxypropane-1, 
2, 3-tricarboxylic acid. Citric acid molecule molecular formula is C6H8O7. Its chemical 
structure is below: 
 
 
 
                        Figure 2-2: The chemical structure of citric acid 
 
Citric acid as an organic acid has the most ability to bind calcium ions enabling 
them to interact with growing brushite cement crystals and inhibit their setting more 
than many other carboxylic acids. (Lilley et al., 2005).  
 
Although adding setting retardant has been shown to improve the mechanical 
performance of brushite cements, there is an upper optimal concentration beyond 
which strength reduction can occur (Hoffmann et al., 2009). Hoffmann also reported 
that at a combination of small particles, reactant and citric acid at concentrations of 800 
mM, the powder to liquid ratio could be raised and provides low porosity cements with 
compressive strength of 52 MPa.  
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Citric acid is a constituent of fruit soft drinks and other food products. One of the 
most common citric acid uses is for preserving foods. It is also added to provide a sour 
and acidic taste to food and drinks. It can easily mix with water thereby, making it 
acidic. Other uses include flavour enhancement, bacterial inhibitor, pH adjustment, and 
as an anti-oxidant. 
 
2.12 Summary 
Early tooth loss will result in alveolar bone loss and subsequently complicate 
treatment outcomes. Alveolar bone resorption as a sequel to premature tooth loss 
results in loss of bone height and volume. This results in aesthetic and functional 
issues in the area of tooth extraction site. It is also leads to inadequate bone for ideal 
implant positioning or placement.  As such, an ideal outcome in the young patient with 
missing teeth either due to trauma or caries or with poor prognosis teeth is to preserve 
bone and soft tissue as long as possible. This will help to improve restorative options 
that can be offered in adulthood after growth has ceased (Day et al., 2008).  
 
These have led to various materials and protocols to preserve or regenerate 
alveolar bone. Thus, the development of brushite cements as a potential bone 
substitute may offer clinicians the opportunity of preserving alveolar bone. The 
combination of self – setting nature, moldability, injectability, biocompatibility, 
remineralising antibacterial effect and also other properties suggests a great potential 
of brushite cements in regenerative therapy.  
 
An important benefit is their ability to act as a reservoir of calcium and 
phosphate ions for remineralisation of hard tissue. Brushite cement is biocompatible, 
bioresorbable and has the osteoconductive properties (Bohner et al., 2000a). Due to its 
excellent bioresorbality, woven bone might substitute the cement after the implantation 
(Bohner et al., 2000a, Dorozhkin, 2008).  
 
Brushite cements are also easy to manipulate and have excellent moldability. It 
can adapt to shape of bone defect and rapidly integrated into the bone structure. It will 
then transform into the new bone by cellular action of the bone cells that is responsible 
for bone remodelling. However, several issues may limit their application. Firstly, 
brushite has a rapid setting reaction which results in: 
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 High porosity – this makes brushite cement relatively weak and gives 
rapid drug release properties  
 
 Weak mechanical strength limiting clinical application. Mechanical 
properties can be improved by using small particle size reactant and 
by adding additives or free ions. 
 
Brushite cements have very short setting time. The original composition of 
brushite cements set within 30 seconds of mixing (Mirtchi et al., 1989). Setting time of 
brushite cements can be increased to a workable length through: 
 
 Using low powder to liquid ratio, or 
 Adding additives or setting retardants 
 
The drawback of low powder to liquid ratio is that the end product will have a 
higher porosity and therefore lower strength. In contrast to ratio manipulation, the effect 
of setting retardant led to precipitation of smaller crystal and thus results in an 
increased setting time, an improvement of mechanical strength and injectability of the 
brushite cement. Examples of setting retardant used are sulphuric acid, sodium 
pyrophosphate and sodium citrate solution (Bohner M et al., 1996).  
  
Material degradation is good for bone repair as it enables full bone remodelling 
but with brushite cements this property can be difficult to control. The drug release from 
brushite cements has been shown to be very rapid. This problem can be addressed by 
modifying the porosity of the cements and by in-cooperating polymer into the 
composition (Bohner et al., 2006). Brushite cement adhesion to the bone also may be 
limited.   
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3 AIM AND OBJECTIVE 
3.1 Aim: 
The aim of this study to produce high strength brushite cements with release of a novel 
antimicrobial ε-polylysine. 
 
3.2 Null Hypothesis  
The null hypothesis was that the addition of citric acid (CA) and / or ε-polylysine (PLS) 
would not improve the mechanical properties, handling and setting characteristics  
 
3.3 Objectives: 
The objectives of these studies are: 
1) To optimize the size of the reactant particles with regards to the handling 
properties and strength. 
2) To optimize the powder to liquid ratio 
3) Assess the effect of varying concentrations of PLS.  
 
This research involves monitoring of the following parameters: 
i) Strength and modulus 
ii) Reaction kinetics 
iii) Cements degradation  
iv) Polylysine release profile 
v) Microstructure 
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4 MATERIAL AND METHODS 
4.1 Materials 
 
Table 4-1: Summary of materials used in experimental brushite cements 
Name Abbreviation Formula Particle sizes 
(µm) 
Monocalcium phosphate 
monohydrate (HIMED)    
MCPM 1 Ca(H2PO4)2.H2O 50 micron 
Monocalcium phosphate 
monohydrate (SIGMA)    
MCPM 2 Ca(H2PO4)2.H2O - 
β-Tricalcium phosphate                                           β-TCP 4 Ca3(PO4)2 4 micron 
β-Tricalcium phosphate                                           β-TCP 6 Ca3(PO4)2 6 micron 
β-Tricalcium phosphate                                           β-TCP 8 Ca3(PO4)2 8 micron 
β-Tricalcium phosphate                                           β-TCP 12 Ca3(PO4)2 12 micron 
β-Tricalcium phosphate                                           β-TCP 34 Ca3(PO4)2 34 micron 
ε-Polylysine PLS C18H36N6O3X2 - 
Citric acid                                         CA C6H8O7 - 
Distilled water -          H2O - 
 
4.1.1 Powder   
4.1.1.1 Monocalcium phosphate monohydrate  
Initial brushite cements were prepared by mixing water with a powder consisting  
of an acidic calcium phosphate and a basic calcium phosphate. The brushite cements 
has calcium to phosphate ratio of 1. Therefore, the source of acidic phosphate ions 
should have a calcium to phosphate ratio lower than 1. The only calcium phosphates 
with this property are monocalcium phosphate monohydrate (MCPM) and monocalcium 
phosphate anhydrous (MCPA). However, the presence of a water molecule in MCPM 
facilitates the setting reaction. These results in cements with better properties that are 
easier to handle compared to cement with MCPA.  
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In this study, MCPM (MW=252 g/mol) was obtained from 2 different 
manufacturers, Himed Medical, US and Sigma-Aldrich, UK. MCPM Himed has particle 
size 53 micron as quoted by the supplier. There was no information with regards to 
particle size of MCPM Sigma provided by the supplier. 
 
 
               Ca (H2PO4)2 -H2O 
 
Figure 4-1: The chemical structure of MCPM 
 
4.1.1.2 β – tricalcium phosphate 
The alkaline calcium source has a calcium to phosphate ratio of 1, therefore a 
compound with a ratio higher than 1 can be used as the alkaline source. The most 
common basic calcium source in brushite cements is tricalcium phosphate (TCP) which 
has a calcium to phosphate ratio of 1.5. It has two crystallographic forms; either β – 
tricalcium phosphate (β-TCP) or α –TCP. β-TCP was the one used in the original 
cement formula presented by Mirtchi (1989). 
 
β-TCP (MW=310 g/mol) with a particle size ranging from 4 micron to 34 micron 
was obtained from Plasma Biotal LTD, UK. The particle sizes were as quoted from the 
supplier as shown in table 4.2. 
 
 
              Ca3 (PO4)2 
 
Figure 4-2: The chemical structure of β - TCP 
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Table 4-2: The chemical structure of β-TCP particle characterisations (quoted 
from suppliers) 
β-TCP Size d10 
µm 
Size d50 
µm 
Size d90 
µm 
Surface 
area m2/g 
Solubility at 
25°C   -logKs 
β-TCP 1 2.1 4.32 8.8 1.65 28.9 
β-TCP 2 3.0 5.78 12.5 1.28 28.9 
β-TCP 3 3.4 7.76 18.0 1.49 28.9 
β-TCP 4 2.82 12.03 27.73 --- 28.9 
β-TCP 5 7.89 33.8 53.6 0.3533 28.9 
 
 
4.1.1.3 ε-polylysine 
ε-polylysine powder was used in the formulation for its antimicrobial. ε-
polylysine was purchase from Handary, Spain. ε-polylysine or Epolyly 
®
 P is 
pharmaceutical grade. Epsilon – polysine is a small polypeptide of the essential amino 
acid L – lysine. It is produced by bacterial fermentation from Streptomyces strains 
growing in Lunia – Bertani bacterial culture media, fully renewable and non – GMO 
(genetic modified). 
 
 
        (C6H12N2O) n 
 
Figure 4-3: The chemical structure of ε-polylysine 
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4.1.2 Liquid  
4.1.2.1 Citric acid 
Citric acid crystals were purchased from Fisher, Longborough, UK. These were 
mixed with distilled water to produce a concentration of 800 mM. 
 
 
  C6H8O7 
 
Figure 4-4: The chemical structure of ε-polylysine 
 
4.2 Methods 
4.2.1 Cement and disc preparation 
  The cement powder consisted of 1.00 g of MCPM and 1.23 g of β-TCP. For all 
experimental formulations, powder phase and liquid phase were weighed using a four-
figure balance. Powders were hand mixed with aqueous solutions on a glass plate to 
produce the cement paste and start the setting reaction. Both powders were mixed for 
about 10 seconds before adding the liquid phase until a homogenous consistency was 
established. Metal washer rings of 10 mm internal diameter and 1 mm depth were used 
as the moulds to prepare the cement discs.  
 
Excess cement was removed with the spatula before sealing top and bottom 
cement with acetate sheet. After mixing, cements were left to set at room temperature 
for 24 hours. The samples were then removed from the moulds and excess material 
removed to get smooth edges. The samples were then placed in a plastic bottle before 
testing as dry samples.  
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For wet samples, the cements were then immersed in 10 ml of distilled water in 
sterilin tubes and left for another 24 hours at 37°C. The cements were then blotted dry 
before testing. The set cement discs were used in mechanical, microstructure, 
degradation and drug release studies. Six samples of each formula were prepared for 
mechanical testing. Five samples for each individual formula were used for testing pH, 
degradation and ε-polylysine release.    
 
4.2.2 First series  
The first series of experimental cements were prepared by using powder 
consisting of 1.23 g TCP (4 to 34 microns) and 1.00 g MCPM from Himed (MCPM 1) or 
Sigma (MCPM 2). The liquid phase consisted of aqueous citric acid (CA) 800 mM with 
powder to liquid ratio (PLR) of 3.3:1 (i.e. 0.68 g of liquid). 
 
4.2.3 Second series 
 For the second series, cements were prepared with PLR of 3.3:1 and 4:1 using 
MCPM 2 (1.00 g) and TCP (1.23 g) particle size of 34 micron as powder phase. The 
liquid phase (0.68 or 0.56 g) was prepared by diluting increasing percentages (10, 20, 
30, 40 and 50 wt %) of ε-polylysine powder in the CA 800 mM solution.  
 
Solutions were stirred until all the powder dissolved and a homogenous liquid 
was produced (see Table 4.2 and table 4.3). In the control formulation, only CA 800 
mM was used as a liquid phase without adding the ε-polylysine powder in 3.3:1 and 4:1 
weight ratio.  
 
 
 
 
 
 
 
 
 
 
66 
 
Table 4-3: Formulation of cements at second series with PLR 3.3:1 
Formulation 
Code 
MCPM Sigma 
powder (g) 
TCP 34micron 
powder (g) 
800mM citric 
acid solution (g) 
ε-polylysine 
powder (g) 
PLS 0% 1.00 1.23 0.68 0 
PLS 10% 1.00 1.23 0.61 0.07 
PLS 20% 1.00 1.23 0.54 0.14 
PLS 30% 1.00 1.23 0.48 0.20 
PLS 40% 1.00 1.23 0.41 0.27 
PLS 50% 1.00 1.23 0.34 0.34 
 
 
Table 4-4: Formulation of cements at second series with PLR 4:1 
Formulation 
Code 
MCPM Sigma 
powder (g) 
TCP 34micron 
powder (g) 
800mM citric 
acid solution (g) 
ε-polylysine 
powder (g) 
PLS 0% 1.00 1.23 0.56 0 
PLS 10% 1.00 1.23 0.50 0.06 
PLS 20% 1.00 1.23 0.44 0.12 
PLS 30% 1.00 1.23 0.39 0.17 
PLS 40% 1.00 1.23 0.34 0.22 
PLS 50% 1.00 1.23 0.28 0.28 
 
 
Figure 4-5: Image showing mixed set cement and its ring mould 
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Figure 4-6: Flowchart of experimental design 
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4.2.4 Mechanical Property Studies 
4.2.4.1 Biaxial flexural strength  
Biaxial flexural strength (BFS) and flexural modulus of the cements were 
measured by using an Instron mechanical testing frame. BFS is the maximum stress 
experienced in the material at its moment of rupture when subjected to bending load. A 
number of standard tests such as compressive and diametral tensile have been used 
for testing mechanical properties of brushite cements. In this study, the BFS test was 
selected over the compressive test. A recent study had showed that brushite cement 
can produce high compressive strength (as discussed earlier); however they are brittle 
and unable to withstand high tensile stresses. Therefore tensile strength is an 
important factor that may influence the clinical success (Zhang et al., 2004). This is due 
to possible application of this cement as dental material which can be subjected to 
flexural stress during mastication.   
 
Standard test methods for determining the flexural strength are either uniaxial 
or biaxial flexural strength (BFS). BFS tests have several advantages over uniaxial test. 
In this test the disc of the cement prepared is supported near its periphery by a 
continuous ring shaped structure and later loaded by a coaxially located ball. In 
addition the disc shape is circularly symmetrical; the stress field is equibiaxial in the 
central region in which it is at a maximum. Therefore, this method will minimise the 
effect of the test specimen edge preparation because the generated stresses are 
lowest at the test specimen edges as shown in figure 4.7 and figure 4.8 (Chung et al., 
2004)  
 
In BFS test, a thin disc is supported by a ring near its periphery and loaded 
through a smaller coaxial ring, a piston or a ball in its central region. The disc is 
subjected to biaxial movement in its central region and the stress is the biaxial in this 
region. BFS is also relatively simple and accurate procedure for preparing the 
specimens. This will help to reduce the operator-induced variability and improves the 
standard for assessing mechanical properties of the cements. 
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4.2.4.2 Biaxial flexural modulus  
Young’s modulus is a measurement of stiffness or elasticity of a material. It 
indicates how much a material will stretch when put under a given stress and resists 
elastic deformation. This can be experimentally determined from the slope of a stress-
strain curve created during tensile tests conducted on a sample of the material. The 
Instron machine produces data in pound (lbs.) and inches, so the data needed to be 
converted to Newton (N) and millimetres (mm). From the load -displacement data, a 
graph was plotted for each sample (load against displacement) to determine the slope 
required for the calculation of modulus based on the following equation showed below:  
  
  E =     
     
Equation 1 
Where: 
∆P/∆W       change in force/change in displacement  
                  gradient of the force displacement curve. 
E            elastic modulus of the disc (from BFS test). 
 βc        central deflection function. For a ball on ring geometry βc is 0.502 
(Higgs et al., 2001) 
 
4.2.5.3 Toughness  
Toughness was determined by measuring the area underneath the stress-strain 
curve. Toughness indicates how much energy a material can absorb before rupturing. 
 
                Energy                           ϵƒ 
                                 =                
                                                          σdϵ 
                 Volume                      0              
                                                                                                 Equation 2 
Where: 
ϵ  strain 
 strain upon failure 
σ  stress 
∆P 
-------- 
∆W 
βca2 
-------- 
t 3 
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4.2.4.4 Test method  
The strength and modulus was determined by biaxial flexural strength testing 
method using the Instron Model 4505 Universal Testing Machine. Each composition 
was replicated into 6 discs of 10 cm diameter and approximately 1mm thickness. For 
dry samples, cements were left to set at room temperature for 24 hours before testing.  
 
For wet samples, the cements were then placed in plastic bottle containing 
10ml distilled water and left in the incubator for another 24 hours at 37°C. This was to 
act as a simulator of the clinical environment. All the wet samples were blotted dry 
before testing was undertaken. For each sample thickness, t was measured (mm) 
accurately to 0.001 mm at three different points and the average thickness recorded.  
 
The hydrated disc / dry sample then were loaded using a spherical tip in an 
Instron mechanical testing jig and the maximum load at break recorded. The specimen 
disc was placed on the knife edge ring support (radius a = 4mm) and then loaded by 
the spherical tip. The instrument crosshead speed was set at 1mm / min. 
 
 The maximum load (kN) at fracture, P and load versus central displacement 
gradient, dP/dw were determined. The strength for each sample was calculated by 
using the average thickness of the cements obtained and the maximum load recorded 
by the computer.  This was calculated using the following formula by Timoshenko 
(Timonshenko and K.S, 1964): 
 
 
 
 
 
Equation 3 
 
Where: 
σ  is biaxial flexural strength. 
P is maximum load. 
a  is support radius. 
t  is average thickness of specimen. 
Ω         is Poisson’s ratio= 0.3 (Charriére et al, 2001) 
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Figure 4-7: Schematic diagram of biaxial flexural strength test. 
 
 
 
 
 Top view 
 
 
 
 
 
 
 
 
 Front view 
 
     
 
       Central axis 
Figure 4-8: Blue area demonstrated the maximum stress region. The stresses are 
equally distributed along its radial direction in which the stresses generated at 
the edge of the specimen are the lowest.  
Set cement 
                                                   a 
 
Set cement 
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4.2.5 Study on setting kinetics 
4.2.5.1 FTIR spectroscopy 
Fourier Transform Infrared (FTIR) spectroscopy uses infrared radiation to 
assess molecule movement vibration. It can help identify relative levels of different 
chemicals in mixtures. With this spectroscopy, infrared radiation is passed through a 
sample. Some of the infrared radiation is absorbed by the sample and some of it is 
passed through or transmitted.  Different chemical bonds absorb different frequencies 
of infrared radiation. The resulting spectra have peaks characteristic of different 
chemical groups at high wavenumbers and ﬁngerprint region unique to each chemical 
at lower wavenumbers.  
 
4.2.5.2 Test method  
Setting reaction and kinetics of the cements was assessed using a Perkin 
Elmer Series 2000 Fourier Transform Infra Red (FTIR) spectrometer (Beaconsfield, 
UK). The background of the instrument was scanned first using an ATR diamond 
attachment without any sample. This was done to ensure that the ratio of light intensity 
through the instrument either with or without the sample could be calculated by the 
computer. Scan number was set at 4 with wavenumbers range 500 to 4000 cm-1 and 
resolution of 8 cm-1.   
 
 For experiments with powder to liquid ratio 3.3:1, approximately 0.43g of each 
formulation paste was used. With powder to liquid ratio 4:1, each formulation was 
prepared by mixing 0.40g powder phase with 0.1g liquid phase. Spectra were obtained 
from within the 60 second from the start of cements mixing using Time-based software 
(Perkin Elmer).  
 
The FTIR time base program is set to start once both of the MCPM and β-TCP 
powders were mixed together. The powder phases of reactants were hand-mixed for 
10 second before the addition of the liquid phase. The unset cements were loaded 
immediately into the metal ring which is put over the centre of an ATR-FTIR diamond at 
37°C within 60 second of mixing the powder and liquid. A layer of acetate sheet was 
placed on top of the cement loaded into the ring.  
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Excess cement was expressed from the side of the metal ring using finger 
pressure over the acetate sheet to ensure contact of the specimen with the diamond 
piece and to standardize the thickness of specimen to about 1 mm. Each experiment 
was set to last for 60 minutes. The setting reactions however were not completed after 
60 minute for experiment containing 30, 40 and 50 wt % of ε-polylysine. Therefore, the 
scan time was extended up to 120 minutes. Spectra were obtained every 6.4s within 60 
seconds from initial cement mixing. Three individual specimens for each of the six 
formulations of brushite cement were scanned. 
 
4.2.6 Scanning electron microscopy (SEM) 
Scanning electron microscopy (SEM) was used to investigate the effect of 
adding citric acid and ε-polylysine on the microstructure of brushite cements. SEM is an 
instrument that produces a magnified image by using electrons instead of light. It uses 
a focused beam of high-energy electrons to generate a variety of signals at the surface 
of solid specimens. A beam of electrons is produced at the top of the microscope by an 
electron gun. The beam travels through electromagnetic fields and lenses, which focus 
the beam down toward the sample. A series of electromagnetic coils pull the beam 
back and forth, scanning it slowly and systematically across the specimen's surface.  
 
The electrons that are reflected off the specimen, known as secondary 
electrons are collected and converted into a signal directed at a screen, similar to 
a television screen. This produces the final image. The signals that derive from 
electron-sample interactions reveal information about the sample including external 
morphology (texture), chemical composition, and crystalline structure and orientation of 
materials making up the sample. All non-metals samples need to be made conductive 
by covering the sample with a thin layer of conductive material.  All water also must be 
removed from the samples because the water would vaporize in the vacuum. 
 
4.2.6.1 Test method for microstructure 
Scanning electron microscopy (Phillip XL-30, Eindhoven, The Netherland) was 
used to examine the morphology of each MCPM, β-TCP and ε-polylysine powder at 
primary beam energy of 5kV and approximately 200 pA.  
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The set brushite cements surface and cross-sectional fracture was also 
determined by using the same method.  The prepared cements were snapped in order 
to obtain cross-sectional fracture image. Firstly, cements were coated by placing it on 
aluminium stubs and sputtered by gold-palladium under vacuum (Polaron E5000, 
Quorum Technology, UK) for 90 seconds at 20 mA. 
 
 For dry samples, the cements were left to set for 24 hours after mixing before 
test was done. For wet samples, the set cements were place in the sterilin tube 
containing 10ml water for another 24 hours at 37°C. Afterward, the cements were 
blotted dry and left again for 24 hours at room temperature before being vacuum and 
ready to be used with SEM. High resolution images of the cement were taken at 
different magnification (x500, x1500, x2500, x3500 and x5000).   
 
4.2.7 Degradation study 
4.2.7.1 Test method for degradation study 
For each formulation, a set of 5 discs (n=5) were prepared and weighed before 
being immersed in 10ml of distilled water in sterilin tubes and kept at 37°C. Each of the 
cements were then removed, blotted dry, weighed again and then replaced in fresh 
distilled water at time points of 1, 2, 4, 6, 24, 72, 168, 336 and 672 hours. All the 
solutions were kept aside for pH analysis and polylysine release. Mass change was 
calculated as:  
 
    (m0 – m t)   x100 
  ∆m (%) =    
m0 
                                 
 
         Equation 4 
 
Where  
m0 is sample mass initially 
mt is sample mass at time 
∆m mass change 
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4.2.8 pH studies 
4.2.8.1 Test method for pH study 
The solutions from the degradation study at different time points were all kept in 
the fridge at 4°C. The solutions were then examined with Jenway 3340 pH/Ion Meters 
(BDH, Poole, Dorset, UK) at room temperature. Before beginning the test, the machine 
was calibrated at pH 3, 7 and 10. The Ion Meter was washed with distilled water every 
time before putting in different solutions to eliminate impurity. From the definition of pH 
 
 [H+] = 10-pH       
Equation 5 
 
[H+] is the acid concentration in moles/l.  This can be converted to acid release 
(in moles) in 10 ml of storage solution by dividing by 100.  Cumulative release is then 
obtained by summing all acid release up to each given time point.      
 
4.2.9 Drug release study 
4.2.9.1 Test method for ε-polylysine (PLS) release profile 
For ε-polylysine (PLS) release, the absorbance of different storage solutions 
from mass loss studies was obtained using the Unicam Ultraviolet-visible (UV) 500 
spectrometer (Thermo Spectrotonic, UK) for a period of up to 4 weeks. Several 
methods were attempted to detect the PLS release. In the following however, Trypan 
blue assay (TB assay) method was used.  
 
There were a few steps needed to be done to produce the TB solution (also 
known as working reagent solution). First of all, 8000 ppm of TB solution was prepared 
by dissolving 0.080 g of TB in 10 ml distilled water. The solution then was diluted 
further by mixing 1 ml of 8000 ppm solution with 99 ml of distilled water to produce 80 
ppm of TB solution which can be used up for 6 month.  
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For determination of a calibration curve, standard PLS solutions were prepared 
in distilled water. PLS solutions of 2, 4, 8, 10, 14, 18 and 20 ppm were made using the 
following dilutions: 
i) 10,000 ppm solution: 0.10000 g of PLS mixed  with 10 ml distilled water 
ii) 100 ppm solution: 1 ml of 10,000 ppm mixed with 99 ml distilled water 
iii) 20 ppm solution: 10 ml of 100 ppm mixed with 40 ml of distilled water 
iv) 18 ppm solution: 18 ml of 20 ppm mixed with 2 ml of distilled water 
v) 14 ppm solution: 14 ml of 20 ppm mixed with 6 ml of distilled water 
vi) 10 ppm solution: 1 ml of 100 ppm mixed with 9 ml of distilled water 
vii) 8 ppm solution: 8 ml of 10 ppm mixed with 2 ml of distilled water 
viii) 4 ppm solution: 4 ml of 10 ppm mixed with 6 ml of distilled water 
ix) 2 ppm solution: 2 ml of 10 ppm mixed with 8 ml of distilled water 
 
The same amount of prepared TB solution and the above PLS solutions were 
mixed to produce PLS standard solutions of 1, 2, 4, 5, 7, 9 and 10 ppm.  The mixture 
was left in the incubator for 1 hour at 37oC and then cooled at room temperature for 
about 4 hours. All the mixture solutions were then centrifuged at 13,000 rpm for 20 
minutes to remove any TB dye that has reacted with PLS. The supernatant solution 
was taken and dispensed in 1.5 ml disposable cuvettes. The absorption spectrum was 
recorded against distilled water as reference buffer between 200 nm – 800 nm with the 
maximum absorbance of the TB dye being observed at 580 nm.  A standard graph was 
then determined by plotting the different concentrations of PLS against the absorbance 
(Grotzky, Manaka et al, 2010). 
 
 In order to determine the amount of antimicrobial release, the solutions from 
degradation study (n=5) at different time points were kept in the fridge at 4°C until 
analysis. For analysis the same amount of TB solution and storage solution was mixed, 
reacted and tested as mention above. Finally, the amount of release was calculated 
using the following equation: 
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                                                                  x 2V 
          % of PLS =                                  x 100 
                                                       M 
         Equation 6 
Where:  
C cumulative concentration of PLS (ppm) 
V volume of storage solution (10 ml) 
M  total mass PLS in sample 
 
The factor 2 accounts for dilution of the storage solution by the dye.  M is equal to: 
 
(Initial mass of specimen)    X (   % of mass PLS in CA)   X 
(Weight fraction of liquid in the specimen) (0.2g) 
 
         Equation 7 
 
4.2.4 Data analysis 
In order to assess mechanical behaviour, PLS release and mass changes at 
each formula, data were analysed by comparing the mean and standard deviation. The 
effect of the different MCPM, PLR and wt % level of PLS on development brushite 
cement was analysed using univariate analysis of variance for all variables and simple t 
test where appropriate using SPSS 22.   In addition, for line fitting the function linest in 
excel was used.  This gives gradients and intercepts in addition to their standard errors.  
95% confidence intervals were estimated assuming they were equal to 2 times 
standard error.   
 
4.2.4.1Simple T test 
 This test is used for comparing the means of two samples. The t-test compares 
the actual difference between two means in relation to the variation in the data 
(expressed as the standard deviation of the difference between the means). In this 
study, the T test where used with mechanical study result. 
C x 10-6 
78 
 
4.2.4.2 Univariate Analysis of Variance 
 Univariate analysis is the simplest form of quantitative (statistical) analysis. It 
explores each variable in a data set, separately. It looks at the range of values, as well 
as the central tendency of the values. It describes the pattern of response to the 
variable as it’s describes each variable on its own. In this study, six samples were 
made for each formula for testing the effect and changes of different MCPM, PLR and 
wt % level of PLS on the mechanical behaviour on the new development brushite 
cement to investigate any evidence of differences between them at the significance 
level 0.05.  
 
4.2.4.3 Error bar analysis 
Throughout this study, 95 % confidence interval (CI) of the mean was 
calculated using: 
 
  1.96 X SD 
CI =  
                √n 
Equation 8 
 
SD  standard deviation 
n  number of samples  
 
Samples prepared were six for mechanical study and five for acid release, degradation 
study and PLS release). Results were considered significantly different when the CI 
error bars did not overlap. 
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5 RESULTS 
5.1 Mechanical properties 
5.1.1 Biaxial flexural strength (BFS) 
5.1.1.1 Biaxial flexural strength with different MCPM and β-TCP particle sizes 
 The mean and 95% confidence intervals of biaxial flexural strength (BFS) using 
different MCPM and TCP with CA 800 mM are presented in Table 5.1. Varying MCPM 
source had no significant effect (p > 0.05) on the flexural strength. Increase in particle 
size however, significantly (p < 0.05) increased the strength as seen by the gradients 
being larger than the error on the gradient. This was additionally confirmed using T – 
test and Univariant test (appendix 1). The highest result was 30.0 MPa with MCPM 2 
and β-TCP particle size of 34 micron. 
 
Table 5-1: Biaxial flexural strength / MPa for different MCPM and β-TCP (n=6). 
 Biaxial flexural strength / MPa (95% CI) 
Different MCPM / Different TCP MCPM Himed (1) MCPM Sigma-Aldrich (2) 
TCP  4 micron  22.2 (2.4) 22.3 (1.7) 
TCP 6 micron  22.5 (2.7) 22.7 (2.7) 
TCP 8 micron  23.0 (2.2) 24.0 (2.4) 
TCP 12 micron  26.4 (2.7) 27.5 (2.8) 
TCP 34 micron  28.5 (1.8) 30.0 (1.1) 
Gradient (95% CI)  0.2 (0.1) 0.3 (0.1) 
Intercept (95% CI) 21.9 (1.8) 22.1 (2.2) 
 
 
Figure 5-1: Biaxial flexural strength (error bars are 95% CI with n=6) for different β-TCP 
and MCPM particle sizes with CA 800mM at PLR 3.3:1. 
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5.1.1.2 Biaxial flexural strength with different powder to liquid ratios (PLR) 
 
The mean and 95% confidence intervals of biaxial flexural strength (BFS) for 
dry samples with increasing percentage of ε-polylysine (PLS) and different PLR 3.3:1 
and 4:1 are presented in Table 5.2. Cements were prepared using MCPM 2, β-TCP of 
34 micron and CA 800mM with increase wt % of PLS showed increase in dry flexural 
strength upon raising PLR from 3.3 to 4.  This is seen as a significant change in the 
intercepts (p < 0.05). The gradients show a reduction in strength with increasing wt % 
of PLS (appendix 2).  
 
Table 5-2: Biaxial flexural strength / MPa for dry samples with different PLR 3.3:1 
and 4:1 (n=6) with increase wt % PLS. *indicates results in two columns are 
significantly different. 
 Biaxial flexural strength / MPa (95% CI) 
Cement code (PLS %) PLR 3.3:1 PLR 4:1 
PLS 0% 30.0 (1.1) 32.5 (1.7) 
PLS 10% 27.9 (1.5) 34.6 (1.8) * 
PLS 20% 25.8 (2.6) 32.4 (2.9) * 
PLS 30% 24.3 (1.4) 30.7 (1.7) * 
PLS 40% 23.7 (2.7) 30.0 (2.2) * 
PLS 50% 23.0 (2.7) 26.5 (2.5) 
Gradient (95% CI)   -14.0 (3.4) -13.0 (7.2) 
Intercept (95% CI) 29.3 (1.0) 34.4 (2.2) * 
 
 
 
Figure 5-2: Biaxial flexural strength (error bars are 95% CI with n=6) for different PLR with 
increase wt % PLS. 
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5.1.1.3 Biaxial flexural strength of wet and dry samples 
The mean and 95% confidence intervals of biaxial flexural strength (BFS) for 
wet and dry samples with ε-polylysine (PLS) are compared in Table 5.3 and Figure 5.3 
Cements were prepared using MCPM 2, β-TCP of 34 micron and CA 800mM with 
increase wt % of PLS at PLR 4:1. Flexural strength decreased after 24 hours water 
immersion. Significant difference (p < 0.05) can be observed between wet and dry 
samples as seen in appendix 3. Wet samples strength however, barely changed on 
raising the level of PLS.  
 
Table 5-3: Biaxial flexural strength / MPa for dry samples and wet samples with 
PLR 4:1 (n=6) with increase wt % PLS. *indicates results in two columns are 
significantly different. 
 Biaxial flexural strength / MPa (95% CI) 
Cement code (PLS %) Dry samples Wet samples 
PLS 0% 32.5 (1.7) 18.3 (3.1) * 
PLS 10% 34.6 (1.8) 20.4 (2.0) * 
PLS 20% 32.4 (2.9) 19.9 (1.5) * 
PLS 30% 30.7 (1.7) 17.9 (1.5) * 
PLS 40% 30.0 (2.2) 17.7 (1.3) * 
PLS 50% 26.5 (2.5) 13.7 (1.2) * 
Gradient (95% CI) -13.0 (7.2) -9.5 (8.4) 
Intercept (95% CI) 34.4 (2.2) 20.3 (2.6) * 
 
 
Figure 5-3: Biaxial Flexural Strength (error bars are 95% CI with n=6) for dry and wet 
samples with increase wt % PLS. 
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5.1.2 Biaxial flexural modulus (Young’s modulus)  
5.1.2.1 Biaxial flexural modulus of different MCPM and β-TCP particle sizes 
Figure and Tables 5.4 show the Young’s modulus for each sample. The error 
bars show the 95% confidence interval. For formulation with different MCPM and TCP 
particle sizes, only MCPM 2 showed a small but experimentally significant (p < 0.05) 
increased modulus with increase TCP particle size as seen in appendix 1. 
 
Table 5-4: Biaxial flexural Modulus / GPa for different MCPM and β-TCP (n=6). 
 Young’s Modulus / GPa (95% CI) 
Different MCPM / Different TCP  MCPM Himed (1) MCPM Sigma-Aldrich (2) 
TCP  4 micron  2.6 (0.4) 1.8 (0.5) 
TCP 6 micron  1.9 (0.7) 2.1 (0.4) 
TCP 8 micron  2.6 (0.7) 2.4 (0.9) 
TCP 12 micron  2.9 (0.6) 2.7 (0.9) 
TCP 34 micron  2.4 (0.5) 3.5 (1.1) 
Gradient (95% CI) 0.0 (0.0) 0.1 (0.0) 
Intercept (95% CI) 2.5 (0.6) 1.9 (0.4)  
 
 
Figure 5-4: Biaxial Flexural Modulus (error bars are 95% CI with n=6) for different β-TCP 
and MCPM particle sizes (n=6). 
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5.1.2.2  Biaxial flexural modulus of different powder to liquid ratio (PLR) 
The mean and 95% confidence intervals of biaxial flexural modulus (Young’s 
modulus) for dry samples with increase wt % of ε-polylysine (PLS) at different PLR 
3.3:1 and 4:1 are presented in Table and Figure 5.5. This formulation was prepared by 
using MCPM 2, β-TCP 34 micron and CA 800 mM with increase wt % PLS. On 
average there was a slight increase of modulus upon increasing the PLR from 3.3:1 to 
4:1. The effect of increasing PLS was not experimentally significant (p > 0.05) except 
with 20 wt % PLS as seen in appendix 2 with 95% confidence. 
 
Table 5-5: Biaxial flexural modulus / GPa for dry samples with different PLR 3.3:1 
and 4:1 (n=6) with increase wt % ε-polylysine. *indicates results in two columns 
are significantly different. 
 Young’s Modulus / GPa (95% CI) 
Cement code (PLS %) PLR 3.3:1 PLR 4:1 
PLS 0% 3.3 (0.6) 3.3 (0.8) 
PLS 10% 2.7 (0.4) 3.4 (0.8) 
PLS 20% 2.2 (0.2) 3.7 (0.9) * 
PLS 30% 2.8 (0.5) 3.4 (0.7) 
PLS 40% 2.7 (0.4) 3.2 (0.6) 
PLS 50% 2.2 (0.6) 2.7 (0.5) 
Gradient (95% CI) -1.4 (1.8) -1.1 (1.4) 
Intercept (95% CI) 3.0 (0.6) 3.6 (0.4) 
 
 
Figure 5-5: Biaxial Flexural Modulus (error bars are 95% CI with n=6) for different PLR 
with increase percentage of wt % PLS. 
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5.1.2.3 Biaxial flexural modulus of wet and dry samples 
The mean and 95% confidence intervals of biaxial flexural modulus (Young’s 
modulus) for wet and dry samples with ε-polylysine (PLS) are presented in Figure and 
Table 5.6. This formulation was prepared by using MCPM 2, β-TCP 34 micron and CA 
800 mM with increase wt % PLS at PLR 4:1. The tread line showed that on average the 
dry sample had higher modulus than the wet samples as expected from previous data 
from flexural strength. However both wet and dry samples modulus did not depend 
significantly (p > 0.05) as seen in appendix 3 on the level of PLS.  
 
Table 5-6: Biaxial flexural modulus / GPa for dry samples and wet samples with 
PLR 4:1 (n=6) with increase percentage of PLS. 
 Young’s Modulus / GPa (95% CI) 
Cement code (PLS %) Dry samples Wet samples 
PLS 0% 3.3 (0.8) 2.0 (0.6) 
PLS 10% 3.4 (0.8) 3.1 (0.3) 
PLS 20% 3.7 (0.9) 2.8 (0.8) 
PLS 30% 3.4 (0.7) 2.8 (0.7) 
PLS 40% 3.2 (0.6) 2.4 (0.5) 
PLS 50% 2.7 (0.5) 1.7 (0.6) 
Gradient (95% CI) -1.1 (1.4) -1.0 (2.6) 
Intercept (95% CI) 3.6 (0.4) 2.7 (0.8) 
 
 
Figure 5-6: Biaxial Flexural Modulus (error bars are 95% CI with n=6) for dry and wet 
samples with increase wt % PLS. 
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5.1.3 Toughness  
5.1.3.1 Toughness of different MCPM and β-TCP particle sizes 
Table and Figure 5.7 show the toughness for each sample. The error bars show 
the 95% confidence interval. For all formulations with either different MCPM or TCP 
particle sizes, there was no significant difference (p > 0.05) or trend as seen appendix 
1. 
 
Table 5-7: Toughness for different MCPM and β-TCP (n=6). 
 Toughness (95% CI) 
Different MCPM / Different TCP  MCPM Himed (1) MCPM Sigma-Aldrich (2) 
TCP  4 micron  0.8 (0.3) 1.2 (0.6) 
TCP 6 micron  0.8 (0.3) 0.7 (0.4) 
TCP 8 micron  0.6 (0.2) 1.1 (0.5) 
TCP 12 micron  0.9 (0.2) 0.8 (0.3) 
TCP 34 micron  0.7 (0.1) 0.8 (0.3) 
Gradient (95% CI) - 0.0 (0.0) - 0.0 (0.0) 
Intercept (95% CI) 0.8 (0.2) 1.0 (0.4)  
 
 
Figure 5-7: Toughness (error bars are 95% CI with n=6) for different TCP and MCPM 
particle sizes with CA 800mM (n=6). 
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5.1.3.2 Toughness of different powder to liquid ratio (PLR) 
The mean and 95% confidence intervals of toughness for dry samples with 
increase percentage of ε-polylysine (PLS) and different PLR 3.3:1 and 4:1 are 
presented in Table and Figure 5.8. All formulations were prepared with MCPM 2, β-
TCP 34 micron and CA 800mM with increase wt % PLS. Increasing PLR or PLS had 
no significant effect (p > 0.05) on the toughness as seen in appendix 2. 
 
Table 5-8: Toughness for dry samples with different PLR 3.3:1 and 4:1 (n=6) with 
increase wt % PLS. 
 Toughness (95% CI) 
Cement code (PLS %) PLR 3.3:1 PLR 4:1 
PLS 0% 1.0 (0.6) 1.7 (0.3) 
PLS 10% 1.1 (0.2) 1.2 (0.3) 
PLS 20% 1.9 (0.9) 1.2 (0.2) 
PLS 30% 1.3 (0.5) 1.8 (0.5) 
PLS 40% 1.5 (0.6) 1.2 (0.2) 
PLS 50% 1.7 (0.4) 1.6 (0.2) 
Gradient (95% CI) 1.2 (1.4) 0.1 (1.4) 
Intercept (95% CI) 1.1 (0.4) 1.4 (0.4) 
 
 
 
Figure 5-8: Toughness (error bars are 95% CI with n=6) for different powder to liquid ratio 
with increase wt % PLS. 
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5.1.3.3 Toughness of wet and dry samples 
 
The mean and 95% confidence intervals of toughness for wet and dry samples 
with ε-polylysine (PLS) are presented in Table and Figure 5.9. Cements were prepared 
by using MCPM 2, β-TCP 34 micron and CA 800 mM with increase wt % PLS at PLR 
4:1.  The trend line showed that on average the dry samples had higher toughness 
than the wet samples. However both wet and dry samples toughness did not depend 
on the level of PLS.  
 
Table 5-9: Toughness of dry samples and wet samples with PLR 4:1 (n=6) with 
increase percentage of PLS.  *indicates results in two columns are significantly 
different. 
 Toughness (95% CI) 
Cement code (PLS %) Dry samples Wet samples 
PLS 0% 1.7 (0.3) 0.8 (0.2) * 
PLS 10% 1.2 (0.3) 1.0 (0.4) 
PLS 20% 1.2 (0.2) 0.8 (0.2) 
PLS 30% 1.8 (0.5) 0.8 (0.2) * 
PLS 40% 1.2 (0.2) 0.7 (0.1) * 
PLS 50% 1.6 (0.2) 0.6 (0.1) * 
Gradient (95% CI) 0.1 (1.6) -0.5 (0.4) 
Intercept (95% CI) 1.4 (0.4) 0.9 (0.1) 
 
 
 
Figure 5-9: Toughness (error bars are 95% CI with n=6) for dry and wet samples with 
increase wt % PLS. 
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5.2 Microstructure study using scanning electron microscopy (SEM) 
5.2.1 Microstructure study of MCPM powder 
SEM image of MCPM 1 and 2 are shown in figure 5.10 and 5.11 respectively. 
MCPM 1 is a ground powder that appeared as spherical, rounded particles.  They look 
as if they have been milled smoothing their edges and producing many smaller fine 
particles. Some particles are less than a few microns but attracted to the larger particle 
surfaces. MCPM 1 had broader distribution of particle size compared to MCPM 2. 
MCPM 2 had narrow distribution of particle size and appears as flat, rhombohedra or 
diamond crystal shapes. MCPM 2 also showed slightly larger size with a much 
smoother surface.  
 
5.2.2 Microstructure study of β-TCP powder 
SEM images of β-TCP with sizes from 4 micron to 34 micron are shown in 
figure 5.12 to 5.16. The smaller β-TCP particles (4 micron to 8 micron) appear very 
similar with small particles clumping to bigger particles. The texture was quite porous 
and dull. With β-TCP size 12 micron however, the surface appears much smoother and 
glossier. For β-TCP powder with 34 micron, the shape appears larger and irregular, 
less spherical and with a surface that was smooth. All β-TCP appeared smaller 
compared with the MCPM’s. 
 
5.2.3 Microstructure study of ε-polylysine powder 
Figure 5.17 shows an SEM image of ε-polylysine (PLS) powder. PLS also had 
smaller particle size compared to MCPM. PLS particles appear as spherical particles 
with dimples similar to those observed with golf balls.   
.  
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Figure 5-10: SEM image of MCPM 1 (HIMED) taken at x100 magnification 
 
 
 
Figure 5-11: SEM image of MCPM 2 (SIGMA) taken at x100 magnification 
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Figure 5-12: SEM image of β-TCP 4.0 micron taken at x1500 magnification 
 
 
 
Figure 5-13: SEM image of β-TCP 6.0 micron taken at x1500 magnification 
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Figure 5-14: SEM image of β-TCP 8.0 micron taken at x1500 magnification 
 
 
 
Figure 5-15: SEM image of β-TCP 12.0 micron taken at x1500 magnification 
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Figure 5-16: SEM image of β-TCP 34.0 micron taken at x1500 magnification 
 
 
Figure 5-17: SEM image of ε-polylysine taken at x1500 magnification 
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5.2.4 Microstructure study of the set cements 
The top surface and fracture surface microstructure of the set cements was 
observed under scanning electron microscopy (SEM) at different magnification (x50, 
x150, x350, x500, x1500, x3500 and x5000). At first specimens were scanned dry and 
then scanned again after being immersed in distilled water for 24 hours. 
 
5.2.4.1  Brushite cements prepared with water 
Figure 5.18 and figure 5.19 shows the morphology of the fracture and top 
surfaces of the brushite cements produced using no citric acid, MCPM 2 and TCP of 34 
micron at x1500 and x500 magnification. The images for wet and dry samples were 
comparable both on the top and fracture surface. The cement surface appeared as non 
– homogenous with areas of porosity with comparable shape and dimension to the 
original MCPM 2 crystals. The brushite crystals were like flat plates stacked on each 
other in the denser parts of the structure. In porous regions, however, large well-
defined 20 to 50 micron long hexagonal rod – like crystals could be observed jutting 
into the large cracks left by the flat MCPM crystals 
 
5.2.4.2  MCPM and citric acid effects on cements microstructure 
 Figures 5.20 to 5.25 shows the morphology of the surfaces of brushite cements 
prepared with MCPM 2 and MCPM 1 (wet samples) with 34 micron TCP and 800 mM 
citric acid at different magnifications. Changing the MCPM particles had a much greater 
effect on SEM images than addition of citric acid or placement in water. Differences 
were more easily observed on the fracture surfaces at low magnification. With MCPM 2 
a lot of long cracks of up to 500 micron length and typically 20-50 micron width were 
observed.  
 
The cracks were of comparable shape and dimension as the original MCPM 2 
particles suggesting that MCPM had dissolved slowly into the water and reprecipated 
away from the resultant crack area. Jutting into the cracks were larger brushite 
hexagonal prisms of the order of 20 to 50 µ in length. Obvious regions where the 
MCPM 2 crystals had been lying flat can also be seen. Within these regions, a layer of 
larger crystals is seen on the fracture surface. On fracture surfaces in other regions 
between cracks, the crystals were more densely packed.  
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 On top surfaces more small pores could be detected.  With MCPM 1 more 
spherical pores could be observed in fracture surfaces with no long cracks. These 
spherical pores were comparable in size and shape to the original MCPM particles 
again suggesting they are formed by slow dissolution of MCPM away from the original 
particles and precipitation elsewhere.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
96 
 
 
Figure 5-18: SEM image of fracture surface brushite cement (wet sample) taken at x500 
magnifications (MCPM 2 + β-TCP 34.0 micron + water)  
 
 
Figure 5-19: SEM image of surface (wet sample) taken at x1500 magnification (MCPM 2 + 
β-TCP 34.0 micron + water) 
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Figure 5-20: SEM image of fracture surface (wet sample) taken at x500 magnification 
(MCPM 2 + β-TCP 34.0 micron + citric acid) 
 
 
 
Figure 5-21: SEM image of fracture surface cement (wet sample) taken at x500 
magnification (MCPM 1 + β-TCP 34.0 micron + citric acid) 
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Figure 5-22: SEM image of fracture surface cement (wet sample) taken at x500 
magnification (MCPM 2 + β-TCP 34.0 micron + citric acid)  
 
 
Figure 5-23: SEM image of fracture surface cement (dry sample) taken at x500 
magnification (MCPM 1 + β-TCP 34.0 micron + citric acid) 
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Figure 5-24: SEM image of surface (wet sample) taken at x1500 magnification (MCPM 2 + 
β-TCP 34.0 micron + citric acid) 
 
 
Figure 5-25: SEM image of surface cement (wet sample) taken at x1500 magnification 
(MCPM 1 + β-TCP 34.0 micron + citric acid)  
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5.2.4.3  ε-Polylysine effect on cements microstructure 
Figures 5.26 to 5.30 show SEM images of set cements with ε-polylysine (PLS) 
(10%, and 50%). Even with the highest level of PLS in the formulation, no obvious 
effect of on structures can be seen except possibly more spherical air bubbles. 
 
 
 
 
Figure 5-26: SEM image of fracture surface (wet sample) taken at x500 magnification 
(MCPM 2 + β-TCP 34.0 micron + 50 wt % PLS in citric acid)  
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Figure 5-27: SEM image of fracture surface cement (wet sample) taken at x500 
magnification (MCPM 2 + β-TCP 34.0 micron + citric acid + 50 wt % PLS) 
 
 
 
Figure 5-28: SEM image of surface cement (wet sample) taken at x500 magnification 
(MCPM 2 + β-TCP 34.0 micron + citric acid + 50 wt % PLS) 
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Figure 5-29: SEM image of fracture surface cement (wet sample) taken at x500 
magnification (MCPM 2 + β-TCP 34.0 micron + citric acid + 10 wt % PLS) 
 
 
Figure 5-30: SEM image of surface (wet sample) taken at x1500 magnification (MCPM 2 + 
β-TCP 34.0 micron + citric acid + 10 wt % PLS) 
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5.3 Handling properties 
Upon mixing with smaller MCPM 1 (HIMED) particles, the cement paste 
became more viscous upon increasing the β-TCP particle size. With MCPM 2 (SIGMA) 
with more crystalline structure, the cement paste remained more fluid like even with the 
largest TCP particle size. This enabled an increase in PLR from 3.3:1 to 4:1 whilst 
maintaining better handling properties. Upon initial increase in wt % of PLS, the paste 
become more viscous and cohesive but the paste become too viscous upon reaching 
50 wt % PLS.  
.  
5.4 Setting kinetics  
5.4.1 Reference spectra  
  FTIR reference spectra for the reactants used in this experiment are shown in 
Figures 5.31 to 5.34. The reference spectrum for monocalcium phosphate 
monohydrate (MCPM) illustrated in figure 5.31 has strong P - O stretch peaks at 1075 
and 955 cm-1 and a moderate peak observed at 850 cm-1 (Hofmann et al., 2006). 
 
 β – tricalcium phosphate (β-TCP) spectrum is illustrated in Figure 5.32. The spectrum 
consists of a broad P-O stretch at 1000 cm-1. Figure 5.33 shows the reference 
spectrum for water. There was a sharp peak observed at 1640 cm-1 and broad peak at 
3300 cm-1 that’s indicating O – H stretching (Hofmann et al., 2006, Young et al., 2008).   
 
The reference spectrum for 800mM citric acid is illustrated in figure 5.34. The 
spectrums consist of water O – H stretching at 1640 and 3300 cm-1. There were 
additional peaks at 1420 and 1532 cm-1 due to symmetric and asymmetric COO- 
stretching. There were also moderate peak corresponding with C = O and C – O 
stretching at 1720, 1016 and 1096 cm-1 (Hofmann et al., 2006, Young et al., 2004).  
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Figure 5-31: Reference spectrum of MCPM (powder phase). 
 
 
 
 
Figure 5-32: Reference spectrum of β - TCP (powder phase) 
 
850 
P – O peaks 
P – O stretch 
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Figure 5-33: Reference spectrum of water (aqueous phase). 
 
 
 
 
Figure 5-34: Reference spectrum of citric acid (aqueous phase). 
 
3300 (O-H stretch) 
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5.4.2 Setting reaction 
5.4.2.1  Setting reaction of brushite cements 
FTIR spectroscopy was used to monitor brushite cements setting reactions and 
setting kinetics. Reference spectra for brushite cements with water at PLR 4:1 and 
37oC shown in figure 5.35. For control formulation the setting reaction was well 
underway at 100 s and practically complete at 3000 s. Three strong peaks (P-O 
peaks), consistent with brushite formation were noted at 1116, 1052 and 980 cm-1. O-H 
peak, which suggest water incorporated during setting reaction, is noted at 1652, 3540 
and 3480 cm-1 (sharp peak) and also 3280 and 3172 cm-1 (broad peak).  
 
5.4.2.2  ε-Polylysine (PLS) effect on setting reaction 
The absorbance spectra for the cements prepared with water and 50 wt % PLS 
are given in figure 5.36. The formulation was prepared at 370C with MCPM 2 without 
CA. These spectra are weaker than in figure 5.35.  This could be due to poorer contact 
with the FTIR diamond and / or much less reaction.  Lower reaction might be due to 
reduced water level available for reaction. 
 
5.4.2.3  Combination effect of citric acid with different PLR on setting reaction 
Example time – dependent absorbance spectra for cements with PLR 3.3:1 and 
4:1 are illustrated in figure 5.37 and 5.38 respectively. The entire specimens were 
prepared at 370C with CA 800 mM. These spectra show all the main features for a 
brushite reaction.  The peaks between 1200 and 1600 that appear and disappear are 
citrate - dicalcium phosphate complex intermediate peaks.  The sharp key brushite 
peaks around 3000, 1640 and 980 appear as the intermediate peaks disappear.  These 
indicate water binding.  With 4:1 PLR the intermediate peaks are more difficult to detect 
possibly because of faster reaction.    
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Figure 5-35: FTIR spectra versus time for brushite cement with PLR 4:1,  MCPM 2,  β-TCP 
34 micron and water 
 
 
 
 
Figure 5-36: FTIR spectra versus time for brushite cement with PLR 4:1, MCPM 2,  β-TCP 
34 micron and water with 50 wt % PLS 
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Figure 5-37: FTIR spectra versus time for brushite cement with PLR 3.3:1, MCPM 2,  β-
TCP 34 micron and CA 
 
 
 
 
Figure 5-38: FTIR spectra versus time for brushite cement with PLR 4:1, MCPM 2,  β-TCP 
34 micron and CA 
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5.4.2.4 Combination effect of citric acid and increase wt % of ε-polylysine (PLS) 
on setting reaction  
Figure 5.39 to figure 5.43 show the absorbance spectra for the cements 
prepared with increasing wt % of PLS from 10 wt % to 50 wt %. The entire formulations 
were prepared at 37oC with MCPM 2 and CA 800 mM. All these figures show that 
increasing PLS caused an increase in the formation of dicalcium phosphate 
complexes. Unlike with citric acid alone these peaks do not disappear with time.  The 
complex peaks may be due to NH and CN stretches or COO symmetric and 
asymmetric stretch peaks dependent upon whether the complexes form with PLS or 
citrate ions.  Note as the complex peaks increase in intensity the water binding brushite 
peaks decrease as does the absorbance change for other peaks.  This could be 
because either less dicalcium phosphate forming or because when it complexes the 
product causes less absorbance change. 
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Figure 5-39: FTIR spectra versus time for brushite cement with PLR 4:1, MCPM 2, β-TCP 
34 micron and CA with 10 wt % PLS 
 
 
Figure 5-40: FTIR spectra versus time for brushite cement with PLR 4:1, MCPM 2, β-TCP 
34 micron and CA with 20 wt % PLS 
 
 
 
Figure 5-41: FTIR spectra versus time for brushite cement with PLR 4:1, MCPM 2, β-TCP 
34 micron and CA with 30 wt % PLS 
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Figure 5-42: FTIR spectra versus time for brushite cement with PLR 4:1, MCPM 2, β-TCP 
34 micron and CA with 40 wt % PLS 
 
 
 
 
Figure 5-43: FTIR spectra versus time for brushite cement with PLR 4:1, MCPM 2, β-TCP 
34 micron and CA with 50 wt % PLS 
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5.4.3 Difference spectra 
Difference spectra were obtained by subtracting each spectrum from the first at 
100 s. The absorbance changes obtained are characteristic of the reactions taking 
place. The following figures from 5.44 to 5.55 represent difference spectra for all 
formulations. All formulations were prepared at 37oC with or without citric acid (CA) 800 
mM.  
 
5.4.3.1  Absorbance change for brushite cements prepared with water and ε-
polylysine (PLS) 
Figures 5.44 to 5.46 show the difference spectra of compositions prepared with 
no citric acid and 0, 20 or 50 wt % PLS. In these formulations no intermediate peaks 
are observed.  Dicalcium P-O peaks (1100, 1052 and 980 cm-1) and bound water O-H 
peaks (1640 and 3100 to 3600 cm-1) are obtained. 
 
5.4.3.2  MCPM and PLR effect on absorbance change  
Figures 5.47 to 5.50 shows difference spectra of cements prepared with CA and 
different PLR or MCPM. The setting reaction involves two processes. The first process 
is observed most readily in Figure 5.47 with MCPM 1 and PLR 3.3. This gives strong 
absorbance increase at 1052, 1100, and between 1200 and 1600 cm-1.  Those 
between 1200 and 1600 are lost as the water binding peaks at 980 and around 3000 
develop.  With higher PLR or MCPM 2 the peak changes are comparable but the 
intermediate peaks are more difficult to detect and the reaction rate is changed.  
 
5.4.3.3  Combined effect of ε-polylysine (PLS) and citric acid on absorbance 
change 
The difference spectra for compositions with different wt % of PLS are 
demonstrated from figure 5.51 to 5.55. These show the gradual change from brushite 
to complex formation with increasing PLS.  
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Figure 5-44: Effect of time on FTIR difference spectra of brushite cement with PLR 4:1 
MCPM 2, β-TCP 34 micron and water 
 
 
Figure 5-45: Effect of time on FTIR difference spectra of brushite cement with PLR 4:1 
MCPM 2, β-TCP 34 micron and water with 20 wt % PLS 
 
 
Figure 5-46: Effect of time on FTIR difference spectra of brushite cement with PLR 4:1 
MCPM 2, β-TCP 34 micron and water with 50 wt % PLS 
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Figure 5-47: Effect of time on FTIR difference spectra of brushite cement with PLR 3.3:1 
MCPM 1, β-TCP 34 micron and CA 
 
 
 
 
 
Figure 5-48: Effect of time on FTIR difference spectra of brushite cement with PLR 3.3:1 
MCPM 2, β-TCP 34 micron and CA 
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Figure 5-49: Effect of time on FTIR difference spectra of brushite cement with PLR 4:1 
MCPM 1, β-TCP 34 micron and CA 
 
 
 
 
 
 
Figure 5-50: Effect of time on FTIR difference spectra of brushite cement with PLR 4:1 
MCPM 2, β-TCP 34 micron and CA 
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Figure 5-51: Effect of time on FTIR difference spectra of brushite cement with PLR 4:1 
MCPM 2, β-TCP 34 micron and CA with 10 wt % PLS 
 
 
Figure 5-52: Effect of time on FTIR difference spectra of brushite cement with PLR 4:1 
MCPM 2, β-TCP 34 micron and CA with 20 wt % PLS 
 
 
Figure 5-53: Effect of time on FTIR difference spectra of brushite cement with PLR 4:1 
MCPM 2, β-TCP 34 micron and CA with 30 wt % PLS 
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Figure 5-54: Effect of time on FTIR difference spectra of brushite cement with PLR 4:1 
MCPM 2, β-TCP 34 micron and CA with 40 wt % PLS 
 
 
 
 
 
 
Figure 5-55: Effect of time on FTIR difference spectra of brushite cement with PLR 4:1 
MCPM 2, β-TCP 34 micron and CA with 50 wt % PLS 
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5.4.4  Absorbance change 
Absorbance change profiles at 980 cm-1 and 1050 cm-1 were obtained by using 
Time base software and subtracting initial absorbance values from all time points. The 
following figures from 5.56 to 5.61 represent the different absorbance profiles for each 
composition of cement prepared at 37oC with or without CA 800 mM. 
 
5.4.4.1  Different MCPM and PLR effect on absorbance change 
  
Figure 5.56 and 5.57 shows absorbance profiles at 980 cm-1 and 1050 cm-1 for 
the 2 different MCPM’s and PLRs. All formulations were prepared with CA 800 mM. 
Greater maximum change was seen with higher PLR possibly due to increased 
brushite density. With higher PLR, more powder was available and less water thereby 
reducing porosity and increasing the amount of brushite in contact with the FTIR 
diamond. Furthermore, using different MCPM gave obvious changes in setting profiles.  
 
With MCPM 1, CA appears more readily able to interact with the cement 
reactants. CA was therefore able to delay the set and provide a snap set.  With MCPM 
2 with more crystalline structure there was no clear delay before reaction but the 1050 
peak reached its maximum value more quickly than the 980 peak.   By comparison with 
Figures 5.56 and 5.57 it can be observed that with MCPM 2 the presence of CA both 
enhances the maximum absorbance change and slows down the absorbance change 
particularly at 980 cm-1. 
  
5.4.4.2  ε-Polylysine (PLS) effect on absorbance change 
  
Figure 5.58 and 5.59 shows brushite cements setting profile at 980 cm-1 and 
1050 cm-1 with different wt % of PLS without CA. All formulations were prepared with 
MCPM 2. Cements prepared with 20 wt % of PLS showed similar absorbance change 
with sample prepared with only water. Absorbance changes of cements prepared with 
50 wt % of PLS however had much reduced maximum change particularly at 980 cm-1.  
This suggests less brushite in contact with the FTIR diamond. 
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5.4.4.3  Combined effect of ε-polylysine (PLS) and citric acid (CA) on absorbance 
change 
  
The 980 and 1050 cm-1 profiles with different wt % of PLS and CA are shown in 
figures 5.60 and 5.61. All formulations were prepared with MCPM 2, β-TCP 34 micron 
and CA 800 mM. By increasing the wt % of PLS both the rate of reaction and maximum 
absorbance changes declined. The effects were reduced at the higher wave number. 
After running the experiment for 3600 seconds, the cements with 50 wt % ε-polylysine 
had an absorbance of 0.6, which only accounts for 1/3 of brushite cements with 10 wt 
% of PLS for the same period of time. The setting of cements with 50 wt % of PLS was 
delayed beyond 3000 seconds. 
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Figure 5-56: Brushite cements setting profile at 980 cm
-1 
with different MCPM (1 or 2), β-
TCP 34 micron and CA at PLR (3.3:1 or 4:1)  
 
 
 
 
Figure 5-57: Brushite cements setting profile at 1050 cm
-1 
with different MCPM (1 or 2), β-
TCP 34 micron and CA at PLR (3.3:1 or 4:1)  
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Figure 5-58: Brushite cements setting profile at 980 cm
-1 
with different wt % of PLS, PLR 
4:1 and without CA (MCPM 2 + β-TCP 34 micron + water) 
 
 
 
 
Figure 5-59: Brushite cements setting profile at 1050 cm
-1 
with different wt % of PLS, PLR 
4:1 and without CA (MCPM 2 + β-TCP 34 micron + water) 
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Figure 5-60: Brushite cements setting profile at 980 cm
-1 
with MCPM 2, β-TCP 34 micron 
and CA with increase wt % PLS. 
  
 
 
 
Figure 5-61: Brushite cements setting profile at 1050 cm
-1 
with MCPM 2, β-TCP 34 micron 
and CA with increase wt % PLS. 
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5.5 Degradation study 
 
5.5.1 Mass loss of set cements with different MCPM 
Figure 5.62 shows the percentage of mass loss time (hours) in water for 
cements with different MCPM, β-TCP particle size of 34 micron and CA 800 mM. The 
first 24 hours showed rapid mass loss for cements with MCPM 2. Cements prepared 
with MCPM 1 overall degraded less than cements prepared with MCPM 2. There was 
significant difference in mass loss between composition with MCPM 1 and MCPM 2. 
Mass losses for both MCPM were increase with time.   
 
 
 
 
Figure 5-62: Mass loss vs log10 for cements composition with MCPM 1 and MCPM 2. Error 
bars shown are 95% CI (n = 5). None overlapping indicates significantly different results 
(p < 0.05). 
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5.5.2 Mass loss of set cements with increase wt % of ε-polylysine (PLS)  
Cumulative mass loss was linear with time  (hours) with a burst material 
release in the first 24 hours for all formulations containing PLS (Figure 5.63). The 
plotted graph shows that there was still increase in mass loss after 24 hours but it was 
very slow. The overall mass loss was increasing for cements with formulation of 0 wt % 
of PLS to 40 w% of PLS. Cements with 50 wt % PLS also showed increase in mass 
loss but become more stable after 72 hours.  
 
 
 
 
 
Figure 5-63: Mass loss vs log10 for cements composition with increase wt % of PLS 
(MCPM 2 + β-TCP 34.0 micron + citric acid 800 mM + increase wt % of PLS). Error bars 
shown are 95% CI (n = 5).   
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5.6 pH study 
5.6.1 pH study for formulation with different MCPM’s 
pH of storage solutions were analysed after 1, 2, 4, 6, 24 hours, 48 hours, 72 
hours, one week, two weeks and 4 weeks. Samples were placed in fresh water at each 
time point. All formulations were prepared with different MCPM, β-TCP 34 micron and 
CA 800 mM. Figure 5.64 shows the changes in the pH levels of distilled water with 
square root of time in the presence of cements prepared with different MCPM. 
Generally, the pH levels were slightly acidic initially but neutral after 24 hours. The pH 
values ranged from 3.8 to 7.2. Figure 5.65 shows the cumulative acid release of 
cement with different MCPM versus square root of time. Effects of changing MCPM 
were not highly significant. 
 
 
Figure 5-64: pH level of composition with MCPM 1 and MCPM 2 at different time point. 
Error bars shown are 95% CI (n = 5).  
 
 
Figure 5-65: Cumulative acid released with MCPM 1 and MCPM 2 at different time point. 
Error bars shown are 95% CI (n = 5) 
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5.6.2 pH study for formulation with increase wt % of ε-polylysine (PLS) 
Figure 5.66 shows the changes of storage solution pH with time and with 
increasing wt% of PLS. Error bars shown are 95% CI with n = 5. Overall all 
formulations were slightly acidic initially with pH ranges from 3.7 to 7.0.  
 
Figure 5.67 shows the cumulative acid release with different wt % of PLS 
versus square root of time. Acid release with 10 to 30 wt % PLS was not significantly 
different from that with no PLS. Formulations with 40% and 50% PLS, however, did 
produce less acid.  
 
 
Figure 5-66: pH level for cements composition with increase wt % of PLS (MCPM 2 + β-
TCP 34.0 micron + citric acid 800 mM + increase wt % of PLS). 
 
 
Figure 5-67: Cumulative acid released with increase wt % of PLS (MCPM 2 + β-TCP 34.0 
micron + citric acid 800 mM + increase wt % of PLS). 
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5.7 ε-Polylysine release profile 
5.7.1 Calibration curve of ε-polylysine  
Table 5.10 shows the average absorbance due to the blue dye trypan blue after 
its reaction with increasing concentrations of ε-polylysine (PLS) from 1 ppm to 10 ppm. 
This dye has peak absorbance at 580 nm and upon reaction with PLS forms a 
precipitate that was removed by centrifugation. The calibration curve was obtained by 
plotting the absorbance at 580 nm against the various level of PLS concentration in 
aqueous solutions (Figure 5.68). 
 
Table 5-10: The average absorbance of various concentration of ε-polylysine  
at 580 nm 
Concentration of ε-polylysine (ppm) Average absorbance at 580 nm (n=3) 
1 0.18 
2 0.36 
4 0.51 
5 0.73 
7 0.78 
9 0.85 
10 0.96 
 
 
 
Figure 5-68: Calibration curve ε-polylysine at 580 nm (n=3).  
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5.7.2  ε-Polylysine release in water 
Figure 5.69 shows the cumulative percentage of ε-polylysine (PLS) release 
rapidly reaches a maximum value in 24 hours. This release percentage is calculated 
according to equation 6 and 7. It shows that cement containing lower level of PLS has 
higher level of release. It decreases with increase wt % of PLS.  Around 4 to 27 % total 
release was observed.  Cement formulations with 10 wt % showed significant highest 
release of PLS compared to other formulation. The PLS percentage release dropped 
dramatically between formulations with 10 wt % of PLS to formulations with 20 wt % of 
PLS.  
 
Figure 5-69: % of PLS released for cements composition with increase wt % of PLS 
(MCPM 2 + β-TCP 34.0 micron + citric acid 800 mM + increase wt % of PLS). 
 
 
 
 
 
 
 
 
 
 
 
129 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 6 
DISCUSSION AND CONCLUSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
130 
 
6 DISCUSSION 
Brushite cements, one of the end products of CPC, have potential as drug carriers 
and bone filling materials. They can also act as a reservoir for calcium and phosphate 
ions for the remineralisation of hard tissues. However, their applications might be 
limited due to a number of issues including low strength, high modulus and brittle 
fracture. Brushite cements may also suffer from poorly controlled setting, degradation 
and drug release. 
 
6.1 Mechanical properties of brushite cements 
6.1.1 Biaxial flexural strength (BFS)  
Strength is the ability of a material to resist deformation under load. The original 
brushite cement formulations had very poor mechanical properties and a number of 
approaches have been explored to address this. Early BFS ranged from 0.7 to 4.5 MPa 
(Bohner et al., 1996). Compressive strength has been reported to range from 1 to a 
maximum of 52 MPa (Gbureck et al., 2005; Hofmann et al., 2009). The highest 24 hour 
wet compressive strength obtained in the study of Hofmann et al. was obtained using 
CA at 800 mM, PLR 4:1, MCPM sieved below 63 micron and 11 micron TCP. Using 
similar powders and liquid but lower PLR (3.3:1) a recent study demonstrated a 24 
hour wet flexural strength of 5 – 8 MPa.  This increased up to 10 MPa with the addition 
of polyacrylic acid (Xia et al., 2014).   
 
In this thesis the difference MCPMs used were much larger than those of 
Hofmann and Xia. The thesis showed that changing MCPM from powder to crystal –
like did not provide any significant effect on the flexural strength. However, an 
increased in TCP particle sizes did provide a small but significant increase in flexural 
strength. The highest result for dry materials was 30.0 MPa with TCP particle size of 34 
micron.  This was much higher than previously observed by Hofmann and Xia and 
comparable to that of glass Ionomer cements (GIC) that have flexural strength between 
20 MPa to 40 MPa (Xie et al., 2000). To optimize the powder to liquid ratio in the above 
thesis, brushite cements were prepared by using MCPM 2, TCP particle size 34 micron 
and increasing percentage of ε-polylysine (PLS). Our study showed that increasing the 
powder to liquid ratio from 3.3:1 to 4:1 increases the flexural strength.  
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This is due to lower porosity by increasing the PLR in cements, thereby helps to 
increase the mechanical properties (Hofmann et al., 2009). It is also observed that the 
strength declined slightly with increased percentage of PLS. FTIR result showed that 
increasing PLS changes chemistry and formed complex rather than brushite, thus 
reducing strength.  
 
The BFS of wet samples was used to mimic what happens with time in a clinical 
environment. As water immersion can strongly affect mechanical properties (Charriére 
et al., 2001), dry strength alone may be misleading with regards to clinical performance 
(Barralet et al., 2004). Wet sample data showed that the strength does not depend on 
the level of PLS. One possible explanation might be due to the surrounding water 
providing more water for the formulation to complete its setting reaction. Even with the 
wet samples however, the flexural strength achieved was still high compared to the 
previous studies mentioned above, 18 MPa with the formulation without PLS and 14 
MPa with 50 wt % of PLS. This new cement will be able to provide support where 
previously brushite cements would not be considered to be able to support any 
significant load. This will help to widen the application of brushite cements to more load 
bearing areas.  
 
6.1.2 Biaxial flexural modulus (BFM) 
Young’s modulus is a measurement of stiffness of an elastic material. Flexural 
modulus was increased by increasing the β-TCP particle size with MCPM 2 but not with 
MCPM 1. Addition of higher percentage of PLS also resulted in decrease of the 
modulus. The decrease in modulus for the wet samples cements is statistically 
significant when compared to dry samples. Flexural modulus achieved from this study 
was 5 times higher for wet samples compared to a recent study (Xia et al., 2014). The 
strength is also 5-6 time higher. That means the new cements have similar strain at 
break to Xia’s study. This could attribute to the denser crystals formed in this study.  
 
6.1.3 Toughness   
Toughness was determined by measuring the area underneath the stress-strain 
curve. Brushite cements are brittle materials. The toughness is therefore proportional to 
strength squared divided by modulus.   
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From this study it was concluded that there were no significant differences in the 
toughness either by changing MCPM and PLR or by adding increase wt % of PLS.   
Any decreases in strength were therefore compensated by decrease in modulus.   
 
6.2 Setting kinetics 
Brushite cement is precipitated through acid – base reaction with the presence of 
an aqueous phase. In MCPM and β-TCP system, brushite cements setting reaction 
begins by the dissolution of MCPM which causes a rapid decrease in pH followed by 
dissolution of β-TCP and uptake of hydrogen ions to precipitate more brushite crystal 
(Bohner and Gbureck, 2008, Mirtchi et al., 1989). The setting reaction of the original 
composition of brushite cements is very rapid, approximately 30 seconds which limits 
the time for manipulation and placement of the cement (Mirtchi et al., 1991). Adding 
any additive to brushite cement such as citric acid (Bohner et al., 2008) or tartaric acid 
(Alkhraisat et al., 2008a) can affect the dissolution of the reagent, precipitation of the 
brushite crystal or both thereby altering the setting reaction time. Another way to 
control the setting reaction of brushite cements is by manipulating powder to liquid 
ratio.  
 
As the profile at 980 cm-1 reflects the forming of brushite cement as a function of 
time, so the value of absorbance will indicate the amount of brushite crystal formed. It 
is generally considered that the forming of brushite crystal is responsible for the setting 
of cement. Brushite formation was marked by formation of strong 980 cm-1 and 
sharpened O – H peaks in the final spectra. In this study, absorbance changes showed 
that the setting reaction was faster without the addition of citric acid. Citric acid had the 
capability to chelate the calcium ions and cause delays in precipitation of brushite 
crystal. Incorporation of citric acid therefore helps to prolong the setting time. This also 
helps to form a workable cement paste (Grases et al., 2000, Barralet et al., 2004).  
 
From the FTIR we can see that an intermediate complex formed with the addition 
of citric acid. When this occurred, the 1050 cm-1 peak increased faster than the 980 cm-
1 peak. The intermediate complex is also known as dicalcium citrate complex. 
Formation of an intermediate complex was due to interaction between negative charge 
citrate ions and positive charge calcium ions (Hofmann et al., 2006). The intermediate 
complex will later dissolve to allow precipitation of brushite crystals.  
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In this thesis the intermediate complex was observed more in the formulation with 
MCPM 1 and PLR 3.3:1. The intermediate peaks were observed at 1532 and 1420 cm-1 
which is consistent with the formation of COO- symmetric and asymmetric stretching 
peak (Xia et al., 2014). Previous studies indicated that with higher PLR the dicalcium 
citrate complex was difficult to detect unless high concentration of citric acid greater 
than 1000 mM was used (Hofmann et al., 2006). This thesis also demonstrated, O – H 
peaks indicating water was bound into the composition. All final peaks were consistent 
with brushite cement (Hofmann et al., 2006). Therefore, addition of citric acid helps to 
delay the setting time but did not interfere with the formation of brushite cements.   
  
PLR was then varied from 3.3:1 to 4:1. Formulations with PLR 4:1 reacted faster 
than 3.3:1.  This was previously attributed to faster crystal precipitation (Hofmann et al., 
2006). It also increased the maximum absorbance change presumably by increasing 
the amount of brushite in contact with the FTIR diamond. With higher PLR, more 
powder was available that provides more absorbance which indicates more brushite 
formation.  
 
A major factor that affected the reaction profile was the type of MCPM. MCPM 1 
showed very similar FTIR profile to that observed by Xia. The absorbance spectra were 
also very similar to those in the work by Hofmann (Xia et al., 2014, Hofmann et al., 
2006). MCPM 1 which has a particle-like powder dissolved slowly, this helped to delay 
the setting time then provide a snap set. For formulations with MCPM 2, citric acid was 
not stopping the early reaction but did broaden the reaction. This showed that citric 
acid was able to delay the set but was not able to provide a snap set with MCPM 2 that 
had a crystalline structure. Varying MCPM had limited effect on maximum absorbance 
change suggesting final cements have similar brushite concentrations.  
 
Upon increased percentage of PLS in the formulation, the absorbance was going 
down and the working time enhanced. The 980 cm-1 peak which indicated formation of 
brushite was decreasing. Adding PLS even at low levels demonstrated that the 
intermediate complex peak was readily detected by the FTIR and significantly higher 
when 50 wt % of PLS was used. The intermediate peak however was not strong in the 
formulation with PLS without citric acid. The intermediate complex form was stable and 
not dissolved over time unlike the dicalcium citrate complex.  
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The stability of such complex is probably attributed by both citric acid and larger 
molecular size of PLS. This indicates that PLS may become solid and interacts with the 
citric acid and formed a new intermediate phase. There may be possible ionic 
interactions which form the broad peaks at 1585 and 1500 – 1300. These would be 
consistent with the formation of NH+3 (amine salt) symmetric and asymmetric stretching 
peaks. It is difficult, however, to distinguish these from the COO- symmetric and 
asymmetric stretch peaks at 1460 – 1400 and 1610 – 1540.  
 
The final spectra of all formulations with more than 20 wt % of PLS did not have 
characteristic water binding brushite peaks. This finding is similar to a previous study 
done with polyacrylic acid and chlorhexidine in brushite cements (Xia et al., 2014). 
Therefore incorporating PLS into the formulation does interfere with formation of 
brushite. The setting time was slowing down and the maximum absorbance was 
decreased with an increased percentage of PLS. 
  
 Another important factor regulating the setting time is the amount of water 
present in the cement paste. More water available for the setting reaction will favour a 
faster precipitation of brushite crystals hence accelerating the setting time. This is 
usually seen when cements with low PLR are used (Mirtchi AA et al., 1989, Alkhraisat 
MH et al., 2010, Tamimi-Marino F et al., 2007). However, our study shows that the 
setting rate not only depends on PLR, but also on the type of MCPM. Formulations with 
50 wt % of PLS decreased the maximum absorbance. This could be because water is 
required to form the brushite cements and in this formulation, there was not enough 
water because PLS had replaced it. This explains the reason for reduction in the 
strength with cements that had same formulation. Also with this formulation, 50 wt % of 
citric acid had been removed and the setting time is expected to accelerate. The setting 
reaction however was slower with increased level of PLS suggesting that PLS may also 
act as a setting retardant. 
 
6.3 Scanning electron microscopy (SEM) 
In this study, the surface of brushite cements prepared with citric acid showed the 
characteristic of small needle-like crystal appearance. This is an expected finding as 
citric acid is known to decrease the crystal growth rate of brushite which results in 
smaller and thinner crystals (Bohner et al., 1996).  
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Smaller crystal sizes produced may result in reduced porosity of cement 
microstructure. SEM image of cements with MCPM 2 exhibit large cracks which had 
the same shape and dimension of the original MCPM 2 particles. The crystals formed 
in this crack were much larger indicating that slow dissolution of the larger MCPM 
particles may have happened in this region.  MCPM dissolved into the water and 
precipitate away from the crack area. This crack was a new finding and had never been 
observed with any brushite cements before. The crack may help as a channel for PLS 
to be released. 
 
By adding increase wt % of PLS into the formulations with MCPM 2, few changes 
were observed by SEM. This is possibly due to PLS acting as a setting retardant and 
causing a delay in the setting reaction and affecting the crystal precipitation in a similar 
manner to citric acid (Tamimi et al., 2008). Furthermore, cements prepared with MCPM 
2 did not show any difference when either dry or wet samples were observed by SEM. 
This showed that high levels of PLS can be added without interfering with crystal 
formation and the cements produced will be stable in any surrounding environment. 
Only pores structure is different between MCPM 1 and MCPM 2. From the fracture 
surface, no large cracks were seen with cement produced by MCPM 1 as seen in the 
formulation with MCPM 2. Very large brushite crystal can be observed in the large 
cracks produced by MCPM 2. 
 
Therefore further research should be done to assess the effect of wt % of PLS on 
crystal structure with MCPM 1 and if this also will improve other properties of brushite 
cements produced. From SEM image done in this study at both high and low 
magnifications, all formulations showed porosities on the fracture surface. Quantitave 
method such as porosity measurement with Archimedes principles could be carried out 
for accurate measurement of porosity (Matejicek et al., 2006).  
 
6.4 Degradation 
Initial, rapid decrease in mass for all cements composition had been observed. 
The same result was reported by previous study (Young et al., 2008). In this study, 
formulations prepared with MCPM 1 were shown to be degradable at a much lesser 
rate compared to cement prepared with MCPM 2. SEM results show that cement 
prepared with MCPM 2 has much more pores left by dissolving MCPM. This indicates 
that more MCPM 2 is dissolving than MCPM 1.  
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This also indicates that MCPM 1 can produce more uniformed cement. This may 
be an advantage because of the concern that brushite cements may disperse before 
they can set in clinical application. Therefore further study with MCPM 1 will be an 
interesting field for future work. However, more degradable cements produced with 
MPCM 2 promise more antimicrobial release.  
 
Addition of PLS showed overall increase degradation for cements prepared with 
up to 40 wt % PLS. The degradation was less with 50 wt % of PLS. Mass loss was 
independent of drug content as expected from other work (Young et al., 2008).  From 
this study, the continuity of total weight loss at the end of the study period suggest that 
both dissolution of brushite or complex and release of PLS. 
 
6.5 ε-polylysine release study 
ε-Polylysine (PLS) was added as an antibacterial agent to produce a new cement 
formulation with antimicrobial properties. Brushite is resorbable but the rate of drug 
release from the system is much higher than the rate of matrix degradation. There are 
various factors involved to determine the drug release kinetics from its carrier. These 
include microstructure of the carrier and degradation of the matrix. Other factors to 
consider are the interaction and bonding between the drugs and the matrix which holds 
it (Ginebra et al., 2006a). Previous studies showed 2 % to 9 wt % of chlorhexidine 
could be incorporated into a brushite cement system (Hofmann et al., 2008, Young et 
al., 2008). These formulations released all their antibacterial within a few days.   
 
 Our study showed that when 50 wt % of PLS was added into the aqueous phase 
of the brushite cement there were significant effects on setting chemistry.   50 wt % 
PLS corresponds with 10 wt % of the total with PLR 4:1. Much less than 30% of the 
drug was released, however, in a few days.  Drug release can be controlled by 
reducing the porosity (Bohner et al., 1997a, Hofmann et al., 2009, Tamimi et al., 2008). 
From the FTIR studies, however, it is more likely that slow PLS release is a result of 
stronger interactions between the brushite cement and drug particularly as it 
increasingly replaces the citric acid retardant.  
 
There was a critical point between 20 and 30 wt % PLS. This is interesting 
because there will be equal number of moles acidic (3 per molecule of citric acid) and 
lysine (1 per mole of lysine) reactive groups at 26 wt %.  
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Before this concentration acid release is approximately constant. After this point, 
both acid release and PLS release are very low. Additionally, brushite no longer forms 
and absorbance profile was very different. Burst release of antimicrobial agents often 
occurs at an early time followed by a longer duration of persistent but reduced release. 
In this study, the high initial release of PLS was noticed in the first hours of soaking 
them in water. This early diffusion could have an effect on the microorganisms and 
colonization particularly if these drugs were entrapped inside the injected area or in 
gaps between the tooth and restoration.  
 
Between 75 – 95 wt % of PLS load in the cements was not released during the 
release study. The PLS release below 30% PLS was approximately proportional to 
level in the cement indicating that the same amount of PLS is being released 
irrespective of its concentration in the formulation. At later times PLS release and 
degradation in vitro were both very slow.  Brushite cements can degrade more rapidly 
in vivo than in vitro due to the action of cells and enzymes from the body (Constantz et 
al., 1998, Grover at al., 2003). Therefore the degradation of brushite cements in vivo 
would be expected to lead to faster release of PLS.  
 
6.6 Conclusion 
This study firstly focused on assessing the effect of different monocalcium 
phosphate monohydrate (MCPM) and β -tricalcium phosphate (β-TCP) particle sizes 
on brushite cement formation. 
 
 Afterwards, the effects of varying the powder to liquid ratio (PLR) and 
concentration of ε-polylysine (PLS) on brushite cements was assessed. The following 
conclusions can be drawn from this study. 
 
6.6.1 Mechanical properties 
The largest particle size of (34 micron) produced the highest flexural strength of 
32.5 MPa at PLR 4 to 1. The handling of brushite cements is better with MCPM 2 
(Sigma) that has crystalline shape. Strength of brushite cements can be decreased by 
decreasing the β-TCP particle sizes and PLR. Decreasing the level of PLS helps to 
produced higher strength cements.  
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Placement of set cements in water will result in decreased in strength down to 
14 MPa. Increase in biaxial flexural strength overall lead to increase in biaxial flexural 
modulus. On average, there is slightly increased in biaxial modulus by increasing PLR 
but increased the wt % of PLS does not had any significant effect on modulus. Cement 
toughness however does not depend with any factor, either different MCPM, PLR or 
level wt % of PLS.  
 
6.6.2 Setting kinetic 
High levels of PLS can be added with only minor reduction in the strength but it 
does significantly delayed the setting time and reduced the brushite cement formation.  
 
6.6.3 Microstructure of the cement 
Adding high level of PLS does not interfere with crystal formation within the 
brushite cement. Cements prepared with MCPM 2 do not showed any obvious 
difference by adding citric acid or adding increase wt % level of PLS. The crystal 
formed also did not changed either in dry condition or placement of the samples in 
water.  
 
6.6.4 Cement degradation 
Set cements with MCPM 1 are less degraded. Incorporation of PLS into the 
composition with MCPM 2 resulted in more degradation except for formulation with 50 
wt % of PLS. 
  
6.6.5 pH and drug release study 
pH study showed that acid released took place within 1 week and stabilised 
afterwards. Up to 30% of PLS was released within 1 month. Remaining PLS is still 
bound within the cements.  
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6.7 Summary 
Brushite cements has a great potential in dental application and as bone 
substitute may offer clinicians the opportunity of preserving alveolar bone. The 
combination of self – setting nature, mouldability, injectability, biocompatibility, 
bioresorbable, has the osteoconductive properties and remineralising antibacterial 
effect suggests a great potential of brushite cements in regenerative therapy. The 
findings of this research demonstrated that brushite cements produced with MCPM 2 
which has crystalline shape, β-TCP 34 micron and citric acid 800 mM produced the 
highest dry and wet flexural strength of 32 MPa and 14 MPa respectively. Very high 
levels of PLS could be introduced into brushite cements without serious detrimental 
effects on mechanical properties. PLS, however, did delay the setting time and altered 
the final chemistry and microstructure of the dicalcium phosphate product. 
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7 FUTURE WORK 
7.1 Investigate effect of MCPM Himed   
Mechanical test study showed that MCPM Himed produced BFS with β-TCP size 
34 micron of 28.5 MPa and comparable to MCPM Sigma that gave 30.0 MPa. Setting 
kinetic result showed that citric acid (CA) readily interacted with the powder type of 
MCPM Himed and was able to delay the setting time. Mass study showed that brushite 
cements produced were more stable. Therefore, it is interesting to know whether by 
using MCPM from Himed with addition of ε-polylysine (PLS) will improve properties of 
brushite cements better than MCPM from Sigma. 
 
7.2 Investigate effect of Strontium 
Strontium can replace calcium to some extent in various biochemical processes 
in the body, including replacing small proportions of the calcium in hydroxyapatite 
crystals of calcified tissues such as bones and teeth. Strontium is believed to impart 
additional strength to these calcified tissues and draw extra calcium into the bones. 
Studies have showed that administering strontium results in reduction of cavities 
incidence (Lippert, 2012, Koletsi-Kounari et al., 2012). To extend the above work in this 
thesis, new formulation was design by using Sr. The initial aim was to keep the moles 
and PLR constant. However, the powder phase failed to mix with the liquid phase 
indicating inadequate liquid available to produce set cements. Further study will need 
to be modified by lowering PLR to assess the effect of Sr into the formulation with the 
same method as had been done in this thesis.  
 
7.3 Cohesion study 
 Study has reported data suggesting thrombosis can possibly be due to the 
released of calcium phosphate particles in the blood stream (Bohner et al., 2006). 
Therefore, it is important to improve the cements paste resistance to disintegration 
upon early contact with blood or other fluids. From this thesis it was observed that by 
increasing the PLR from 3.3:1 to 4:1, the brushite cements paste become less viscous 
indicating increase in cohesion. Cohesion had been observed to improve by adding 
increase level of PLS into the formulation. Three methods to determine cohesion had 
been suggested including visual inspection, measurement of geometrical size of the 
cement and a setting time test (Gilmore needle).  
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7.4 Cement adhesion to dentine and bone 
Adhesion between the brushite cements and the tooth or bone is very 
important. Therefore, it is interesting to know whether the presence of PLS in the 
composition will improve the bonding capability. The potential chemical bonding 
capability from PLS might increase adhesive properties of the brushite cements. 
Adhesion properties of PLS could be assessed through a push out test.  
 
7.5 Antibacterial study 
This study has shown that PLS was released over a period of time. Therefore, it 
is important to understand if interaction between CA and PLS or the concentration of 
PLS is adequate for minimum inhibitory concentration required to exert an antibacterial 
activity. Subsequently effectiveness of antibacterial effect of PLS should be studied 
using various microbiology techniques (e.g MIC and agar diffusion test).  
 
7.6 Cement injectibility 
It is important to have good cement injectability particularly for minimal invasive 
surgical procedures that required injection of the cements into the bone defect (Baroud 
et al., 2005). During the injection process, the liquid to powder ratios should not change 
in order to be capable for injectability but many brushite cements were found to suffer 
from phase separation during injection thus making it hard for them to be injected. 
Development of injectable brushite cements with PLS releasing properties offers a 
quick and easy placement method for this material. From this study it had been showed 
that adding PLS can help to produce paste like cements. However, further study needs 
to be carried out to determine the injectability of the compositions used above.  
 
7.7 Final composition of the cements 
Further studies needs to be done using Raman to analyse final composition of 
the cements. Raman mapping is a technique for generating detailed chemical images 
based on a sample’s Raman spectra. These spectra can then be used to generate 
images showing location and amount of different species.  
 
143 
 
7.8 Cement porosity 
It has been shown that the mechanical performance of brushite cements is 
inversely correlated to its porosity. In addition, less porous cements have been shown 
to regulate better drug release (Hofmann et al., 2009). This study only provided a 
qualitative assessment of the cements microstructure with the SEM images. However, 
further studies need to be done as a quantitave analysis of cements porosity and to 
understand the effect of PLS on the microstructure and drug release properties.  
 
7.9 Adding polyacrylic acid 
Previous study by Mohd Razi (Xia et al., 2014) showed that polyacrylic acid 
(PAA) addition helped to slow down (possibly overly) the release kinetics of 
chlorhexidine and increase the flexural strength. The drug release kinetics was affected 
by addition of polymer to the composition. Hence, it is very interesting to observe the 
interaction of PAA with calcium phosphate and PLS.  
 
7.10 Comparison to commercial product 
Further studies need to be carried out to compare the modified brushite 
cements with other commercial brushite cements. Currently, brushite cements have 
been studied to be used as reinforcements of osteosynthesis screw. However, the 
current brushite cements still have poor mechanical properties, no or limited 
antimicrobial effect and short working time. Therefore, it is essential to investigate the 
above modified cements and assess whether it has properties comparable or better 
than available product.  
 
7.11 In vivo assessment of brushite cements 
Post – extraction, alveolar bone remodelling often results in aesthetic 
compromises in the area of tooth extraction due to alveolar ridge resorption. 
Techniques to preserve natural bone and soft tissue contours are of great interest to 
clinicians. Therefore, the above antibacterial releasing brushite cements offer possible 
bone substitute following tooth extraction. Ultimately, the final modified brushite 
cements formulation should be examined in vivo.  
144 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 8 
REFERENCE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
145 
 
8 REFERENCES 
 
ABERG, J., BRISBY, H., HENRIKSSON, H. B., LINDAHL, A., THOMSEN, P. & ENGQVIST, H. 2010.  
Premixed acidic calcium phosphate cement: characterization of strength and 
microstructure. J Biomed Mater Res B Appl Biomater, 93, 436-41. 
ADAM LP & RJC, W. 1985. A photomicrogrammatic method for monitoring changes in the 
residual alveolar ridge form. J Oral Rehabil 443-50. 
AHN, J., CHOI, J., JOO, C. H., SEO, I., KIM, D., YOON, S. Y., KIM, Y. K. & LEE, H. 2004. 
Susceptibility of mouse primary cortical neuronal cells to coxsackievirus B. J Gen Virol, 
85, 1555-64. 
ALKHRAISAT, M. H., MARINO, F. T., RETAMA, J. R., JEREZ, L. B. & LOPEZ-CABARCOS, E. 2008a. 
Beta-tricalcium phosphate release from brushite cement surface. J Biomed Mater Res 
A, 84, 710-7. 
ALKHRAISAT, M. H., MARINO, F. T., RODRIGUEZ, C. R., JEREZ, L. B. & CABARCOS, E. L. 2008b. 
Combined effect of strontium and pyrophosphate on the properties of brushite 
cements. Acta Biomater, 4, 664-70. 
ALKHRAISAT, M. H., RUEDA, C., CABREJOS-AZAMA, J., LUCAS-APARICIO, J., MARINO, F. T., 
TORRES GARCIA-DENCHE, J., JEREZ, L. B., GBURECK, U. & CABARCOS, E. L. 2010. 
Loading and release of doxycycline hyclate from strontium-substituted calcium 
phosphate cement. Acta Biomater, 6, 1522-8. 
ALKHRAISAT, M. H., RUEDA, C., MARINO, F. T., TORRES, J., JEREZ, L. B., GBURECK, U. & 
CABARCOS, E. L. 2009. The effect of hyaluronic acid on brushite cement cohesion. Acta 
Biomater, 5, 3150-6. 
AMBARD, A. J. & MUENINGHOFF, L. 2006. Calcium phosphate cement: review of mechanical 
and biological properties. J Prosthodont, 15, 321-8. 
AMLER, M. H. 1969. The time sequence of tissue regeneration in human extraction wounds. 
Oral Surg Oral Med Oral Pathol, 27, 309-18. 
ANDRESEN, J., ANDREASEN, F. M. & ANDERSSON, L. (eds.) 2007. Textbook and color atlas of 
traumatic injuries to the teeth, Copenhagen: Oxford: Blackwell Munksgaard. 
ARAUJO, M. G. & LINDHE, J. 2009. Ridge preservation with the use of Bio-Oss collagen: A 6-
month study in the dog. Clin Oral Implants Res, 20, 433-40. 
ARTZI, Z., TAL, H. & DAYAN, D. 2000. Porous bovine bone mineral in healing of human 
extraction sockets. Part 1: histomorphometric evaluations at 9 months. J Periodontol, 
71, 1015-23. 
ASFTA, M. 1999. Standard specification for acrylic bone cement, ASTM F451- 99a., West 
Conshohocken, PA, ASTM International. 
ATWOOD, D. A. 1973. Reduction of residual ridges in the partially edentulous patient. Dent Clin 
North Am, 17, 747-54. 
BAROUD, G., CAYER, E. & BOHNER, M. 2005. Rheological characterization of concentrated 
aqueous beta-tricalcium phosphate suspensions: the effect of liquid-to-powder ratio, 
milling time, and additives. Acta Biomater, 1, 357-63. 
BARRALET, J. E., GROVER, L. M. & GBURECK, U. 2004. Ionic modification of calcium phosphate 
cement viscosity. Part II: hypodermic injection and strength improvement of brushite 
cement. Biomaterials, 25, 2197-203. 
BATH, B.-M. & FEHRENBACH, M. J. (eds.) 2006. Dental embryology, histology and anatomy: 
Elsevier Saunders. 
BELKOFF, S. M. & MOLLOY, S. 2003. Temperature measurement during polymerization of 
polymethylmethacrylate cement used for vertebroplasty. Spine (Phila Pa 1976), 28, 
1555-9. 
146 
 
BERLEMANN, U., FERGUSON, S. J., NOLTE, L. P. & HEINI, P. F. 2002. Adjacent vertebral failure 
after vertebroplasty. A biomechanical investigation. J Bone Joint Surg Br, 84, 748-52. 
BOANINIA, E., GAZZANOB, M. & BIGIA, A. 2009. Ionic substitutions in calcium phosphates 
synthesized at low temperature. Acta Biomaterialia, 6, 1882–1894. 
BODIC, F., HAMEL, L., LEROUXEL, E., BASLE, M. F. & CHAPPARD, D. 2005. Bone loss and teeth. 
Joint Bone Spine, 72, 215-21. 
BOHNER M, LEMAITRE J & TA, R. 1996. Effects of sulfate, pyrophosphate, and citrate ions on 
the physicochemical properties of cements made of beta-tricalcium phosphate-
phosphoric acid-water mixtures.  . J Am Ceram Soc  1427-34. 
BOHNER, M., DOEBELIN, N. & BAROUD, G. 2006. Theoretical and experimental approach to 
test the cohesion of calcium phosphate pastes. Eur Cell Mater, 12, 26-35. 
BOHNER, M. & GBURECK, U. 2008. Thermal reactions of brushite cements. J Biomed Mater Res 
B Appl Biomater, 84, 375-85. 
BOHNER, M., GBURECK, U. & BARRALET, J. E. 2005. Technological issues for the development 
of more efficient calcium phosphate bone cements: a critical assessment. Biomaterials, 
26, 6423-9. 
BOHNER, M., LEMAITRE, J., VAN LANDUYT, P., ZAMBELLI, P. Y., MERKLE, H. P. & GANDER, B. 
1997a. Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic 
delivery system. J Pharm Sci, 86, 565-72. 
BOHNER, M., MERKLE, H. P., LANDUYT, P. V., TROPHARDY, G. & LEMAITRE, J. 2000a. Effect of 
several additives and their admixtures on the physico-chemical properties of a calcium 
phosphate cement. J Mater Sci Mater Med, 11, 111-6. 
BOHNER, M., MERKLE, H. P. & LEMAITRE, J. 2000b. In vitro aging of a calcium phosphate 
cement. J Mater Sci Mater Med, 11, 155-62. 
BOHNER, M., VAN LANDUYT, P., MERKLE, H. P. & LEMAITRE, J. 1997b. Composition effects on 
the pH of a hydraulic calcium phosphate cement. J Mater Sci Mater Med, 8, 675-81. 
BRESCIANI, E., BARATA TDE, J., FAGUNDES, T. C., ADACHI, A., TERRIN, M. M. & NAVARRO, M. F. 
2004. Compressive and diametral tensile strength of glass ionomer cements. J Appl 
Oral Sci, 12, 344-8. 
CAI, S., ZHAI, Y., XU, G., LU, S., ZHOU, W. & YE, X. 2011. Preparation and properties of calcium 
phosphate cements incorporated gelatin microspheres and calcium sulfate dihydrate 
as controlled local drug delivery system. Journal of Materials Science: Materials in 
Medicine, 22. 
CALISKAN, M. K. & TURKUN, M. 1995. Clinical investigation of traumatic injuries of permanent 
incisors in Izmir, Turkey. Endod Dent Traumatol, 11, 210-3. 
CAMA, G., BARBERIS, F., BOTTER, R., CIRILLO, P., CAPURRO, M., QUARTO, R., SCAGLIONE, S., 
FINOCCHIO, E., MUSSI, V. & VALBUSA, U. 2009. Preparation and properties of 
macroporous brushite bone cements. Acta Biomater, 5, 2161-8. 
CAMELO, M., NEVINS, M. L., SCHENK, R. K., SIMION, M., RASPERINI, G., LYNCH, S. E. & NEVINS, 
M. 1998. Clinical, radiographic, and histologic evaluation of human periodontal defects 
treated with Bio-Oss and Bio-Gide. Int J Periodontics Restorative Dent, 18, 321-31. 
CARLSSON, G. E. & PERSSON, G. 1967. Morphologic changes of the mandible after extraction 
and wearing of dentures. A longitudinal, clinical, and x-ray cephalometric study 
covering 5 years. Odontol Revy, 18, 27-54. 
CARMAGNOLA, D., ADRIAENS, P. & BERGLUNDH, T. 2003. Healing of human extraction sockets 
filled with Bio-Oss. Clin Oral Implants Res, 14, 137-43. 
CAWOOD, J. I. & HOWELL, R. A. 1988. A classification of the edentulous jaws. Int J Oral 
Maxillofac Surg, 17, 232-6. 
147 
 
CHERNG, A., TAKAGI, S. & CHOW, L. C. 1997. Effects of hydroxypropyl methylcellulose and 
other gelling agents on the handling properties of calcium phosphate cement. J 
Biomed Mater Res, 35, 273-7. 
CHUNG, S. M., YAP, A. U., CHANDRA, S. P. & LIM, C. T. 2004. Flexural strength of dental 
composite restoratives: comparison of biaxial and three-point bending test. J Biomed 
Mater Res B Appl Biomater, 71, 278-83. 
CONSTANTZ, B. R., BARR, B. M., ISON, I. C., FULMER, M. T., BAKER, J., MCKINNEY, L., 
GOODMAN, S. B., GUNASEKAREN, S., DELANEY, D. C., ROSS, J. & POSER, R. D. 1998. 
Histological, chemical, and crystallographic analysis of four calcium phosphate 
cements in different rabbit osseous sites. J Biomed Mater Res, 43, 451-61. 
COSTANTINO, P. D. & FRIEDMAN, C. D. 1994. Synthetic bone graft substitutes. Otolaryngol Clin 
North Am, 27, 1037-74. 
CYPHER, T. J. & GROSSMAN, J. P. 1996. Biological principles of bone graft healing. J Foot Ankle 
Surg, 35, 413-7. 
DAY, P. F., KINDELAN, S. A., SPENCER, J. R., KINDELAN, J. D. & DUGGAL, M. S. 2008. Dental 
trauma: part 2. Managing poor prognosis anterior teeth--treatment options for the 
subsequent space in a growing patient. J Orthod, 35, 143-55. 
DE LA RIVA, B., SANCHEZ, E., HERNANDEZ, A., REYES, R., TAMIMI, F., LOPEZ-CABARCOS, E., 
DELGADO, A. & EVORA, C. 2009. Local controlled release of VEGF and PDGF from a 
combined brushite-chitosan system enhances bone regeneration. J Control Release, 
143, 45-52. 
DESAI, S. & CHANDLER, N. 2009. Calcium hydroxide-based root canal sealers: a review. J Endod, 
35, 475-80. 
DOROZHKIN, S. 2008. calcium orthophosphate cements for biomedical application. Journal of 
materials science, 43. 
FIALKOV, J. A., HOLY, C., FORREST, C. R., PHILLIPS, J. H. & ANTONYSHYN, O. M. 2001. 
Postoperative infections in craniofacial reconstructive procedures. J Craniofac Surg, 12, 
362-8. 
FICKL, S., ZUHR, O., WACHTEL, H., STAPPERT, C. F., STEIN, J. M. & HURZELER, M. B. 2008. 
Dimensional changes of the alveolar ridge contour after different socket preservation 
techniques. J Clin Periodontol, 35, 906-13. 
FILIPPI, A., POHL, Y. & VON ARX, T. 2001. Decoronation of an ankylosed tooth for preservation 
of alveolar bone prior to implant placement. Dent Traumatol, 17, 93-5. 
FLAUTRE, B., LEMAITRE, J., MAYNOU, C., VAN LANDUYT, P. & HARDOUIN, P. 2003. Influence of 
polymeric additives on the biological properties of brushite cements: an experimental 
study in rabbit. J Biomed Mater Res A, 66, 214-23. 
FORSBERG, C. M. & TEDESTAM, G. 1990. Traumatic injuries to teeth in Swedish children living 
in an urban area. Swed Dent J, 14, 115-22. 
FRAYSSINET, P., GINESTE, L. & ROUQUET, N. 1998. [Osseointegration of 2 different types of 
calcium phosphate materials: ceramics and ionic cements]. Morphologie, 82, 3-7. 
FRAYSSINET, P., ROUDIER, M., LERCH, A., CEOLIN, J. L., DEPRES, E. & ROUQUET, N. 2000. Tissue 
reaction against a self-setting calcium phosphate cement set in bone or outside the 
organism. J Mater Sci Mater Med, 11, 811-5. 
FUKUTOME, A., M, K. & AIUCHI, M. 1995. A combined chronic toxicity and carcinogenicity 
study of polylysine powder in rats by peroral dietary administration. Clinical report. 
GALEA, H. 1984. An investigation of dental injuries treated in an acute care general hospital. J 
Am Dent Assoc, 109, 434-8. 
GBURECK, U., DEMBSKI, S., THULL, R. & BARRALET, J. E. 2005. Factors influencing calcium 
phosphate cement shelf-life. Biomaterials, 26, 3691-7. 
148 
 
GINEBRA, M. P., ESPANOL, M., MONTUFAR, E. B., PEREZ, R. A. & MESTRES, G. 2010. New 
processing approaches in calcium phosphate cements and their applications in 
regenerative medicine. Acta Biomater, 6, 2863-73. 
GINEBRA, M. P., TRAYKOVA, T. & PLANELL, J. A. 2006a. Calcium phosphate cements as bone 
drug delivery systems: a review. J Control Release, 113, 102-10. 
GINEBRA, M. P., TRAYKOVA, T. & PLANELL, J. A. 2006b. Calcium phosphate cements: 
competitive drug carriers for the musculoskeletal system? Biomaterials, 27, 2171-7. 
GIOCONDI, J. L., EL-DASHER, B. S., NANCOLLAS, G. H. & ORME, C. A. 2010. Molecular 
mechanisms of crystallization impacting calcium phosphate cements. Philos Trans A 
Math Phys Eng Sci, 368, 1937-61. 
GRASES, F., RAMIS, M. & COSTA-BAUZA, A. 2000. Effects of phytate and pyrophosphate on 
brushite and hydroxyapatite crystallization. Comparison with the action of other 
polyphosphates. Urol Res, 28, 136-40. 
GROSS, U., SCHMITZ, H. J. & STRUNZ, V. 1988. Surface activities of bioactive glass, aluminum 
oxide, and titanium in a living environment. Ann N Y Acad Sci, 523, 211-26. 
GROSSARDT, C., EWALD, A., GROVER, L. M., BARRALET, J. E. & GBURECK, U. 2010. Passive and 
active in vitro resorption of calcium and magnesium phosphate cements by 
osteoclastic cells. Tissue Eng Part A, 16, 3687-95. 
GROVER, L. M., GBURECK, U., WRIGHT, A. J., TREMAYNE, M. & BARRALET, J. E. 2006. 
Biologically mediated resorption of brushite cement in vitro. Biomaterials, 27, 2178-
85. 
GROVER, L. M., HOFMANN, M. P., GBURECK, U., KUMARASAMI, B. & BARRALET, J. E. 2008. 
Frozen delivery of brushite calcium phosphate cements. Acta Biomater, 4, 1916-23. 
GROVER, L. M., KNOWLES, J. C., FLEMING, G. J. & BARRALET, J. E. 2003. In vitro ageing of 
brushite calcium phosphate cement. Biomaterials, 24, 4133-41. 
GUO, F. & LI, B. [Effects of collagen on the properties of TTCP/MCPM bone cement]. 2010. 
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 27, 328-31. 
HABIB, M., BAROUD, G., GITZHOFER, F. & BOHNER, M. 2008. Mechanisms underlying the 
limited injectability of hydraulic calcium phosphate paste. Acta Biomater, 4, 1465-71. 
HABIBOVIC, P., GBURECK, U., DOILLON, C. J., BASSETT, D. C., VAN BLITTERSWIJK, C. A. & 
BARRALET, J. E. 2008. Osteoconduction and osteoinduction of low-temperature 3D 
printed bioceramic implants. Biomaterials, 29, 944-53. 
HAMANO, Y. 2011. Occurrence, biosynthesis, biodegradation, and industrial and medical 
applications of a naturally occurring epsilon-poly-L-lysine. Biosci Biotechnol Biochem, 
75, 1226-33. 
HAMANO, Y., NICCHU, I., SHIMIZU, T., ONJI, Y., HIRAKI, J. & TAKAGI, H. 2007. epsilon-Poly-L: -
lysine producer, Streptomyces albulus, has feedback-inhibition resistant aspartokinase. 
Appl Microbiol Biotechnol, 76, 873-82. 
HAN, B., MA, P. W., ZHANG, L. L., YIN, Y. J., YAO, K. D., ZHANG, F. J., ZHANG, Y. D., LI, X. L. & 
NIE, W. 2009. beta-TCP/MCPM-based premixed calcium phosphate cements. Acta 
Biomater, 5, 3165-77. 
HASSAN, S. M., MOBARAK, E. H. & FAWZI, E. M. 2008. The efficacy of different regimens of 
chlorhexidine as an antimicrobial agent for a group of egyptians. J Egypt Public Health 
Assoc, 83, 435-50. 
HEASMAN, P. A., HEASMAN, L., STACEY, F. & MCCRACKEN, G. I. 2001. Local delivery of 
chlorhexidine gluconate (PerioChip) in periodontal maintenance patients. J Clin 
Periodontol, 28, 90-5. 
HEINI, P. F., BERLEMANN, U., KAUFMANN, M., LIPPUNER, K., FANKHAUSER, C. & VAN 
LANDUYT, P. 2001. Augmentation of mechanical properties in osteoporotic vertebral 
149 
 
bones--a biomechanical investigation of vertebroplasty efficacy with different bone 
cements. Eur Spine J, 10, 164-71. 
HIGGS, W. A., LUCKSANASOMBOOL, P., HIGGS, R. J. & SWAIN, M. V. 2001. A simple method of 
determining the modulus of orthopedic bone cement. J Biomed Mater Res, 58, 188-95. 
HIRAKI, J., ICHIKAWA, T., NINOMIYA, S., SEKI, H., UOHAMA, K., SEKI, H., KIMURA, S., 
YANAGIMOTO, Y. & BARNETT, J. W., JR. 2003. Use of ADME studies to confirm the 
safety of epsilon-polylysine as a preservative in food. Regul Toxicol Pharmacol, 37, 
328-40. 
HOFMANN, M. P., ANNE M. YOUNG, UWE GBURECK, NAZHA, S. N. & BARRALET, J. E. 2006a. 
FTIR-monitoring of a fast setting brushite bone cement: effect of intermediate phases. 
Journal of Materials Chemistry, 3199-3206. 
HOFMANN, M. P., MOHAMMED, A. R., PERRIE, Y., GBURECK, U. & BARRALET, J. E. 2009. High-
strength resorbable brushite bone cement with controlled drug-releasing capabilities. 
Acta Biomater, 5, 43-9. 
HOFMANN, M. P., NAZHAT, S. N., GBURECK, U. & BARRALET, J. E. 2006b. Real-time monitoring 
of the setting reaction of brushite-forming cement using isothermal differential 
scanning calorimetry. J Biomed Mater Res B Appl Biomater, 79, 360-4. 
HOU, C. H., CHEN, C. W., HOU, S. M., LI, Y. T. & LIN, F. H. 2009. The fabrication and 
characterization of dicalcium phosphate dihydrate-modified magnetic nanoparticles 
and their performance in hyperthermia processes in vitro. Biomaterials, 30, 4700-7. 
HOUMARD, M., FU, Q., GENET, M., SAIZ, E. & TOMSIA, A. P. 2013. On the structural, 
mechanical, and biodegradation properties of HA/beta-TCP robocast scaffolds. J 
Biomed Mater Res B Appl Biomater, 101, 1233-42. 
HUAN, Z. & CHANG, J. 2009. Novel bioactive composite bone cements based on the beta-
tricalcium phosphate-monocalcium phosphate monohydrate composite cement 
system. Acta Biomater, 5, 1253-64. 
IKENAGA, M., HARDOUIN, P., LEMAITRE, J., ANDRIANJATOVO, H. & FLAUTRE, B. 1998. 
Biomechanical characterization of a biodegradable calcium phosphate hydraulic 
cement: a comparison with porous biphasic calcium phosphate ceramics. J Biomed 
Mater Res, 40, 139-44. 
IMAI, Y. & ISHIKAWA, M. 1997. New initiator system for bonding to dentin using 
methylcyclohexanedione. Dent Mater J, 16, 31-9. 
JEFFCOAT, M. K. 1993. Bone loss in the oral cavity. J Bone Miner Res, 8 Suppl 2, S467-73. 
JIANG, P. J., PATEL, S., GBURECK, U., CALEY, R. & GROVER, L. M. 2009. Comparing the efficacy 
of three bioceramic matrices for the release of vancomycin hydrochloride. J Biomed 
Mater Res B Appl Biomater, 93, 51-8. 
KAHAR, P., IWATA, T., HIRAKI, J., PARK, E. Y. & OKABE, M. 2001. Enhancement of epsilon-
polylysine production by Streptomyces albulus strain 410 using pH control. J Biosci 
Bioeng, 91, 190-4. 
KANIA, M. J., KEELING, S. D., MCGORRAY, S. P., WHEELER, T. T. & KING, G. J. 1996. Risk factors 
associated with incisor injury in elementary school children. Angle Orthod, 66, 423-32. 
KAWAI, T., KUBOTA, T., HIRAKI, J. & IZUMI, Y. 2003. Biosynthesis of epsilon-poly-L-lysine in a 
cell-free system of Streptomyces albulus. Biochem Biophys Res Commun, 311, 635-40. 
KHAIROUN, I., DRIESSENS, F. C., BOLTONG, M. G., PLANELL, J. A. & WENZ, R. 1999. Addition of 
cohesion promotors to calcium phosphate cements. Biomaterials, 20, 393-8. 
KINNUNEN, I., AITASALO, K., POLLONEN, M. & VARPULA, M. 2000. Reconstruction of orbital 
floor fractures using bioactive glass. J Craniomaxillofac Surg, 28, 229-34. 
KITO, M., ONJI, Y., YOSHIDA, T. & NAGASAWA, T. 2002. Occurrence of epsilon-poly-L-lysine-
degrading enzyme in epsilon-poly-L-lysine-tolerant Sphingobacterium multivorum 
OJ10: purification and characterization. FEMS Microbiol Lett, 207, 147-51. 
150 
 
KLAMMERT, U., REUTHER, T., JAHN, C., KRASKI, B., KUBLER, A. C. & GBURECK, U. 2009. 
Cytocompatibility of brushite and monetite cell culture scaffolds made by three-
dimensional powder printing. Acta Biomater, 5, 727-34. 
KOLETSI-KOUNARI, H., MAMAI-HOMATA, E. & DIAMANTI, I. 2012. An in vitro study of the 
effect of aluminum and the combined effect of strontium, aluminum, and fluoride 
elements on early enamel carious lesions. Biol Trace Elem Res, 147, 418-27. 
KUEMMERLE, J. M., OBERLE, A., OECHSLIN, C., BOHNER, M., FREI, C., BOECKEN, I. & VON 
RECHENBERG, B. 2005. Assessment of the suitability of a new brushite calcium 
phosphate cement for cranioplasty - an experimental study in sheep. J 
Craniomaxillofac Surg, 33, 37-44. 
LEVIN, L., ZIGDON, H. & MAYER, Y. 2008. [Alveolar ridge preservation following tooth 
extraction]. Refuat Hapeh Vehashinayim, 25, 41-6, 83. 
LILLEY, K. J., GBURECK, U., WRIGHT, A. J., FARRAR, D. F. & BARRALET, J. E. 2005. Cement from 
nanocrystalline hydroxyapatite: effect of calcium phosphate ratio. J Mater Sci Mater 
Med, 16, 1185-90. 
LIN, S., WANG, Z., QI, J. C., WU, J. H., TIAN, T., HOU, L. L., HAO, L. M. & YANG, J. Q. 2011. One-
pot fabrication and antimicrobial properties of novel PET nonwoven fabrics. Biomed 
Mater, 6, 045009. 
LINDHE, J., LANG, P. N. & KARRING 2008. clinical periodontology and implant dentistry. 
Blackwell Munksgaard, Singapore. 
LIPPERT, F. 2012. The effects of lesion baseline characteristics and different Sr:Ca ratios in 
plaque fluid-like solutions on caries lesion de- and remineralization. Arch Oral Biol, 57, 
1299-306. 
LOCHER, C. P., PUTNAM, D., LANGER, R., WITT, S. A., ASHLOCK, B. M. & LEVY, J. A. 2003. 
Enhancement of a human immunodeficiency virus env DNA vaccine using a novel 
polycationic nanoparticle formulation. Immunol Lett, 90, 67-70. 
LOPEZ, M. S., MECERREYES, D., LOPEZ-CABARCOS, E. & LOPEZ-RUIZ, B. 2006. Amperometric 
glucose biosensor based on polymerized ionic liquid microparticles. Biosens 
Bioelectron, 21, 2320-8. 
LU, J. X., ABOUT, I., STEPHAN, G., VAN LANDUYT, P., DEJOU, J., FIOCCHI, M., LEMAITRE, J. & 
PROUST, J. P. 1999. Histological and biomechanical studies of two bone colonizable 
cements in rabbits. Bone, 25, 41S-45S. 
MA, D. D. & WEI, A. Q. 1996. Enhanced delivery of synthetic oligonucleotides to human 
leukaemic cells by liposomes and immunoliposomes. Leuk Res, 20, 925-30. 
MA, J., SMIETANA, M. J., KOSTROMINOVA, T. Y., WOJTYS, E. M., LARKIN, L. M. & ARRUDA, E. 
M. 2012. Three-dimensional engineered bone-ligament-bone constructs for anterior 
cruciate ligament replacement. Tissue Eng Part A, 18, 103-16. 
MALMGREN, B. 2000. Decoronation: how, why, and when? J Calif Dent Assoc, 28, 846-54. 
MARINO, F. T., TORRES, J., HAMDAN, M., RODRIGUEZ, C. R. & CABARCOS, E. L. 2007. 
Advantages of using glycolic acid as a retardant in a brushite forming cement. J Biomed 
Mater Res B Appl Biomater, 83, 571-9. 
MARTIN, I. G., DALY, C. G. & LIEW, V. P. 1990. After-hours treatment of anterior dental trauma 
in Newcastle and western Sydney: a four-year study. Aust Dent J, 35, 27-31. 
MATEJICEK, P., CIGLER, P., PROCHAZKA, K. & KRAL, V. 2006. Molecular assembly of 
metallacarboranes in water: light scattering and microscopy study. Langmuir, 22, 575-
81. 
MATSUNAGA, K., MURATA, H. & SHITARA, K. 2010. Theoretical calculations of the 
thermodynamic stability of ionic substitutions in hydroxyapatite under an aqueous 
solution environment. J Phys Condens Matter, 22, 384210. 
151 
 
METZ, J., SARGENT, P. & CHU, T. M. 2006. Bovine albumin release and degradation analysis of 
dicalcium phosphate dihydrate cement. Biomed Sci Instrum, 42, 296-301. 
MEYER, U., T, M. & J, H. (eds.) 2009. Fundamentals of tissue engineering and regenerative 
medicine. 
MICHEL, M., IZQUIERDO, A., DECHER, G., VOEGEL, J. C., SCHAAF, P. & BALL, V. 2005. Layer by 
layer self-assembled polyelectrolyte multilayers with embedded phospholipid vesicles 
obtained by spraying: integrity of the vesicles. Langmuir, 21, 7854-9. 
MICHEL, M., VAUTIER, D., VOEGEL, J. C., SCHAAF, P. & BALL, V. 2004. Layer by layer self-
assembled polyelectrolyte multilayers with embedded phospholipid vesicles. 
Langmuir, 20, 4835-9. 
MIRTCHI, A. A., LEMAITRE, J. & MUNTING, E. 1989. Calcium phosphate cements: action of 
setting regulators on the properties of the beta-tricalcium phosphate-monocalcium 
phosphate cements. Biomaterials, 10, 634-8. 
MIRTCHI, A. A., LEMAITRE, J. & MUNTING, E. 1991. Calcium phosphate cements: effect of 
fluorides on the setting and hardening of beta-tricalcium phosphate-dicalcium 
phosphate-calcite cements. Biomaterials, 12, 505-10. 
MOORE, W. R., GRAVES, S. E. & BAIN, G. I. 2001. Synthetic bone graft substitutes. ANZ J Surg, 
71, 354-61. 
NAJJAR, M. B., KASHTANOV, D. & CHIKINDAS, M. L. 2009. Natural Antimicrobials ε-Poly-l-lysine 
and Nisin A for Control of Oral Microflora. 143-147. 
NORTON, M. R., ODELL, E. W., THOMPSON, I. D. & COOK, R. J. 2003. Efficacy of bovine bone 
mineral for alveolar augmentation: a human histologic study. Clin Oral Implants Res, 
14, 775-83. 
NURIT, J., MARGERIT, J., TEROL, A. & BOUDEVILLE, P. 2002. pH-metric study of the setting 
reaction of monocalcium phosphate monohydrate/calcium oxide-based cements. J 
Mater Sci Mater Med, 13, 1007-14. 
O'BRIEN, M. 1994. Children's dental health in United Kingdom 1993. London: Office of 
Population Censuses and survey. 
OSTLER, M. S. & KOKICH, V. G. 1994. Alveolar ridge changes in patients congenitally missing 
mandibular second premolars. J Prosthet Dent, 71, 144-9. 
PASQUIER, G., FLAUTRE, B., LECLET, H. & HARDOUIN, P. 1998. Experimental evaluation of a 
percutaneous injectable biomaterial used in radio-interventional bone-filling 
procedures. J Mater Sci Mater Med, 9, 333-6. 
PAXTON, J. Z., DONNELLY, K., KEATCH, R. P., BAAR, K. & GROVER, L. M. 2010. Factors affecting 
the longevity and strength in an in vitro model of the bone-ligament interface. Ann 
Biomed Eng, 38, 2155-66. 
PELTOLA, M. J., SUONPAA, J. T., ANDERSSON, H., MAATTANEN, H. S., AITASALO, K. M., YLI-
URPO, A. & LAIPPALA, P. J. 2000. In vitro model for frontal sinus obliteration with 
bioactive glass S53P4. J Biomed Mater Res, 53, 161-6. 
PEREZ, R. A., KIM, H.-W. & MARIA-PAU 2012. Polymeric additives to enhance the functional 
properties of calcium phosphate cements. J Tissue Eng. 
PIETROKOVSKI, J. & MASSLER, M. 1967. Alveolar ridge resorption following tooth extraction. J 
Prosthet Dent, 17, 21-7. 
PINA, S., TORRES, P. M., GOETZ-NEUNHOEFFER, F., NEUBAUER, J. & FERREIRA, J. M. 2010. 
Newly developed Sr-substituted alpha-TCP bone cements. Acta Biomater, 6, 928-35. 
PINA, S., VIEIRA, S. I., REGO, P., TORRES, P. M., DA CRUZ E SILVA, O. A., DA CRUZ E SILVA, E. F. & 
FERREIRA, J. M. Biological responses of brushite-forming Zn- and ZnSr- substituted 
beta-tricalcium phosphate bone cements. Eur Cell Mater, 20, 162-77. 
PITTS, N. B., BOYLES, J., NUGENT, Z. J., THOMAS, N. & PINE, C. M. 2004. The dental caries 
experience of 14-year-old children in England and Wales. Surveys co-ordinated by the 
152 
 
British Association for the Study of Community Dentistry in 2002/2003. Community 
Dent Health, 21, 45-57. 
ROBERTS, G. & LONGHURST, P. (eds.) 1996. Oral and Dental Trauma in Children and 
Adolescents: Oxford University Press. 
RYF, C., MD, S. G., RADZIEJOWSKI, M., BLAUTH, M. & HANSON, B. 2009. A New Injectable 
Brushite Cement: First Results in Distal Radius and Proximal Tibia Fractures. 35, 389-
396. 
RYSER, H. J. & SHEN, W. C. 1980. Conjugation of methotrexate to poly (L-lysine) as a potential 
way to overcome drug resistance. Cancer, 45, 1207-11. 
SANCHEZ-PANIAGUA LOPEZ, M., TAMIMI, F., LOPEZ-CABARCOS, E. & LOPEZ-RUIZ, B. 2009. 
Highly sensitive amperometric biosensor based on a biocompatible calcium phosphate 
cement. Biosens Bioelectron, 24, 2574-9. 
SCHROEDER, H. E. 1986. [Healing and regeneration following periodontal treatment]. Dtsch 
Zahnarztl Z, 41, 536-8. 
SHEN, W. C. & RYSER, H. J. 1981. Poly(L-lysine) has different membrane transport and drug-
carrier properties when complexed with heparin. Proc Natl Acad Sci U S A, 78, 7589-
93. 
SHIMA, S., MATSUOKA, H., IWAMOTO, T. & SAKAI, H. 1984. Antimicrobial action of epsilon-
poly-L-lysine. J Antibiot (Tokyo), 37, 1449-55. 
TAMIMI-MARINO, F., MASTIO, J., RUEDA, C., BLANCO, L. & LOPEZ-CABARCOS, E. 2007. Increase 
of the final setting time of brushite cements by using chondroitin 4-sulfate and silica 
gel. J Mater Sci Mater Med, 18, 1195-201. 
TAMIMI, F., SHEIKH, Z. & BARRALET, J. 2012. Dicalcium phosphate cements: brushite and 
monetite. Acta Biomater, 8, 474-87. 
TAMIMI, F., TORRES, J., BETTINI, R., RUGGERA, F., RUEDA, C., LOPEZ-PONCE, M. & LOPEZ-
CABARCOS, E. 2008. Doxycycline sustained release from brushite cements for the 
treatment of periodontal diseases. J Biomed Mater Res A, 85, 707-14. 
TAMIMI, F., TORRES, J., LOPEZ-CABARCOS, E., BASSETT, D. C., HABIBOVIC, P., LUCERON, E. & 
BARRALET, J. E. 2009. Minimally invasive maxillofacial vertical bone augmentation 
using brushite based cements. Biomaterials, 30, 208-16. 
TAMIMI, F. M., TORRES, J., TRESGUERRES, I., CLEMENTE, C., LOPEZ-CABARCOS, E. & BLANCO, L. 
J. 2006. Bone augmentation in rabbit calvariae: comparative study between Bio-Oss 
and a novel beta-TCP/DCPD granulate. J Clin Periodontol, 33, 922-8. 
THEISS, F., APELT, D., BRAND, B., KUTTER, A., ZLINSZKY, K., BOHNER, M., MATTER, S., FREI, C., 
AUER, J. A. & VON RECHENBERG, B. 2005. Biocompatibility and resorption of a brushite 
calcium phosphate cement. Biomaterials, 26, 4383-94. 
THIERRY, A. R., RAHMAN, A. & DRITSCHILO, A. 1993. Overcoming multidrug resistance in 
human tumor cells using free and liposomally encapsulated antisense 
oligodeoxynucleotides. Biochem Biophys Res Commun, 190, 952-60. 
THOMAS, P., SCHUH, A., EBEN, R. & THOMSEN, M. 2008. [Allergy to bone cement 
components]. Orthopade, 37, 117-20. 
THOMES, B., MURRAY, P. & BOUCHIER-HAYES, D. 2002. Development of resistant strains of 
Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. J Bone Joint 
Surg Br, 84, 758-60. 
TIMONSHENKO, S. & K.S (eds.) 1964. Theory of plates and shells: MCGraw Hill Higher 
Education. 
TSUJITA, T., TAKAICHI, H., TAKAKU, T., AOYAMA, S. & HIRAKI, J. 2006. Antiobesity action of 
epsilon-polylysine, a potent inhibitor of pancreatic lipase. J Lipid Res, 47, 1852-8. 
TSUJITA, T., TAKAICHI, H., TAKAKU, T., SAWAI, T., YOSHIDA, N. & HIRAKI, J. 2007. Inhibition of 
lipase activities by basic polysaccharide. J Lipid Res, 48, 358-65. 
153 
 
TURNER, T. M., URBAN, R. M., SINGH, K., HALL, D. J., RENNER, S. M., LIM, T. H., TOMLINSON, 
M. J. & AN, H. S. 2008. Vertebroplasty comparing injectable calcium phosphate cement 
compared with polymethylmethacrylate in a unique canine vertebral body large defect 
model. Spine J, 8, 482-7. 
VAN DE BELT, H., NEUT, D., SCHENK, W., VAN HORN, J. R., VAN DER MEI, H. C. & BUSSCHER, H. 
J. 2001. Staphylococcus aureus biofilm formation on different gentamicin-loaded 
polymethylmethacrylate bone cements. Biomaterials, 22, 1607-11. 
VAN LANDUYT, P., PETER, B., BELUZE, L. & LEMAITRE, J. 1999. Reinforcement of osteosynthesis 
screws with brushite cement. Bone, 25, 95S-98S. 
WAELTI, E. R. & GLUCK, R. 1998. Delivery to cancer cells of antisense L-myc oligonucleotides 
incorporated in fusogenic, cationic-lipid-reconstituted influenza-virus envelopes 
(cationic virosomes). Int J Cancer, 77, 728-33. 
XIA, W., M. R. MOHD RAZI, P. ASHLEY, E. A. ABOU NEEL, AND, M. P. H. & YOUNG, A. M. 2014. 
Quantifying effects of interactions between polyacrylic acid and chlorhexidine in 
dicalcium phosphate – forming cements J. Mater. Chem. , 1673-1680. 
XIE, D., BRANTLEY, W. A., CULBERTSON, B. M. & WANG, G. 2000. Mechanical properties and 
microstructures of glass-ionomer cements. Dent Mater, 16, 129-38. 
YIN, Y., YE, F., CAI, S., YAO, K., CUI, J. & SONG, X. 2003. Gelatin manipulation of latent 
macropores formation in brushite cement. J Mater Sci Mater Med, 14, 255-61. 
YOSHIDA, T. & NAGASAWA, T. 2003. epsilon-Poly-L-lysine: microbial production, 
biodegradation and application potential. Appl Microbiol Biotechnol, 62, 21-6. 
YOUNG, A. M., NG, P. Y., GBURECK, U., NAZHAT, S. N., BARRALET, J. E. & HOFMANN, M. P. 
2008. Characterization of chlorhexidine-releasing, fast-setting, brushite bone cements. 
Acta Biomater, 4, 1081-8. 
YU, H., DENG, C., TIAN, H., LU, T., CHEN, X. & JING, X. 2011. Chemo-physical and biological 
evaluation of poly(L-lysine)-grafted chitosan copolymers used for highly efficient gene 
delivery. Macromol Biosci, 11, 352-61. 
ZHANG, Y., PAJARES, A. & LAWN, B. R. 2004. Fatigue and damage tolerance of Y-TZP ceramics 
in layered biomechanical systems. J Biomed Mater Res B Appl Biomater, 71, 166-71. 
 
154 
 
 
 
 
 
 
 
                       APPENDICES 
155 
 
9 APPENDIX 
Appendix 1: 
 
1.1 : T-Test for different MCPM and β-TCP particle sizes for mechanical 
properties (MPa, GPa and toughness) at PLR 3.3:1 with CA 800 mM. 
 
T-Test: Test_measure = 1 MPa 
Group Statistics 
 company N Mean Std. Deviation Std. Error Mean 
powder_a4.32 
1 SIGMA 6 22.300 2.0852 .8513 
2 HIMED 6 22.167 2.9582 1.2077 
powder_b5.78 
1 SIGMA 6 22.667 3.3446 1.3654 
2 HIMED 6 22.467 3.3548 1.3696 
powder_c7.76 
1 SIGMA 6 23.950 2.9878 1.2198 
2 HIMED 6 22.967 2.7645 1.1286 
powder_d12.03 
1 SIGMA 6 27.467 3.4407 1.4047 
2 HIMED 6 26.417 3.3973 1.3869 
powder_e33.8 
1 SIGMA 6 30.033 1.3545 .5530 
2 HIMED 6 28.500 2.2352 .9125 
 
 
 
Independent Samples Testa 
 
Levene's Test for 
Equality of Variances t-test for Equality of Means 
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
powder_a4.32 Equal variances 
assumed 
.090 .770 .090 10 .930 .1333 1.4775 
Equal variances 
not assumed 
  .090 8.985 .930 .1333 1.4775 
powder_b5.78 Equal variances 
assumed 
.050 .827 .103 10 .920 .2000 1.9340 
Equal variances 
not assumed 
  .103 10.000 .920 .2000 1.9340 
powder_c7.76 Equal variances 
assumed 
.000 .990 .592 10 .567 .9833 1.6618 
Equal variances 
not assumed 
  .592 9.940 .567 .9833 1.6618 
powder_d12.03 Equal variances 
assumed 
.036 .854 .532 10 .606 1.0500 1.9740 
Equal variances 
not assumed 
  .532 9.998 .606 1.0500 1.9740 
powder_e33.8 Equal variances 
assumed 
.429 .527 1.437 10 .181 1.5333 1.0670 
Equal variances 
not assumed 
  1.437 8.236 .188 1.5333 1.0670 
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Test_measure = 2 GPa 
Group Statistics
a
 
 company N Mean Std. Deviation Std. Error Mean 
powder_a4.32 1 SIGMA 6 1.817 .6494 .2651 
2 HIMED 6 2.567 .5279 .2155 
powder_b5.78 1 SIGMA 6 2.083 .5076 .2072 
2 HIMED 6 1.867 .9309 .3801 
powder_c7.76 1 SIGMA 6 2.400 1.1524 .4705 
2 HIMED 6 2.650 .9050 .3695 
powder_d12.03 1 SIGMA 6 2.717 1.1161 .4556 
2 HIMED 6 2.850 .7007 .2861 
powder_e33.8 1 SIGMA 6 3.517 1.3848 .5653 
2 HIMED 6 2.433 .6121 .2499 
 
 
I 
 
independent Samples Test
a
 
 
Levene's Test for 
Equality of 
Variances t-test for Equality of Means 
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
powder_a4.32 Equal variances 
assumed 
.321 .584 -2.195 10 .053 -.7500 .3416 
Equal variances not 
assumed 
  -2.195 9.600 .054 -.7500 .3416 
powder_b5.78 Equal variances 
assumed 
6.485 .029 .501 10 .628 .2167 .4329 
Equal variances not 
assumed 
  .501 7.732 .631 .2167 .4329 
powder_c7.76 Equal variances 
assumed 
.021 .887 -.418 10 .685 -.2500 .5982 
Equal variances not 
assumed 
  -.418 9.468 .685 -.2500 .5982 
powder_d12.03 Equal variances 
assumed 
2.738 .129 -.248 10 .809 -.1333 .5380 
Equal variances not 
assumed 
  -.248 8.412 .810 -.1333 .5380 
powder_e33.8 Equal variances 
assumed 
1.336 .275 1.753 10 .110 1.0833 .6181 
Equal variances not 
assumed 
  1.753 6.882 .124 1.0833 .6181 
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Test_measure = 3 toughness 
Group Statistics
a
 
 company N Mean Std. Deviation Std. Error Mean 
powder_a4.32 1 SIGMA 6 1.200 .7348 .3000 
2 HIMED 6 .817 .3312 .1352 
powder_b5.78 1 SIGMA 6 .683 .4792 .1956 
2 HIMED 6 .750 .3886 .1586 
powder_c7.76 1 SIGMA 6 1.133 .6377 .2603 
2 HIMED 6 .550 .2258 .0922 
powder_d12.03 1 SIGMA 6 .833 .3830 .1563 
2 HIMED 6 .867 .1966 .0803 
powder_e33.8 1 SIGMA 6 .733 .3933 .1606 
2 HIMED 6 .667 .0816 .0333 
 
 
 
Independent Samples Test
a
 
 
Levene's Test for 
Equality of 
Variances t-test for Equality of Means 
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
powder_a4.32 Equal variances 
assumed 
3.471 .092 1.165 10 .271 .3833 .3291 
Equal variances not 
assumed 
  1.165 6.950 .282 .3833 .3291 
powder_b5.78 Equal variances 
assumed 
.358 .563 -.265 10 .797 -.0667 .2519 
Equal variances not 
assumed 
  -.265 9.590 .797 -.0667 .2519 
powder_c7.76 Equal variances 
assumed 
5.362 .043 2.112 10 .061 .5833 .2762 
Equal variances not 
assumed 
  2.112 6.235 .077 .5833 .2762 
powder_d12.03 Equal variances 
assumed 
3.616 .086 -.190 10 .853 -.0333 .1758 
Equal variances not 
assumed 
  -.190 7.465 .855 -.0333 .1758 
powder_e33.8 Equal variances 
assumed 
8.996 .013 .407 10 .693 .0667 .1640 
Equal variances not 
assumed 
  .407 5.430 .700 .0667 .1640 
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1.2: UNIANOVA result for different MCPM and β-TCP particle sizes for 
mechanical properties (MPa, GPa and toughness) 
 
company = 1 SIGMA, Test_measure = 1 MPa 
Custom Hypothesis Tests 
Contrast Results (K Matrix)
a
 
powder Polynomial Contrast
b
 
Dependent Variable 
result 
Linear Contrast Estimate 6.409 
Hypothesized Value 0 
Difference (Estimate - Hypothesized) 6.409 
Std. Error 1.127 
Sig. .000 
95% Confidence Interval for Difference Lower Bound 4.087 
Upper Bound 8.731 
 
 TCP powder Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 22.300 1.127 19.978 24.622 
2 22.667 1.127 20.345 24.989 
3 23.950 1.127 21.628 26.272 
4 27.467 1.127 25.145 29.789 
5 30.033 1.127 27.711 32.355 
 
Profile Plots 
 
159 
 
company = 1 SIGMA, Test_measure = 2 GPa 
 
Custom Hypothesis Tests 
Contrast Results (K Matrix)
a
 
powder Polynomial Contrast
b
 
Dependent 
Variable 
result 
Linear Contrast Estimate 1.275 
Hypothesized Value 0 
Difference (Estimate - Hypothesized) 1.275 
Std. Error .415 
Sig. .005 
95% Confidence Interval for Difference Lower Bound .420 
Upper Bound 2.130 
 
 
powder Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 1.817 .415 .962 2.672 
2 2.083 .415 1.228 2.938 
3 2.400 .415 1.545 3.255 
4 2.717 .415 1.862 3.572 
5 3.517 .415 2.662 4.372 
 
Profile Plots 
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company = 1 SIGMA, Test_measure = 3 toughness 
 
Custom Hypothesis Tests 
Contrast Results (K Matrix)
a
 
powder Polynomial Contrast
b
 
Dependent 
Variable 
result 
Linear Contrast Estimate -.248 
Hypothesized Value 0 
Difference (Estimate - Hypothesized) -.248 
Std. Error .222 
Sig. .275 
95% Confidence Interval for Difference Lower Bound -.705 
Upper Bound .209 
 
powder Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 1.200 .222 .743 1.657 
2 .683 .222 .226 1.140 
3 1.133 .222 .676 1.590 
4 .833 .222 .376 1.290 
5 .733 .222 .276 1.190 
 
Profile Plots 
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company = 2 HIMED, Test_measure = 1 MPa 
 
Custom Hypothesis Tests 
Contrast Results (K Matrix)
a
 
powder Polynomial Contrast
b
 
Dependent 
Variable 
result 
Linear Contrast Estimate 5.255 
Hypothesized Value 0 
Difference (Estimate - Hypothesized) 5.255 
Std. Error 1.214 
Sig. .000 
95% Confidence Interval for Difference Lower Bound 2.755 
Upper Bound 7.754 
 
powder Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 22.167 1.214 19.667 24.666 
2 22.467 1.214 19.967 24.966 
3 22.967 1.214 20.467 25.466 
4 26.417 1.214 23.917 28.916 
5 28.500 1.214 26.001 30.999 
 
Profile Plots 
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company = 2 HIMED, Test_measure = 2 GPa 
 
Custom Hypothesis Tests 
Contrast Results (K Matrix)
a
 
powder Polynomial Contrast
b
 
Dependent 
Variable 
result 
Linear Contrast Estimate .227 
Hypothesized Value 0 
Difference (Estimate - Hypothesized) .227 
Std. Error .307 
Sig. .467 
95% Confidence Interval for 
Difference 
Lower Bound -.406 
Upper Bound .859 
 
powder Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 2.567 .307 1.934 3.199 
2 1.867 .307 1.234 2.499 
3 2.650 .307 2.017 3.283 
4 2.850 .307 2.217 3.483 
5 2.433 .307 1.801 3.066 
 
 
Profile Plots 
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company = 2 HIMED, Test_measure = 3 toughness 
Contrast Results (K Matrix)
a
 
powder Polynomial Contrast
b
 
Dependent 
Variable 
result 
Linear Contrast Estimate -.058 
Hypothesized Value 0 
Difference (Estimate - Hypothesized) -.058 
Std. Error .109 
Sig. .600 
95% Confidence Interval for Difference Lower Bound -.283 
Upper Bound .167 
 
 
powder Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 .817 .109 .592 1.041 
2 .750 .109 .525 .975 
3 .550 .109 .325 .775 
4 .867 .109 .642 1.091 
5 .667 .109 .442 .891 
 
Profile Plots 
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Appendix 2 
 
2.1: Unianova for dry samples mechanical properties (MPa, GPA and toughness) with 
different PLR and increase wt % of PLS (MCPM 2, β-TCP 34 micron and CA 800 mM (n=6)) 
 
 
PLS_percentage = 1 PLS 0%, Test_measure = 1 MPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 17.763
b
 1 17.763 5.685 .038 
Intercept 11718.750 1 11718.750 3750.400 .000 
PLR 17.763 1 17.763 5.685 .038 
Error 31.247 10 3.125   
Total 11767.760 12    
Corrected Total 49.010 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 30.033 .722 28.425 31.641 
2 PLR 4:1 32.467 .722 30.859 34.075 
 
 
PLS_percentage = 1 PLS 0%, Test_measure = 2 GPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model .030
b
 1 .030 .024 .881 
Intercept 144.213 1 144.213 113.943 .000 
PLR .030 1 .030 .024 .881 
Error 12.657 10 1.266   
Total 156.900 12    
Corrected Total 12.687 11    
 
Dependent Variable:    
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 3.517 .459 2.493 4.540 
2 PLR 4:1 3.417 .459 2.393 4.440 
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PLS_percentage = 1 PLS 0%, Test_measure = 3 Toughness 
 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 3.741
b
 1 3.741 19.005 .001 
Intercept 20.021 1 20.021 101.715 .000 
PLR 3.741 1 3.741 19.005 .001 
Error 1.968 10 .197   
Total 25.730 12    
Corrected Total 5.709 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 .733 .181 .330 1.137 
2 PLR 4:1 1.850 .181 1.446 2.254 
 
 
PLS_percentage = 2 PLS 10%, Test_measure = 1 MPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 131.341
b
 1 131.341 34.411 .000 
Intercept 11712.501 1 11712.501 3068.644 .000 
PLR 131.341 1 131.341 34.411 .000 
Error 38.168 10 3.817   
Total 11882.010 12    
Corrected Total 169.509 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 27.933 .798 26.156 29.710 
2 PLR 4:1 34.550 .798 32.773 36.327 
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PLS_percentage = 2 PLS 10%, Test_measure = 2 GPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 2.001
b
 1 2.001 2.738 .129 
Intercept 103.841 1 103.841 142.086 .000 
PLR 2.001 1 2.001 2.738 .129 
Error 7.308 10 .731   
Total 113.150 12    
Corrected Total 9.309 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 2.533 .349 1.756 3.311 
2 PLR 4:1 3.350 .349 2.572 4.128 
 
 
PLS_percentage = 2 PLS 10%, Test_measure = 3 Toughness 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model .030
b
 1 .030 .307 .592 
Intercept 15.413 1 15.413 157.816 .000 
PLR .030 1 .030 .307 .592 
Error .977 10 .098   
Total 16.420 12    
Corrected Total 1.007 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 1.083 .128 .799 1.368 
2 PLR 4:1 1.183 .128 .899 1.468 
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PLS_percentage = 3 PLS 20%, Test_measure = 1 MPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 129.363
b
 1 129.363 11.064 .008 
Intercept 10138.453 1 10138.453 867.103 .000 
PLR 129.363 1 129.363 11.064 .008 
Error 116.923 10 11.692   
Total 10384.740 12    
Corrected Total 246.287 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 25.783 1.396 22.673 28.894 
2 PLR 4:1 32.350 1.396 29.240 35.460 
 
 
PLS_percentage = 3 PLS 20%, Test_measure = 2 GPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 7.841
b
 1 7.841 11.974 .006 
Intercept 101.501 1 101.501 155.003 .000 
PLR 7.841 1 7.841 11.974 .006 
Error 6.548 10 .655   
Total 115.890 12    
Corrected Total 14.389 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 2.100 .330 1.364 2.836 
2 PLR 4:1 3.717 .330 2.981 4.453 
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PLS_percentage = 3 PLS 20%, Test_measure = 3 Toughness 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 1.763
b
 1 1.763 2.718 .130 
Intercept 28.830 1 28.830 44.445 .000 
PLR 1.763 1 1.763 2.718 .130 
Error 6.487 10 .649   
Total 37.080 12    
Corrected Total 8.250 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 1.933 .329 1.201 2.666 
2 PLR 4:1 1.167 .329 .434 1.899 
 
 
PLS_percentage = 4 PLS 30%, Test_measure = 1 MPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 124.163
b
 1 124.163 32.663 .000 
Intercept 9086.003 1 9086.003 2390.215 .000 
PLR 124.163 1 124.163 32.663 .000 
Error 38.013 10 3.801   
Total 9248.180 12    
Corrected Total 162.177 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 24.300 .796 22.526 26.074 
2 PLR 4:1 30.733 .796 28.960 32.507 
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PLS_percentage = 4 PLS 30%, Test_measure = 2 GPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model .607
b
 1 .607 1.344 .273 
Intercept 118.441 1 118.441 261.941 .000 
PLR .607 1 .607 1.344 .273 
Error 4.522 10 .452   
Total 123.570 12    
Corrected Total 5.129 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 2.917 .275 2.305 3.528 
2 PLR 4:1 3.367 .275 2.755 3.978 
 
 
PLS_percentage = 4 PLS 30%, Test_measure = 3 Toughness 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model .853
b
 1 .853 2.498 .145 
Intercept 28.830 1 28.830 84.380 .000 
PLR .853 1 .853 2.498 .145 
Error 3.417 10 .342   
Total 33.100 12    
Corrected Total 4.270 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 1.283 .239 .752 1.815 
2 PLR 4:1 1.817 .239 1.285 2.348 
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PLS_percentage = 5 PLS 40%, Test_measure = 1 MPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 118.441
b
 1 118.441 12.307 .006 
Intercept 8634.968 1 8634.968 897.217 .000 
PLR 118.441 1 118.441 12.307 .006 
Error 96.242 10 9.624   
Total 8849.650 12    
Corrected Total 214.683 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 23.683 1.267 20.861 26.505 
2 PLR 4:1 29.967 1.267 27.145 32.789 
 
 
PLS_percentage = 5 PLS 40%, Test_measure = 2 GPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 1.080
b
 1 1.080 3.133 .107 
Intercept 103.253 1 103.253 299.574 .000 
PLR 1.080 1 1.080 3.133 .107 
Error 3.447 10 .345   
Total 107.780 12    
Corrected Total 4.527 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 2.633 .240 2.099 3.167 
2 PLR 4:1 3.233 .240 2.699 3.767 
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PLS_percentage = 5 PLS 40%, Test_measure = 3 Toughness 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model .141
b
 1 .141 .443 .521 
Intercept 21.068 1 21.068 66.215 .000 
PLR .141 1 .141 .443 .521 
Error 3.182 10 .318   
Total 24.390 12    
Corrected Total 3.322 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 1.433 .230 .920 1.946 
2 PLR 4:1 1.217 .230 .704 1.730 
 
 
PLS_percentage = 6 PLS 50%, Test_measure = 1 MPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 35.021
b
 1 35.021 3.379 .096 
Intercept 7345.801 1 7345.801 708.723 .000 
PLR 35.021 1 35.021 3.379 .096 
Error 103.648 10 10.365   
Total 7484.470 12    
Corrected Total 138.669 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 23.033 1.314 20.105 25.962 
2 PLR 4:1 26.450 1.314 23.521 29.379 
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PLS_percentage = 6 PLS 50%, Test_measure = 2 GPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model 1.333
b
 1 1.333 3.127 .107 
Intercept 68.163 1 68.163 159.883 .000 
PLR 1.333 1 1.333 3.127 .107 
Error 4.263 10 .426   
Total 73.760 12    
Corrected Total 5.597 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 2.050 .267 1.456 2.644 
2 PLR 4:1 2.717 .267 2.123 3.311 
 
 
PLS_percentage = 6 PLS 50%, Test_measure = 3 Toughness 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable:   score   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Corrected Model .003
b
 1 .003 .022 .886 
Intercept 32.670 1 32.670 211.228 .000 
PLR .003 1 .003 .022 .886 
Error 1.547 10 .155   
Total 34.220 12    
Corrected Total 1.550 11    
 
Dependent Variable:   score   
PLR Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 PLR 3.3:1 1.667 .161 1.309 2.024 
2 PLR 4:1 1.633 .161 1.276 1.991 
173 
 
Appendix 3 
 
3.1: Unianova for dry vs wet samples at PLR 4:1 and increase wt % of PLS on mechanical 
properties (MPa, GPA and toughness) (MCPM 2, β-TCP 34 micron and CA 800 mM (n=6)) 
 
PLS_percentage = 1 PLS 0%, Test_measure = 1 MPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 604.920
b
 1 604.920 61.484 .000 
Intercept 7721.613 1 7721.613 784.823 .000 
Sample_condition 604.920 1 604.920 61.484 .000 
Error 98.387 10 9.839   
Total 8424.920 12    
Corrected Total 703.307 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 32.467 1.281 29.613 35.320 
2 Wet samples 18.267 1.281 15.413 21.120 
 
 
PLS_percentage = 1 PLS 0%, Test_measure = 2 GPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 6.021
b
 1 6.021 9.636 .011 
Intercept 88.021 1 88.021 140.871 .000 
Sample_condition 6.021 1 6.021 9.636 .011 
Error 6.248 10 .625   
Total 100.290 12    
Corrected Total 12.269 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 3.417 .323 2.698 4.136 
2 Wet samples 2.000 .323 1.281 2.719 
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PLS_percentage = 1 PLS 0%, Test_measure = 3 Toughness 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 3.308
b
 1 3.308 21.832 .001 
Intercept 21.068 1 21.068 139.059 .000 
Sample_condition 3.308 1 3.308 21.832 .001 
Error 1.515 10 .152   
Total 25.890 12    
Corrected Total 4.823 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 1.850 .159 1.496 2.204 
2 Wet samples .800 .159 .446 1.154 
 
 
PLS_percentage = 2 PLS 10%, Test_measure = 1 MPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 597.841
b
 1 597.841 101.971 .000 
Intercept 9069.501 1 9069.501 1546.948 .000 
Sample_condition 597.841 1 597.841 101.971 .000 
Error 58.628 10 5.863   
Total 9725.970 12    
Corrected Total 656.469 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 34.550 .989 32.347 36.753 
2 Wet samples 20.433 .989 18.231 22.636 
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PLS_percentage = 2 PLS 10%, Test_measure = 2 GPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model .241
b
 1 .241 .413 .535 
Intercept 123.521 1 123.521 211.932 .000 
Sample_condition .241 1 .241 .413 .535 
Error 5.828 10 .583   
Total 129.590 12    
Corrected Total 6.069 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 3.350 .312 2.656 4.044 
2 Wet samples 3.067 .312 2.372 3.761 
 
 
PLS_percentage = 2 PLS 10%, Test_measure = 3 Toughness 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model .083
b
 1 .083 .454 .516 
Intercept 14.520 1 14.520 79.056 .000 
Sample_condition .083 1 .083 .454 .516 
Error 1.837 10 .184   
Total 16.440 12    
Corrected Total 1.920 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 1.183 .175 .793 1.573 
2 Wet samples 1.017 .175 .627 1.407 
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PLS_percentage = 3 PLS 20%, Test_measure = 1 MPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 465.007
b
 1 465.007 56.698 .000 
Intercept 8190.188 1 8190.188 998.621 .000 
Sample_condition 465.007 1 465.007 56.698 .000 
Error 82.015 10 8.202   
Total 8737.210 12    
Corrected Total 547.022 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 32.350 1.169 29.745 34.955 
2 Wet samples 19.900 1.169 17.295 22.505 
 
 
PLS_percentage = 3 PLS 20%, Test_measure = 2 GPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 2.803
b
 1 2.803 2.639 .135 
Intercept 125.453 1 125.453 118.092 .000 
Sample_condition 2.803 1 2.803 2.639 .135 
Error 10.623 10 1.062   
Total 138.880 12    
Corrected Total 13.427 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 3.717 .421 2.779 4.654 
2 Wet samples 2.750 .421 1.812 3.688 
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PLS_percentage = 3 PLS 20%, Test_measure = 3 Toughness 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model .403
b
 1 .403 6.798 .026 
Intercept 11.603 1 11.603 195.562 .000 
Sample_condition .403 1 .403 6.798 .026 
Error .593 10 .059   
Total 12.600 12    
Corrected Total .997 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 1.167 .099 .945 1.388 
2 Wet samples .800 .099 .578 1.022 
 
 
PLS_percentage = 4 PLS 30%, Test_measure = 1 MPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 492.801
b
 1 492.801 126.874 .000 
Intercept 7100.468 1 7100.468 1828.054 .000 
Sample_condition 492.801 1 492.801 126.874 .000 
Error 38.842 10 3.884   
Total 7632.110 12    
Corrected Total 531.643 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 30.733 .805 28.941 32.526 
2 Wet samples 17.917 .805 16.124 19.709 
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PLS_percentage = 4 PLS 30%, Test_measure = 2 GPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 1.080
b
 1 1.080 1.582 .237 
Intercept 112.853 1 112.853 165.313 .000 
Sample_condition 1.080 1 1.080 1.582 .237 
Error 6.827 10 .683   
Total 120.760 12    
Corrected Total 7.907 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 3.367 .337 2.615 4.118 
2 Wet samples 2.767 .337 2.015 3.518 
 
 
PLS_percentage = 4 PLS 30%, Test_measure = 3 Toughness 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 3.101
b
 1 3.101 15.595 .003 
Intercept 20.541 1 20.541 103.307 .000 
Sample_condition 3.101 1 3.101 15.595 .003 
Error 1.988 10 .199   
Total 25.630 12    
Corrected Total 5.089 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 1.817 .182 1.411 2.222 
2 Wet samples .800 .182 .394 1.206 
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PLS_percentage = 5 PLS 40%, Test_measure = 1 MPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 453.870
b
 1 453.870 86.638 .000 
Intercept 6806.803 1 6806.803 1299.339 .000 
Sample_condition 453.870 1 453.870 86.638 .000 
Error 52.387 10 5.239   
Total 7313.060 12    
Corrected Total 506.257 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 29.967 .934 27.885 32.049 
2 Wet samples 17.667 .934 15.585 19.749 
 
 
PLS_percentage = 5 PLS 40%, Test_measure = 2 GPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 1.841
b
 1 1.841 3.861 .078 
Intercept 96.901 1 96.901 203.217 .000 
Sample_condition 1.841 1 1.841 3.861 .078 
Error 4.768 10 .477   
Total 103.510 12    
Corrected Total 6.609 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 3.233 .282 2.605 3.861 
2 Wet samples 2.450 .282 1.822 3.078 
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PLS_percentage = 5 PLS 40%, Test_measure = 3 Toughness 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model .801
b
 1 .801 21.742 .001 
Intercept 11.021 1 11.021 299.208 .000 
Sample_condition .801 1 .801 21.742 .001 
Error .368 10 .037   
Total 12.190 12    
Corrected Total 1.169 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 1.217 .078 1.042 1.391 
2 Wet samples .700 .078 .525 .875 
 
 
PLS_percentage = 6 PLS 50%, Test_measure = 1 MPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 491.520
b
 1 491.520 81.042 .000 
Intercept 4824.030 1 4824.030 795.388 .000 
Sample_condition 491.520 1 491.520 81.042 .000 
Error 60.650 10 6.065   
Total 5376.200 12    
Corrected Total 552.170 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 26.450 1.005 24.210 28.690 
2 Wet samples 13.650 1.005 11.410 15.890 
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PLS_percentage = 6 PLS 50%, Test_measure = 2 GPa 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 3.308
b
 1 3.308 6.946 .025 
Intercept 57.641 1 57.641 121.052 .000 
Sample_condition 3.308 1 3.308 6.946 .025 
Error 4.762 10 .476   
Total 65.710 12    
Corrected Total 8.069 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 2.717 .282 2.089 3.344 
2 Wet samples 1.667 .282 1.039 2.294 
 
 
PLS_percentage = 6 PLS 50%, Test_measure = 3 Toughness 
 
Tests of Between-Subjects Effects
a
 
Dependent Variable: score 
Source Type III Sum of 
Squares 
df Mean Square F Sig. 
Corrected Model 3.000
b
 1 3.000 73.770 .000 
Intercept 15.413 1 15.413 379.016 .000 
Sample_condition 3.000 1 3.000 73.770 .000 
Error .407 10 .041   
Total 18.820 12    
Corrected Total 3.407 11    
 
Dependent Variable: score 
Sample_condition Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Dry samples 1.633 .082 1.450 1.817 
2 Wet samples .633 .082 .450 .817 
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Development of novel remineralising antimicrobial brushite cements 
Abstract: 
Background: Brushite cements have potential as drug carriers and bone filling 
materials. They can also act as a reservoir for calcium and phosphate ions in 
remineralisation of hard tissues.  
Objective: To optimize brushite cement properties and assess the effect of 
incorporation of a novel polymeric antimicrobial (PAM).  
Method: Cement powders were mixed with aqueous solutions at a powder to liquid 
ratio (PLR) of 3.3:1 or 4:1 to produce cement pastes and start the setting reaction. The 
powder consisted of 1g of monocalcium phosphate monohydrate (MCPM) and 1.23g of 
β - tricalcium phosphate (β-TCP). MCPM from two sources was employed (particles 
sizes of 53 and 65 micron). Additionally β-TCP particle size ranged from 4 to 34 
micron. The liquid phase was prepared by dissolving PAM powder (0, 10, 20, 30, 40 or 
50 wt%) in 800 mM aqueous citric acid. Biaxial Flexural strength was determined with a 
ball on ring jig and Instron frame. Setting kinetics and microstructure were examined 
using FTIR and SEM.  
Results: The viscosity of the brushite cements was advantageously lowered with 
MCPM of larger particle size. The largest particle size of β-TCP (34 micron) also gave 
cements of higher flexural strength (up to 30 MPa). Higher PLR increased strength by 5 
– 7MPa. High levels of PAM could be added with only a minor reduction in the strength 
however setting time was delayed and less brushite formed. Adding PAM resulted in a 
more homogenous and less porous structure.  
Conclusion: Brushite cement strength can be raised by optimising component particle 
size and raising powder content. High levels of PAM can be added without significant 
reduction in strength but the setting time is delayed and final brushite crystal 
microstructure altered.  
 
